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Due to the ever-growing requirement for chiral compounds, new conditions for
stereoselective synthesis are in constant development. Asymmetric organocataly-
sis is well-studied, with peptide catalysts popular due to their modular and highly-
functionalisable nature. One such example of their utility is in the Michael reaction,
a well-studied carbon-carbon bond forming reaction.
[2.2]Paracyclophane is an aromatic industrial precursor compound with remarkable
structural and electronic properties. Its conformational bulk and rigidity make it an
attractive target for integration into sterically-hindered unnatural amino acids for
incorporation into peptides that may be effective organocatalysts.
An updated route to 4-amino-13-[2.2]paracyclophane-carboxylic acid (Pca) was de-
veloped and optimised. The synthetic route comprises four steps with an overall
yield of 50%. This compares with previous routes which had yields between 7 and
48% for 6 - 7 steps. Peptide coupling conditions for the poorly-reactive Pca were
developed with some success; including devising a route for direct synthesis of a
glycine residue on Pca’s aniline. Four new Pca-containing peptides were described.
The above work sets the stage for development of interesting new planar chiral pep-
tide compounds with diverse chemistry.
Three Pca-containing peptides were studied as asymmetric organocatalysts in Michael
addition between trans-β-nitrostyrene and hexanal and were compared to proline,
a known catalyst for this reaction. These tests were performed to probe the rela-
tionship between relative conformation between the carboxylic acid and amine moi-
eties of the catalyst, and the catalyst’s stereoselectivity. The Pca-containing catalysts
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1.72 Nájera’s BINAM prolinamide catalyst in aldol reactions between ke-
tones and β-ketoesters. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
1.73 Generic Michael addition. . . . . . . . . . . . . . . . . . . . . . . . . . . 62
1.74 Takasu et al.’s aza-Michael addition to form tetrahydroisoquinoline
1.131 with asymmetric organocatalyst 1.130. . . . . . . . . . . . . . . . . 62
1.75 Phase-transfer-catalysed asymmetric aza-Michael addition in synthe-
sis of Letermovir 1.133. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
1.76 Iron(III)-salen complex catalysed asymmetric and regioselective thia-
Michael addition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
1.77 Michael addition in enantioselective synthesis of steroid precursor
cardenolide 1.137. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
1.78 Cu(OTf)2 as asymmetric catalyst in Michael addition in synthesis of
1.137. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
1.79 Asymmetric intramolecular Michael addition in the synthesis of lyco-
poserramine-Z with chiral phosphoric acid 1.138. . . . . . . . . . . . . 66
1.80 4-Amino[2.2]paracyclophane-13-carboxylic acid 1.141 . . . . . . . . . . 68
2.1 Pearson’s pseudopeptide 2.1 and analogous [2.2]paracyclophane pseu-
dopeptide 2.2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
2.2 Unnatural cyclic amino acids. . . . . . . . . . . . . . . . . . . . . . . . . 70
2.3 Ortho, pseudo-geminal, and pseudo-ortho substitution of Pca. . . . . . . 71
2.4 A β-turn-like conformation. . . . . . . . . . . . . . . . . . . . . . . . . . 71
2.5 Substitution patterns for disubstituted [2.2]paracyclophane. . . . . . . 72
2.6 Ma et al.’s synthesis of pseudo-ortho 4-amino[2.2]paracyclophane-12-
carboxylic acid. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
2.7 Pelter’s first synthesis of pseudo-geminal Pca. . . . . . . . . . . . . . . . 75
2.8 Pelter’s pseudo-geminal Pca synthesis via an oxazoline. . . . . . . . . . 76
2.9 Ma’s pseudo-geminal Pca synthesis via an oxazoline. . . . . . . . . . . . 77
xxiii
2.10 Oxime route for Pca synthesis. . . . . . . . . . . . . . . . . . . . . . . . . 79
2.11 Friedel-Crafts acylation of [2.2]paracyclophane. . . . . . . . . . . . . . 80
2.12 Acyl chloride formation with oxalyl chloride and catalytic DMF. . . . . 81
2.13 Methyl ester formation from acyl chloride. . . . . . . . . . . . . . . . . 82
2.14 Reiche formylation of 4-formyl[2.2]paracyclophane 2.13. . . . . . . . . 83
2.15 1H NMR spectrum of 2.19. . . . . . . . . . . . . . . . . . . . . . . . . . . 84
2.16 13-Formyl[2.2]paracyclophane-4-carboxylic acid 2.19. . . . . . . . . . . 85
2.17 Hydroxylamine condensation with 2.19, affording oxime product 2.20. 86
2.18 Mechanism for proposed Beckmann rearrangement to form amine. . . 86
2.19 Koser’s reagent 2.31. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
2.20 Oxime rearrangement to hydroxamic acid mediated by Koser’s reagent. 87
2.21 Proposed mechanism for Lossen-type rearrangement to amine via an
isocyanate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
2.22 Synthesis of 4-amino-13-bromo[2.2]paracyclophane 2.37. . . . . . . . . 89
2.23 Ester hydrolysis of Pca-OMe 2.21 to Pca 2.3. . . . . . . . . . . . . . . . . 90
2.24 Basic ester hydrolysis mechanism. . . . . . . . . . . . . . . . . . . . . . 90
2.25 Nitro route for synthesis of Pca. . . . . . . . . . . . . . . . . . . . . . . . 92
2.26 Methyl ester protection of carboxylic acid in nitro methodology. . . . . 93
2.27 Nitration of [2.2]paracyclophane. . . . . . . . . . . . . . . . . . . . . . . 94
2.28 Formylation of 4-nitro[2.2]paracyclophane. . . . . . . . . . . . . . . . . 95
2.29 Synthesis of 2.45. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
2.30 The C(H)=N peak region on the 1H NMR spectrum of 2.45. . . . . . . . 96
2.31 Pinnick oxidation of 2.39. . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
2.32 Oxidation mechanism of aldehyde 2.39 using Pinnick conditions. . . . 98
2.33 2-Methyl-2-butene as chlorine scavenger. . . . . . . . . . . . . . . . . . 98
2.34 Oxidation of aldehyde 2.39 using KMnO4. . . . . . . . . . . . . . . . . . 100
2.35 Acid/base work up procedure for aldehyde oxidation. . . . . . . . . . 101
2.36 Resolution of 2.48 by crystallisation of the cinchonine salt. . . . . . . . 103
2.37 Cinchonidine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
2.38 Attempted resolution of 2.40 with cinchonine. . . . . . . . . . . . . . . 104
2.39 Reduction of the aryl nitro group to the amine with zinc and ammo-
nium chloride. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
xxiv
2.40 Methyl ester protection of carboxylic acid via acyl chloride. . . . . . . . 108
2.41 Optimised route for synthesis of Pca. . . . . . . . . . . . . . . . . . . . . 109
2.42 Diastereomer formations for attempted resolution by recrystallisation
during Pca synthesis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
3.1 Model peptide structure design. . . . . . . . . . . . . . . . . . . . . . . . 111
3.2 Examples of potential peptide structures with variations at the N-
terminus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
3.3 Examples of potential peptide structures with variations at the C-
terminus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
3.4 Pca analogues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
3.5 Example 2,6-diaminobenzoic acid peptide derivative of 2,6-diaminotoluene
as Brønsted acid catalyst. . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
3.6 Coupling of N-pivaloyl valine to o-toluidine via benzotriazole ester. . . 115
3.7 Carbodiimide coupling reagents . . . . . . . . . . . . . . . . . . . . . . 116
3.8 Carbodiimide peptide coupling mechanism. . . . . . . . . . . . . . . . 117
3.9 Racemisation mechanism in oxazolone route. . . . . . . . . . . . . . . . 117
3.10 Example benzotriazole derivative additives. . . . . . . . . . . . . . . . 118
3.11 Formation of N-acylurea isomer. . . . . . . . . . . . . . . . . . . . . . . 118
3.12 Neighbouring group effect in HOAt. . . . . . . . . . . . . . . . . . . . . 118
3.13 Benzotriazole additives in peptide coupling with carbodiimides. . . . . 119
3.14 Attempted coupling conditions between N-pivaloyl valine and an-
thranilic acid’s nitrogen atom. . . . . . . . . . . . . . . . . . . . . . . . . 119
3.15 Attempted coupling between N-protected valine and 2,6-diaminotol-
uene. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
3.16 Boc protection of amino acids. . . . . . . . . . . . . . . . . . . . . . . . . 120
3.17 Attempted coupling between N-pivaloyl valine and 2,6-diaminotoluene
via acyl chloride. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
3.18 Attempted coupling between N-pivaloyl valine and 2,6-diaminotoluene
with peptide coupling reagents. . . . . . . . . . . . . . . . . . . . . . . . 121
3.19 Attempted coupling of N-pivaloyl valine to 3.23. . . . . . . . . . . . . . 121
3.20 Attempted coupling to N-pivaloyl chloride to 3.23. . . . . . . . . . . . . 122
xxv
3.21 Aminium-uronium salt peptide coupling reagents. . . . . . . . . . . . . 123
3.22 Peptide coupling mechanism with TBTU. . . . . . . . . . . . . . . . . . 123
3.23 Undesirable guanidino derivative formation. . . . . . . . . . . . . . . . 124
3.24 Pca-Phe synthetic scheme. . . . . . . . . . . . . . . . . . . . . . . . . . . 124
3.25 Phenylalanine coupling to [2.2]paracyclophane carboxylic acid 3.24
via acyl chloride 3.27. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
3.26 Acyl chloride formation mechanism with thionyl chloride. . . . . . . . 125
3.27 Diastereomers of Pca-containing dipeptide. . . . . . . . . . . . . . . . . 126
3.28 (RP,S)-3.25. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
3.29 X-ray crystal structure of (RP,S)-3.25. . . . . . . . . . . . . . . . . . . . . 127
3.30 H NMR spectra of 3.25. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
3.31 Reduction of nitro group to give Pca-Phe. . . . . . . . . . . . . . . . . . 129
3.32 Pseudo-dipeptide 3.26. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
3.33 Attempted coupling of amino acid to Pca-Phe’s N-terminus. R = L-
amino acid residue. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
3.34 Peptide bond formation (A) from mixed carbonic anhydrides and car-
bamate formed from side reaction (B). . . . . . . . . . . . . . . . . . . . 131
3.35 Chloroformate peptide coupling reagents. . . . . . . . . . . . . . . . . . 131
3.36 Mixed anhydride formation mechanism with ethyl chloroformate and
N-methylmorpholine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
3.37 Proposed synthetic scheme for tripeptide synthesis starting with Pca-
OMe. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
3.38 Nitrogen lone pair participation in aromatic resonance in Pca-OMe. . . 134
3.39 Orbital overlap in Pca-OMe. . . . . . . . . . . . . . . . . . . . . . . . . . 134
3.40 Tosylation of methyl 4-amino[2.2]paracyclophane-13-carboxylate 3.30. 135
3.41 Synthesis of triazene 3.33. . . . . . . . . . . . . . . . . . . . . . . . . . . 135
3.42 Carbonyldiimiazole. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
3.43 Active ester formation with CDI showing generation of an imidazole
molecule. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
3.44 Boc-valine coupling with aniline. . . . . . . . . . . . . . . . . . . . . . . 137
3.45 Pivaloyl amide formation with Pca. . . . . . . . . . . . . . . . . . . . . . 138
3.46 Amide coupling between Boc-proline and 4-amino[2.2]paracyclophane.138
xxvi
3.47 Peptide coupling between Boc-proline and Pca-OMe. . . . . . . . . . . 139
3.48 N-Hydroxysuccinimide (NHS). . . . . . . . . . . . . . . . . . . . . . . . 139
3.49 Peptide coupling mechanism between Boc-proline and Pca-OMe us-
ing DCC and NHS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
3.50 Possible neighbouring group effect between Pca-OMe and Boc-Pro-OSu.141
3.51 Boc-Pro-Pca-OMe, numbered. . . . . . . . . . . . . . . . . . . . . . . . . 142
3.52 Proline coupling to Pca compared with the Pca starting material. . . . 142
3.53 Proposed oxime reduction to methylamine 3.45. . . . . . . . . . . . . . 143
3.54 Proposed reductive amination with Boc-prolinal 3.46. . . . . . . . . . . 143
3.55 Reductive amination of Pca with benzaldehyde. . . . . . . . . . . . . . 144
3.56 Imine formation mechanism. . . . . . . . . . . . . . . . . . . . . . . . . 144
3.57 Reduction of the imine to complete reductive amination. . . . . . . . . 145
3.58 Proposed reaction between Boc-Pro-OTs 3.50 and Pca-OMe 3.30. . . . . 146
3.59 Methyl ester cleavage of Boc-Pro-Pca-OMe. . . . . . . . . . . . . . . . . 147
3.60 Mechanism of Boc cleavage with TFA. . . . . . . . . . . . . . . . . . . . 148
3.61 Pro-Pca 3.7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
3.62 H NMR spectrum of 3.7. . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
3.63 Synthetic scheme for mono-substituted 4-prolinamido[2.2]paracyclophane
from 4-nitro[2.2]paracyclophane. . . . . . . . . . . . . . . . . . . . . . . 151
3.64 Gly-Pca-OH 3.34, with its ethanamide moiety. . . . . . . . . . . . . . . 151
3.65 Synthetic route to Gly-Pca-OMe. . . . . . . . . . . . . . . . . . . . . . . 152
3.66 Mechanism of formation of 3.35. . . . . . . . . . . . . . . . . . . . . . . 152
3.67 Orbital diagram of the α-carbonyl bromide of 3.35 demonstrating the
orbital blending. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
3.68 Transformation of bromide 3.35 to azide 3.36. . . . . . . . . . . . . . . . 153
3.69 Reduction with triphenylphosphine following the Staudinger mecha-
nism. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
3.70 Reduction of the azide to the amine. . . . . . . . . . . . . . . . . . . . . 154
3.71 Gly-Pca 3.34. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
3.72 Attempted imine formation between Gly-Pca and camphor. . . . . . . 155
3.73 Coupling Boc-Pro-OSu 3.38 to Gly-Pca-OMe 3.39. . . . . . . . . . . . . 156
3.74 Deprotection of tripeptide 3.39. . . . . . . . . . . . . . . . . . . . . . . . 156
xxvii
3.75 1H NMR of Boc-Pro-Gly-Pca. . . . . . . . . . . . . . . . . . . . . . . . . 157
3.76 Delocalisation of nitrogen lone pair causing hindered rotation about
the amide bond. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
3.77 Attempted couplings between pseudo-tripeptide 3.40 and natural amino
acids. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
3.78 Isobutyl ester of Boc-Pro-Gly-Pca-OH. . . . . . . . . . . . . . . . . . . . 159
3.79 Coupling phenylalanine to the carboxylic acid of [2.2]paracyclophane
derivatives via the acyl chloride. . . . . . . . . . . . . . . . . . . . . . . 160
3.80 Acyl chloride formation with cyanuric chloride. . . . . . . . . . . . . . 160
3.81 Attempted coupling of Phe-OMe to Boc-Pro-Gly-Pca-OH. . . . . . . . . 161
3.82 Attempted coupling of glycine to Boc-Pro-Gly-Pca-OH 3.40. . . . . . . 162
3.83 Pseudopeptide 3.41. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
3.84 N-H region of the Pro-Gly-Pca spectrum in variable temperature 1H
NMR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
3.85 Synthesis of the mono 4-Pro-Gly-amido[2.2]paracyclophane. i) Zn,
NH4Cl ii) a. bromoacetyl bromide, b. NaN3, c. H2, Pd/C iii) Boc-Pro-
OSu iv) CF3COOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
3.86 Attempted synthesis of Gly-Pca-Phe. . . . . . . . . . . . . . . . . . . . . 164
3.87 Attempted amide coupling between Pca-Phe-OMe 3.44 and bromoacetyl
bromide. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165
3.88 Pca derivatives synthesised this project. . . . . . . . . . . . . . . . . . . 166
4.1 Asymmetric Michael addition between trans-β-nitrostyrene and hex-
anal. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
4.2 Mechanism of Michael addition between trans-β-nitrostyrene and hex-
anal catalysed by proline. . . . . . . . . . . . . . . . . . . . . . . . . . . 168
4.3 Syn product formation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
4.4 Aldehyde proton peak for the syn and anti diastereomers of 2-butyl-
4-nitro-3-phenylbutanal. . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
4.5 Major and minor syn product HPLC peaks. . . . . . . . . . . . . . . . . 171
4.6 Catalysts tested in asymmetric organocatalysed Michael addition. . . . 172
4.7 Newman projections of Michael addition with DL-proline catalyst. . . . 173
xxviii
4.8 Syn and anti transition states in Wennemers’ anti-selective Michael ad-
dition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176
4.9 Possible configurations of the enamine intermediate. . . . . . . . . . . 177
4.10 Computational model of RP,S-Pro-Gly-Pca. . . . . . . . . . . . . . . . . 178
4.11 Computational model of SP,S-Pro-Gly-Pca. . . . . . . . . . . . . . . . . 178
4.12 Computational model of RP,S-Pro-Pca. . . . . . . . . . . . . . . . . . . . 179
4.13 Computational model of SP,S-Pro-Pca. . . . . . . . . . . . . . . . . . . . 180
4.14 R-group functionalisation of glycine. . . . . . . . . . . . . . . . . . . . . 182
4.15 Wennemers’ N-alkylated tripeptide and a Pca analogue. . . . . . . . . . 183
4.16 Acyl fluoride activation for peptide coupling with Pca-OMe. . . . . . . 184
4.17 Synthesis of thioether 4.10. . . . . . . . . . . . . . . . . . . . . . . . . . . 184
4.18 Exemplar sulfide-catalysed asymmetric bromolactonisation. . . . . . . 185
xxix
List of Tables
2.1 Conditions tested for ester hydrolysis of Pca-OMe 2.21. . . . . . . . . . 91
4.1 Results of asymmetric Michael addition between trans-β-nitrostyrene









ATR attenuated total reflectance
aq. aqueous
approx. approximately






































HATU hexafluorophosphate azabenzotriazole tetramethyl uronium
HBTU hexafluorophosphate benzotriazole tetramethyl uronium
HOAt 1-hydroxy-7-azabenzotriazole
HOBt hydroxybenzotriazole
HOMO highest occupied molecular orbital
HPLC high-performance liquid chromatography



















ppm parts per million
Rf retention factor
ROESY rotating frame overhauser effect spectroscopy
RSM returned starting material
RT room temperature















1.1 [2.2]Paracyclophane: a peculiar pro-planar chiral compound
The cyclophanes are a class of polycyclic hydrocarbons with one or more aryl rings
joined by hydrocarbon chains of varying length. Examples are shown in Figure 1.1.
Among them, [2.2]paracyclophane (1.1) is a cyclophane with peculiar properties
arising from its rather disfavoured conformation. Two ethyl bridges link the two
aryl rings with para substitution, holding them stacked face-to-face. This gives rise
to great steric strain and rigidity, and π-π transannular electronic interactions. These
properties give [2.2]paracyclophane its range of useful and interesting applications,
for instance in polymeric surface films and coatings,1,2 optoelectronic materials,3–6
and asymmetric catalysis.7–10
FIGURE 1.1: Cyclophanes. 1.1 [2.2]paracyclophane, 1.2 [2.2]metacy-
clophane, 1.3 dracophane, a natural metacyclophane isolated from
Dracaena cinnabari Balf,11 1.4 [8]Paracyclophane.
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1.1.1 [2.2]Paracyclophane structure
[2.2]Paracyclophane’s structure (Fig. 1.2) with its “bent and battered”12 benzene
rings gives it unique properties. The rings are held within each other’s van der Waals
radii giving them a shared π-electron system. The ethylene groups that bridge the
two benzene rings are longer than a normal C-C single bond (1.63 Å compared with
1.54 Å). The bond angles of these four bridging carbon atoms, at 114.5°, are also
wider than an ideal tetrahedral bonding angle of 109.5°.13 The rings are not truly
eclipsing, but rather rotate about 5° in plane.14 They are deformed into a shallow
boat-like conformation due to the large amount of strain, rather than being perfectly
parallel and planar as most (including Figure 1.1) diagrammatic representations sug-
gest. The HOMO of [2.2]paracyclophane is higher than the analogous alkylbenzene,
which one on hand increases its reactivity.15 On the other hand, [2.2]paracyclophane
can be resistant to some transformations, due to its buckled structure, steric effects
and its unique π-π interactions.
FIGURE 1.2: Models of [2.2]paracyclophane showing the boat-like
structure and twist.
The proximity of [2.2]paracyclophane’s aryl rings prevents rotation of the rings around
the axis between the carbon atoms attached to the ethylene bridges without bond
breaking. This gives [2.2]paracyclophane higher rigidity than similar cyclophanes.
In cyclophanes with meta bridging substitutions or longer bridging alkyl chains, for
example [4.4]paracyclophane (1.5, Fig. 1.3), the rings may freely rotate about their
axes, so their conformation is less rigidly defined.
The rigid structure of [2.2]paracyclophane allows a high degree of control over the
conformation of its derivatives. Chemical moieties may be arranged in space with
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FIGURE 1.3: [4.4]Paracyclophane 1.5.
precise design in a number of substitution patterns. The common nomenclature for
the substitution patterns of disubstituted [2.2]paracyclophane compounds is shown
in Figure 1.4. Certainly, higher levels of substitution are also possible, however it is
unnecessary to discuss these here since this project deals only in mono- or disubsti-
tuted [2.2]paracyclophane compounds. Depending on the desired derivative, some
substitution patterns are more accessible than others.16
Aryl directing effects apply to [2.2]paracyclophane substitutions, however due to
its unique electronic properties there are some unexpected differences. For example,
the nitro group is a meta-directing group due to its electron withdrawing nature; thus
we expect meta- or pseudo-meta electrophilic aromatic substitutions to occur. As il-
lustrated in Chapter 2, formylation of 4-nitro[2.2]paracyclophane selectively occurs
instead at the pseudo-geminal position. This is due to transannular electronic effects,
as well as the nitro group’s ability to abstract a proton, facilitating the final restora-
tion of aromaticity.
FIGURE 1.4: Substitution patterns for disubstituted [2.2]paracyclo-
phane. Numbering is explained in Figure 1.11.
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Transannular electronic effects are the interaction of π-electrons between the two
aryl decks due to their close proximity in space.17,18 Electron-withdrawing groups
on one deck, which would be meta-directing on a single aromatic ring, may direct
to the corresponding pseudo-meta or pseudo-geminal position on the opposing ring;
similarly electron-donating groups on one deck will encourage pseudo-ortho and
pseudo-para substitution on the opposite deck. The electrons of the two aryl rings
exhibit transannular delocalisation through overlap of their orbitals. It helps explain
some of the interesting reactivity and properties [2.2]paracyclophane possesses, such
as increased reactivity to some processes and decreased reactivity to others.19,20
There is also some evidence to suggest that substituents on one deck can sterically
hinder substitution on the opposing deck of [2.2]paracyclophane.21 These effects
must be taken into consideration when designing a synthetic route; however, trial
and error often prevails.
Under normal circumstances, the [2.2]paracyclophane regioisomers do not intercon-
vert. However, the ethylene bridges of [2.2]paracyclophane will cleave above 200°C
to give a diradical species that permits substituted examples to undergo regioiso-
merisation. The bridge-cleaving rotational isomerisation is a useful way of generat-
ing regioisomers, particularly where one isomer is difficult to form or isolate.
An example of the utility of this regioisomerisation is the formation of 4,12-dibromo-
[2.2]paracyclophane (1.7) which is usually synthesised via the 4,16-dibromo-[2.2]-
paracyclophane (1.6) regioisomer. Thermal isomerisation at 230°C gives a 50:50
mixture of the pseudo-para and pseudo-ortho isomers; the pseudo-para dibromo-
[2.2]paracyclophane regioisomer is highly insoluble and may be separated from the
reaction mixture by recrystallisation. This leaves the mother liquor enriched with
4,12-dibromo-[2.2]paracyclophane. This recrystallisation and thermal isomerisation
process may be repeated several times to give reasonable (around 70%) yields of the
desired pseudo-ortho regioisomer. The synthesis of PhanePhos (1.8) proceeds in this
manner (Scheme 1.5).22,23
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SCHEME 1.5: Synthesis of PhanePhos: i) Br2/Fe. ii) Diglyme, heat.
iii) a. t-BuLi; b. MgBr ·OEt2; c. Ph2P(O)Cl. iv) HSiCl3, 140°C.
1.1.2 Synthesis of [2.2]paracyclophane
[2.2]Paracyclophane was first described in 1949 by Brown and Farthing, who iso-
lated it as a dimerisation product from the pyrolysis of p-xylene.13 They suspected
that “the strained system may only be formed under drastic pyrolysis conditions
and low pressures”. However, perhaps unsurprisingly, only two years later Cram
and Steinberg reported the “standard organic synthesis” of the molecule, which had
gained interest due to its suspected electronic and aromatic properties.24
This first synthetic route (Scheme 1.6) involved bromomethylation of 1,2-diphenyl-
ethane (1.9) followed by intramolecular Wurtz coupling to give [2.2]paracyclophane
(1.1) with an overall yield of 49%.
SCHEME 1.6: Cram and Steinberg’s synthesis of [2.2]paracyclophane:
i) HBr, 1,3,5-trioxane. ii) Na.
Another synthetic route to [2.2]paracyclophane uses Hofmann elimination, described
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in 1960 by Winberg et al. (Scheme 1.7).25 This route is quite low-yielding (17%), how-
ever, since the main product is poly(p-xylene), also known as parylene.
SCHEME 1.7: Weinberg et al.’s 1,6-Hofmann elimination route to
[2.2]paracyclophane.
Other synthetic routes used include sulfur-photoextrusion of dithiaphane 1.10 (Scheme
1.8) and regiospecific syntheses of polysubstituted [2.2]paracyclophanes based on
Winberg’s method.26,27 The synthesis of [2.2]paracyclophane for study of its deriva-
tives is unnecessary, however, since it is available cheaply in bulk from industrial
suppliers due to its use in functionalised electronics coatings.28
SCHEME 1.8: Preparation of [2.2]paracyclophane by sulfur photoex-
trusion.
1.1.3 Planar chirality
Most [2.2]paracyclophane derivatives are planar chiral, with certain exceptions, such
as meso compounds like 4,5- or 4,13- or 4,16-dibromo[2.2]paracyclophane (Fig. 1.9),
where the internal mirror plane or rotation axis of the identical substituents intro-
duces symmetry.
Planar chirality is derived from two elements that are held out-of-plane with re-
stricted rotation about the bridging bond or bonds.29 The most well-known exam-
ples of planar chirality in chemistry are based on metal-organic complexes such as
ferrocene or η6-metal aryl complexes, examples of which are shown in Figure 1.10.30
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FIGURE 1.9: Meso dibromo-[2.2]paracyclophane regioisomers. 1.11:
4,5-; 1.12: 4,13-; 1.6: 4,16-.
FIGURE 1.10: Planar chiral metallocenes based on ferrocene (left) and
(η6-arene)chromium.
8 Chapter 1. Introduction
Planar chirality is assigned using the designators RP and SP using the same general
method as assigning an asymmetrical carbon atom with the Cahn-Ingold-Prelog pri-
ority rules (CIP rules). For [2.2]paracyclophane, the more highly-substituted aryl
ring will be treated as the chiral plane. The closest out-of plane carbon atom to the
chiral plane is designated as the pilot atom (labelled “1” in Fig. 1.11). Where two or
more candidates exist, the atom closest to the highest priority group according to the
CIP rules is chosen (“X” in Fig. 1.11). Viewing the molecule from the pilot atom, the
three closest adjacent atoms in the chiral plane will be clockwise in an RP molecule
and anticlockwise in an SP molecule.31
FIGURE 1.11: Atom numbering and stereochemical assignment of
[2.2]paracyclophane molecules.
It is also possible to assign [2.2]paracyclophane compounds M/P based on a sense of
helicity. This work will use RP and SP designations in accordance with the bulk of
the [2.2]paracyclophane literature.
Most research on the effect of planar chirality on stereoselective processes has fo-
cused on ferrocene and other aromatic transition metal complexes.32,33 [2.2]Paracy-
clophane offers an alternative to these organometallic complexes due to its more
robust nature. It is not as sensitive to atmosphere or harsh reagents and conditions.
It offers the additional distinction that ferrocene and η-6 aryl complexes require 2 or
more substituents on a single ring to be chiral, whereas [2.2]paracyclophane requires
one (Fig. 1.12). This can also be considered a disadvantage for [2.2]paracyclophane,
as a directing group on the metallocene ring may be used to make a single enan-
tiomer. In the synthesis of enantiopure [2.2]paracyclophane compounds, the addi-
tion of the first substituent must be controlled, or else the two enantiomers must be
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resolved. The former is hard, while the latter is wasteful.
FIGURE 1.12: Structural similarity of ferrocene (left) and [2.2]paracy-
clophane (right)
The utility of [2.2]paracyclophane’s planar chirality is widely studied; of course
to investigate chirality one must first separate stereoisomers. [2.2]Paracyclophane
derivatisation reactions do not occur stereospecifically but form mixtures of the RP
and SP enantiomers. Selective derivatisation of unsubstituted [2.2]paracyclophane
is highly sought-after but currently, to the best of our knowledge, unattained. The
situation becomes more complicated when another chiral entity is introduced to
[2.2]paracyclophane; for instance, in the case of the DL-phenylalanine coupling with
[2.2]paracyclophane-4-carboxylic acid (Fig. 1.13). The resulting amide 1.13 now ex-
ists as 4 stereoisomers: SP,R, RP,S, SP,S, and RP,R.
FIGURE 1.13: Diastereomers and enantiomers of 1.13.
The formation of mixtures of stereoisomers is undesirable as this leads to challenging
separation and lower yields. A better strategy is to selectively form only the desired
stereochemistry of the compound to limit wasted material and time spent resolving
the stereoisomers. In some cases, the diastereomers can have different reactivities,
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which can be helpful if trying to isolate one particular stereoisomer, or a hindrance
if more than one is required. It can further increase the complexity of the mixture of
products obtained which potentially makes separation more problematic.
An example of reactivity differing between diastereomers is in Bolm’s palladation
of oxazolines (RP,S)-1.14 and (SP,S)-1.14, which resulted in metal insertion at dif-
ferent locations depending on the diastereomer (Scheme 1.14).34 Bolm separates the
oxazoline diastereomers before formation of the Pd complexes, which may indicate
that these regioisomers are difficult to separate. It is considered ideal to complete as
many transformations as possible before separating isomers, otherwise every step
after resolution must be performed twice.
SCHEME 1.14: Differing regioselectivity depending on stereochem-
istry in palladation of oxazolines. i) Pd(OAc)2, AcOH.
Ligands with two or more chiral elements have the possibility of co-operation or
antagonism between them, resulting in differing activities between diastereomers,
such as observed with [2.2]paracyclophane with Bräse’s chiral ketimines (1.15 and
1.16), Hou’s chiral oxazolines (1.17), and Bolm’s oxazoline palladium complexes
(1.14, Scheme 1.14).34–37 Similar systems have been investigated in Nájera’s BINAM
catalysts (1.18) or in the ferrocene-analogue ruthenocenylbisphosphines (1.19) (Fig.
1.15).38,39
These studies suggested varying importance of the planar chiral elements of their
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FIGURE 1.15: Diastereomeric ligand and catalyst examples.
systems. In asymmetric catalysts with more than one chiral element, the diastere-
omer of the catalyst giving the best performance does so due to a cooperative effect
between the chiral elements, since these groups are arranged in space differently de-
pending on their absolute configuration. Diastereomers with complementary stere-
ochemistry give better yields and selectivities.
For Bräse’s ketimine compounds 1.15 and 1.16,36 the compounds with complemen-
tary chirality (SP,S) had better yield and selectivity in enantioselective addition of
diethylzinc to aldehydes than its RP,S diastereomer (Scheme 1.16). The reaction
mechanism involves formation of a complex between the zinc and the [2.2]para-
cyclophane ligand. They found that the difference in side chain between 1.15 and
1.16 influenced the stereochemical outcome of the product, with 1.15 giving in gen-
eral better enantioselectivity, probably due the additional steric bulk of the phenyl
group. The RPS diastereomers had lower catalyst activity, pointing to a decreased
affinity for the substrate in the catalyst binding pocket. Bräse found that the planar
chiral element had a decisive effect on product configuration, with the RP and SP
giving reciprocal stereochemical outcomes in the reaction product regardless of the
point chirality.
Hou’s oxazoline compounds (1.17) were tested in the same diethylzinc addition reac-
tion as Bräse’s, albeit with a higher catalyst loading (5 mol %).37 They found similar
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SCHEME 1.16: Bräse’s ketimine ligands in asymmetric diethylzinc ad-
dition of aldehydes. i) Zn(C2H5)2, 1 mol % 1.15 or 1.16.
results, where there was a clear difference in activity and selectivity between the cat-
alysts with complementary stereochemistry ((RP,R), giving the R product) and those
with antagonistic stereochemistry. The catalyst with the best selectivity had a bulky
benzyl R group on the side chain, echoing Bräse’s results. Hou tested an additional
variable in the reaction where the configuration of the point chiral side chain was
reversed; in these reactions, it was the (SP,S) diastereomer that gave better yield and
ee (of the S product). The absolute chirality of either chiral element was less impor-
tant than the relative configuration between them; either enantiomer of the alcohol
product of the reaction may be obtained by using the corresponding catalyst.
In Nájera’s examination of asymmetric aldol condensation catalysed by prolinamide
BINAM derivatives (discussed further in Section 1.4, Scheme 1.72), one diastereomer
(Sa,R-1.18) gave better enantioselectivity than the other (Sa,S) (64% ee (S) vs. 32% ee
(R) in aldol reaction with acetone and 2-phenyl-2-oxoacetate, Scheme 1.17).38 Com-
putational models showed that Sa,R-1.18 gave a greater difference in steric hindrance
between phenyl group of the substrate and the binaphthyl portion of the catalyst,
favouring formation of the less hindered enantiomer more heavily. The stereoiso-
mers with opposite axial configuration (Ra,s and Ra,R) were not tested; it would be
interesting to see if, as for the [2.2]paracyclophane compounds described above, the
bulky binaphthyl element had a greater effect on ee than the point chiral prolines.
1.1.4 Resolution
There are several methods for resolving enantiomers of [2.2]paracyclophane com-
pounds. Not all methods will be discussed here, but examples will be given of
derivatisation; salt formation; and chromatographic methods such as flash chro-
matography and HPLC. All these methods tend to involve some trial and error to
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SCHEME 1.17: Nájera’s BINAM prolinamide catalyst in aldol re-
actions between ketones and β-ketoesters. i) 20 mol % 1.18,
ClCH2CO2H.
find a suitable or optimal resolution. Additionally, one must consider that if both
enantiomers, or several diastereomers, are desired, the earlier in a synthetic pathway
the separation is performed, the more synthetic steps must be performed multiple
times - once for each stereoisomer. If all stereoisomers are not required then material
is wasted.
Kinetic resolution
Kinetic resolution is an attractive option but is not widely applicable. In kinetic res-
olution, an asymmetric catalyst is used in the reaction of a racemic starting material
to give a single enantiomer of product while the other enantiomer is returned as
starting material. The name kinetic resolution refers to its utilisation of differing rates
of reaction of each enantiomer due to differing transition state energies with a chiral
catalyst. It relies on one enantiomer reacting faster than the other and this leads to
two different compounds. This makes separation easier; it also gives two different
enriched enantiomers. It is an efficient way of preparing a single enantiomer if only
one is required.
Kinetic resolution relies on one enantiomer reacting faster than the other to give two
separable products. The efficiency can be measured by krel, which is a measure of the
difference in rate of reaction of one enantiomer compared to the other. For krel > 1,
14 Chapter 1. Introduction
kinetic resolution can theoretically give a high % ee of the recovered starting material
at the expense of yield: as the reaction time goes on longer, more of the enantiomer
which reacts at a slower rate will be converted. For the product, high ee can only be
obtained with a very high krel since with low krel there will almost immediately be
some small conversion of the undesired enantiomer of the product.
Kinetic resolution is useful in situations where a very high ee is required; where
the racemic substrate and catalyst are readily prepared or accessible; and where the
starting material and product are easily separated. Common kinetic resolution re-
actions in synthetic chemistry include acylation of alcohols, epoxidation of alkenes,
ring-closing metathesis, and many other examples.40–45
For example, enantiomerically pure PhanePhos may be produced by kinetic reso-
lution; interestingly, using PhanePhos itself as a ligand. The RP enantiomer of the
racemic pseudo-ortho dibromo[2.2]paracyclophane precursor 1.17 may be selectively
prepared by Buchwald-Hartwig amination, giving a mixture of products including
the SP-benzylamine 1.20, R = Br, and RP-1.17, with the SP enantiomer reaction 3-4
times faster than the RP enantiomer (Scheme 1.18). The RP-1.17 is then separated by
chromatography.46
SCHEME 1.18: Kinetic resolution of 1.17. i) BnNH2, NaOt-Bu, (S)-
PhanePhos, Pd2dba3.
Chromatography
Column chromatography using silica or alumina gel is a more appealing method
for resolving diastereomers which have different Rf values. Chiral chromatogra-
phy may be used to separate enantiomers with a chiral stationary phase. This can
be limited by suitability of the chiral stationary phase available, and/or the HPLC
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throughput capacity; but this is still the most common method of isolating enan-
tiomerically pure 4,12-dibromo[2.2]paracyclophane 1.17- the other being the kinetic
resolution described above.47
Recrystallisation
Resolution by recrystallisation of diastereomers is another advantageous option if
both the RP and SP forms of the compound are needed, and if the two diastereomers
have different solubilities. It is particularly attractive if diastereomers can be formed
through making a salt with a chiral partner, since it is trivial to form and neutralise
salts. Derivatives of [2.2]paracyclophane tend to be crystalline because [2.2]para-
cyclophane’s shape and aryl decks encourage regular stacking. Pye and Rossen’s
original synthesis of PhanePhos involved selective crystallisation of diastereomeric
salts formed between tartaric acid and the phosphine oxide.22
Resolution using recrystallisation can also be achieved with chiral auxiliaries, cova-
lently adding a stereogenic centre. Enantiopure 4-hydroxy[2.2]paracyclophane may
be prepared via diastereomeric esters, using the chiral auxiliary (1S)-camphanoyl
chloride (1.21) or (S)-naproxene acid chloride (1.22) (Fig. 1.19) or the imine 1.23 with
chiral auxiliary (R)-1-phenylethylamine (Fig. 1.20).48–51 The diastereomers in each
case are separated by fractional recrystallisation giving de of >98% in each case and
between 14 and 22% yield.
FIGURE 1.19: Diastereomeric esters of 4-
hydroxy[2.2]paracyclophane.
1.1.5 [2.2]Paracyclophane in asymmetric catalysis
[2.2]Paracyclophane’s planar chirality makes it an attractive scaffold for asymmet-
ric catalysis. PhanePhos (1.8) is a ligand for hydrogenation and is one of the most
commonly-used [2.2]paracyclophane-centred asymmetric ligands (Fig. 1.21). This
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FIGURE 1.20: Diastereomeric imine for resolution of 4-
hydroxy[2.2]paracyclophane.
is due to its excellent selectivity compared with other similar catalysts.22 Pye and
Rossen demonstrated that PhanePhos performs well in challenging transformations
that similar rhodium bisphosphine catalysts achieved only moderate enantioselec-
tivities under harsh conditions.
SCHEME 1.21: PhanePhos-Rh complex catalysed hydrogenation.
In an example reduction of tetrahydropyrazine 1.25 to give the HIV drug Crixivan
precursor 1.26, BINAP (1.27) gave 56% ee and Et-DuPHOS (1.28) gave 50% ee with
strong conditions (70 bar, 40 °C, 24 hours); PhanePhos 1.8 performed the same re-
duction under milder conditions (1.5 bar, -40°C, 6 hours) with 86 % ee (Scheme 1.22).
Bräse’s [2.2]paracyclophane catalysts have been discussed above (Section 1.1.3) as
interesting examples of [2.2]paracyclophane compounds that contain planar and
point chirality. They are efficient catalysts with 1.15 (R=Ph) performing enantios-
elective addition of diphenylzinc to imines via an imine precursor (Scheme 1.23, top
reaction). The best example gave the product where R = 4-Me in 99% yield and 94%
ee with 5 mol % catalyst loading.
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SCHEME 1.22: PhanePhos in asymmetric hydrogenation of the Crixi-
van precursor 1.25.
SCHEME 1.23: Bräse’s bidentate ligands for asymmetric catalytic aryl
transfer and conjugate addition.
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Ligand 1.16 (R=Me) performs well in an enantioselective copper-free conjugate ad-
dition of organozinc compounds to α,β-unsaturated aldehydes (Scheme 1.23, lower
reaction) with low catalyst loading (2 mol %). Addition to cinnamaldehyde (R1 =
Ph, R2 = H) with diethylzinc and SP,S-1.16 gave 46% of the (R) 1,4-product with 97%
ee. The RP,S-1.16 gave the (S) 1,4-product with 43% yield and 98% ee, again showing
the important of the planar chiral element of the catalyst in determining the config-
uration of the product.
Glatzhofer’s salicylidene [2.2]paracyclophane ligand 1.29 was effective for copper-
-catalysed cyclopropanation with very low catalyst loadings (0.1 mol %).52 In a re-
action between styrene and ethyl diazoacetate, 1.29 gave 93% conversion in a 1.9:1
trans/cis ratio; the trans isomer has 76% ee and the cis isomer had 61% ee (Scheme
1.24).
SCHEME 1.24: Glatzhofer’s cyclopropanation.
This compares favourably with Nozaki’s analogous ligand 1.30, which gave 72%
yield of a 2:1 trans/cis ratio and 6% ee of each isomer in the same reaction.53 The
[2.2]paracyclophane ligand gives better enantiomeric excess due to the hindered ro-
tation between the imine methyl group and the [2.2]paracyclophane scaffold. This
makes a more structurally rigid binding pocket around the catalytic copper centre
which is more sterically demanding.
These examples illustrate how [2.2]paracyclophane, with its unique structural prop-
erties, is an excellent planar chiral scaffold for asymmetric catalysts. The selectivities
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FIGURE 1.25: Nozaki ligand 1.30 for cyclopropanation.
and yields of these examples indicate that [2.2]paracyclophane-based asymmetric
catalysts are a worthwhile target for further development.
1.2 Unnatural amino acids
1.2.1 Terminology
The term amino acid is generally accepted to refer to the 20 “canonical” amino acids
that are encoded by DNA. These are composed of an amine, a carboxylic acid, and
a side chain, or R group, all attached to the same, central tetrahedral carbon atom.
All of these ”natural” amino acids, with the exception of glycine, whose R group
is simply -H, have a stereocentre at the central α-carbon (Fig. 1.26, 1.31). The R
group determines the identity and function of the amino acid, and these vary from
short alkyl chains to functionalised side chains such as glutamic acid, which has a
carboxylic acid; asparagine, which has an amine; histidine, which has an imidazole;
and phenylalanine, which contains an aryl ring. The natural amino acid proline
(1.32) is a special case in which the R group forms a ring linking to the α-N.
Technically, any molecule containing an amine and a carboxylic acid, no matter how
many other atoms and/or functional groups are present, might be considered an
amino acid. A slightly narrower definition refers to all such amino acids found in
biological systems, including those that are not coded by DNA: some amino acids
may undergo additional structural modifications (for example, 4-hydroxyproline,
1.33), or post-translational modifications (for instance, glycosylation or acylation)
after incorporation into peptides. Somewhere between natural and unnatural amino
acids exist a vast array of biologically created molecules that are non-proteinogenic:
for instance, γ-aminobutyric acid (1.34), a neurotransmitter, and folic acid (1.35), a B
vitamin.
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FIGURE 1.26: Examples of natural and unnatural amino acids.
The term unnatural amino acid will refer to synthetic molecules which resemble a nat-
ural amino acid but with side-chain (1.36) or backbone (1.37) modifications, rather
than any molecule that contains both amine and carboxylic acid functional groups.54,55
This review will focus on a few synthetic unnatural amino acids that have clear rel-
evance to this project.
1.2.2 Unnatural cyclic amino acids
The synthesis, characteristics, and utility of cyclic amino acids will be discussed
here, as they restrict conformational freedom; something the target of this project
will also do, albeit while differing from these examples in many ways. Proline is the
only canonical cyclic amino acid. This gives it a number of powerful functions, like
manipulating the conformation of amide bonds in peptide secondary structure, for
instance causing the important hairpin turn structural motif. Proline residues func-
tion prevalently as a catalytic site in enzymes and synthetic catalysts. Chemists have
wanted to mimic these properties, so many cyclic unnatural amino acids have been
produced, too.
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There are many unnatural cyclic amino acids; and similarly innumerable ways to
make them. Three examples have been chosen which show the variety of synthetic
approaches available and their utility. These examples are all fundamentally differ-
ent to the unnatural amino acids synthesised for this project; the closest example to a
[2.2]paracyclophane containing amino acid is the ferrocene-centred example, below
(Section 1.2.3).
1-Aminocyclohexanecarboxylic acid
An example of an unnatural cyclic amino acid is the α,α-disubstituted 1-aminocyclo-
hexanecarboxylic acid 1.37. It has seen some interest in peptide structural studies
since its increased steric bulk and hindered rotation increases rigidity in the peptide
chain, leading to increased conformational stability; thus peptides containing this
unnatural amino acid residue might find use as catalysts.55,56 However, outside of
this arena its potential is largely untapped, probably because it is achiral.
A popular synthetic route to 1-aminocyclohexanecarboxylic acid proceeds via a hy-
dantoin 1.38 which is hydrolysed to the amino acid (Scheme 1.27).57,58
SCHEME 1.27: Cyclic amino acid synthesis by hydantoin hydrolysis.
i) KCN, (NH4)2CO3, EtOH/H2O. ii) 60% H2SO4, 160°C.
Another produces the amine by azidation of the corresponding alcohol 1.39 using
bis(p-nitrophenyl)phosphorazidate followed by azide reduction to the amine by cat-
alytic hydrogenation (Scheme 1.28).59 The azide substitution is an SN2 mechanism
which is unfavourable on quaternary carbons; here it is achieved using the reagent
bis(p-nitrophenyl)phosphorazidate (p-NO2DPPA), which is more active than the un-
substituted parent DPPA due to the presence of the electron-withdrawing p-nitro
groups.
These synthetic methods also work for cyclic amino acids of other ring sizes and,
in the case of the hydantoin methodology, with other substituents. The hydantoin
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SCHEME 1.28: Cyclic amino acid synthesis by azide substitution and
reduction. i) p-NO2DPPA, DBU. ii) Pd/C, H2.
methodology is also seen in the synthesis of ferrocene-containing amino acids (Sec-
tion 1.2.3) as well as industrial synthesis of the natural amino acid methionine.60
1.2.3 Ferrocene-centred amino acid
Arguably the closest unnatural amino acid to the work described in this thesis in-
volves ferrocenes with amine and carboxylic acid functionality (Fig. 1.29).61 The ear-
liest example of a ferrocene-centred amino acid analogue was from Herrick showing
1,1’-ferrocenedicarboxylic acid (1.40) can be used as a β-turn mimic in peptides.62
FIGURE 1.29: Amine and carboxylic acid functionalised ferrocenes.
The corresponding 1,1’-ferrocenediamine (1.41) may be used similarly; these sym-
metrically functionalised compounds form parallel peptide strands (1.43, Fig. 1.30).
This was followed by studies showing 1’-aminoferrocene-1-carboxylic acid (Fca, 1.42)
incorporating peptide strands are antiparallel (1.44) as is characteristic in nature.63
Ferrocene derivatives, like [2.2]paracyclophanes, can be planar chiral, however the
compounds described in Figures 1.29 and 1.30 hold a single substituent on each ring
and do not exhibit planar chirality. Ferrocene derivatives require two substituents on
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FIGURE 1.30: Parallel (left) and anti-parallel (right) peptide strand
configuration on ferrocene derivatives.
one ring to be planar chiral. This is a limitation of ferrocene compared to [2.2]para-
cyclophane: Fca is essentially a bulky glycine analogue with no inherent chirality.
The distance between the rings of ferrocene is 3.32 Å; this is close to the distance be-
tween hydrogen bonded N-O pairs in a β-sheet, which makes ferrocene an attractive
backbone for the construction of peptides.64
Typically, ferrocene derivatives with substituents on both cyclopentadienyl (cp) decks
tend toward an anti configuration since this configuration is sterically favoured,
however Fca-containing peptides are held closer to an eclipsed configuration due
to the hydrogen bonding between the peptide strands on either deck (1.45). Where
no hydrogen bonding is possible, for instance in the case of the bisproline compound
1.46, the compound’s crystal structure shows that it adopts the staggered conforma-
tion.62
NMR spectra of the Fca peptides reveals the effects of hydrogen bonding, or lack
thereof, between the peptide strands. Hydrogen bonded carbonyl carbons have
higher 13C chemical shifts because of deshielding from the hydrogen bond, and in-
deed this is seen in the difference between the spectra of the mono- and bisvaline
compounds 1.45 and 1.47 in their ester carbonyl chemical shifts with a difference of
2.1 ppm. Meanwhile, the mono- and bisproline compound’s ester carbonyl chemi-
cal shifts are virtually identical, differing by only 0.2 ppm, which is expected since
hydrogen bonding is not possible between the two proline residues. Additionally,
only 3 cp C chemical shifts are observed for the bis(proline) compound 1.46, indicat-
ing the rings may rotate; 5 cp chemical shifts are seen for the analogous bis(valine)
compound, indicating the rotation is hindered by the hydrogen bonding between
then NH and ester CO groups (Fig. 1.31). Similar differences are observed for the IR
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spectra of these compounds.
FIGURE 1.31: Syn and anti configuration for ferrocene compounds
with and without hydrogen bonding.
Synthesis of ferrocene amino acid
A number of groups have shown interest in the attractive structural and electronic
properties and applications of Fca. Therefore, several synthetic approaches to Fca
are described below.
The first synthesis of Fca was published by Butler’s group and started with metal-
halogen exchange of 1,1’-dibromoferrocene 1.48 (Scheme 1.32).65 Benzylhydroxy-
lamine reacts with the mono-lithiated product to form 1’-bromoferrocene-1-amine
1.49. A further metal-halogen exchange followed by quenching with carbon dioxide
gives the Fca as the zwitterion 1.50. The group described difficulties in this synthesis
with the formation of intermediates and side products, and with the stability of the
compounds; this also lead to complications purifying products, and it was found
that Fca-OMe 1.51 had the best stability and ease of isolation.
Ueyama et al. followed with a synthetic route that began with a synthesis of N-
acetamidoferrocene 1.52 previously described in the literature (Scheme 1.33).66 Friedel-
Crafts reaction with 2,6-dichlorobenzoyl chloride and subsequent hydrolysis with
t-BuOK afforded the carboxylic acid 1.51 specifically at the opposing ring due to
the acetamide’s deactivating effect. Acetamide cleavage with HCl gave Fca as the
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SCHEME 1.32: Butler’s synthesis of Fca from 1,1’-dibromoferrocene.
i) n-BuLi, ii) BnONH2, iii) CO2, iv) AcCl, MeOH.
HCl salt 1.42 ·HCl, which was stable at low pH, but N-protection with Boc 1.54 was
found to provide stability at higher pH.
SCHEME 1.33: Ueyama’s synthesis of Fca from N-
acetamidoferrocene. i) 2,6 – Cl2C6H3COCl, AlCl3, ii) t-BuOK,
iii) 6 M HCl, iv) Boc2O.
A synthesis which improved upon Ueyama’s route was reported by Heinze et al.
in 2004 which increased their low yield (from 28% to 51%) by altering the initial
synthesis of N-acetamidoferrocene 1.52 (Scheme 1.34). They also reported better
yields in the subsequent introduction of the carboxylic acid moiety to the opposing
ring.64
The original conditions involved the reaction of iodoferrocene 1.55 with phthalimide
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SCHEME 1.34: Heinze’s synthesis of Fca based on Ueyama’s route.
i) t-BuLi, ii) I2, iii) copper phthalimide, iv) NH2NH2 ·H2O, v) Ac2O,
NaOAc. vi) a. 2,6 – Cl2C6H3COCl, AlCl3, b. t-BuOK, c. 6 M HCl.
catalysed by Cu2O in pyridine in Gabriel-like conditions.67 Along with the desired
product 1.56, ferrocene dimers were formed. Pre-forming the copper-phthalimide
and using solvent-free conditions prevents dimerisation. Reaction with hydrazine
(the Ing-Manske procedure) gives aminoferrocene 1.57, and finally N-acetamidoferrocene
1.52 is formed by amide formation with acetic anhydride. Optimisation of reaction
conditions from Ueyama’s paper increased their yields to give the hydrochloride salt
of Fca 1.42 ·HCl. The major improvement was in the hydrolysis step to furnish the
carboxylic acid, which was increased from 41% to 70% by optimising the stoichiom-
etry of the added water.
Ueyama and Heinze’s methods suffered from long linear synthetic routes necessi-
tated by addition and removal of protecting groups, while Butler’s synthesis where
the amine is formed followed by the carboxylic acid results in a mixture of insepara-
ble compounds. An alternative strategy used by Erb et al. employed the selective re-
action of a single carboxylic acid of ferrocene-1,1’-dicarboxylic acid 1.40 (Fig. 1.35).61
One acid was converted to an aniline by the Curtius rearrangement. Whereas previ-
ous methods which formed the amine by Curtius rearrangement employed sodium
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azide, here, diphenylphosphoryl azide (DPPA) was used to promote desymmetri-
sation of the dicarboxylic acid and limit formation of side products such as the di-
azide. The Curtius rearrangement of the resulting acyl azide 1.58 with t-BuOH gives
the N-Boc-protected Fca 1.54. This method has a lower yield (around 40% from the
dicarboxylic acid), however it has the advantage of fewer synthetic steps.
SCHEME 1.35: Erb’s synthesis of Fca using optimised Curtius rear-
rangement. i) DPPA, Et3N, ii) t-BuOH, 110°C.
Ferrocene amino acid peptides
Fca can be incorporated into a peptide using standard coupling conditions such
as the use of classic peptide coupling reagents such as EDC/HOBt, DCC/HOBt,
HBTU/HOBt; and acyl chloride and acyl fluoride activation of the carboxylic acid
moiety.63,64,68–75 An example using DDC and HOBt is shown below (Scheme 1.36).
Fmoc-protection of the N-terminus (1.59) with Fmoc-Cl should be carried out in
buffered solution since Fca is sensitive to basic conditions. Boc-protection is gen-
erally avoided for organometallic complexes since its removal required the use of
strong acid.
SCHEME 1.36: Carboxylic acid activation for peptide coupling with
Fca. i) 9-Fluorenylmethyl chloroformate. ii) DCC, HOBt. iii) C-
terminus protected amino acid or peptide R-NH2.
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Solid-phase peptide synthesis (SPPS) protocols have also been employed in the syn-
thesis of Fca-containing peptides (Scheme 1.37).76,77 SPPS is a well-established meth-
od for building synthetic peptides.78 While Fmoc was used in the example above, in
this example, the Fmoc-terminated oligopeptides were unstable so a combination
of Boc- and Fmoc-protection was used. SPPS facilitates the multiple couplings and
purifications required for stepwise production of oligopeptides since the peptide
remains bound to the resin beads while the excess reagents and side products are
washed away by appropriate solvents.
SCHEME 1.37: Solid phase peptide synthesis of Fca-containing pep-
tides. i) DIC, HOBt. ii) piperidine. iii) N-terminus protected amino
acid or peptide R’-COOH, iv) TFA.
1’-Aminoferrocene-1-carboxylic acid-centred peptides have been used for structural
studies, confirming the importance of intramolecular hydrogen bonding and, to a
smaller extent, steric hindrance as conformational determinants in the secondary
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structure of these peptide strands.69,73,79,80 Heinze et al. found the hydrogen bond-
ing motif seen in compound 1.45 (Fig. 1.31) with the hydrogen bonds crossing the
side chains forming 9- and 11- membered rings was most common and encouraged
the β-like sheet arrangement.79 Barišić et al. found that absolute configuration of
natural amino acid residues in Fca-centred peptides did not influence the peptide’s
conformation, nor did the steric bulkiness of side chain protecting groups.69 Rather,
the most important factor dictating the conformation was the number and position
of hydrogen bonding donor and acceptor groups. This can be seen in the different
hydrogen bonding seen in 1.61, which has exclusively interchain hydrogen bonds;
while the constituents of 1.60 allow both inter- and intrachain hydrogen bonds (Fig.
1.38).
FIGURE 1.38: Intra- and interchain hydrogen bonding in Fca-
containing peptides.
The structure of and electronic interaction and communication between redox-active
centres of polypeptides containing several Fca units has been studied: ferrocene
polymers often display electronic communication between the metal sites modu-
lated by the distance between the ferrocene units; however large organic groups
between the ferrocene units insulate against this electronic communication.74,75,81–83
The activity of Fca peptides have also been studied: a group of proline-containing
Fca peptides were tested for anticancer activity and mostly found wanting; Kraatz’s
group has found promising results with their Fca peptides as surface-bound nerve
agent detectors and protein detectors; naphthyl-derived Fca peptides show promise
as anion receptors.70–72,84
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1.2.4 Adamantane-centred amino acids
Schreiner’s γ-aminoadamantanecarboxylic acid (Aca, 1.62) is of pertinence to the
work presented in this thesis due to the fact adamantane is very rigid and places
functionality in specific points in 3-dimensional space. This is analogous to the struc-
ture of [2.2]paracyclophane which is also used as a scaffold about which functional
groups may be precisely arranged.
Schreiner’s research on Aca followed studies on aminoadamantanes found in sev-
eral earlier potential pharmaceuticals such as the antiviral adamantadine (1.63) and
tromantadine (1.64), and the Alzheimer’s treatment drug memantine (1.65) (Fig.
1.39).85,86
FIGURE 1.39: Amine derivatives of adamantane.
Aca resembles a class of GABA analogues used as anticonvulsants; the synthesis of
Aca and derivatives was studied for their potential use as pharmaceuticals.87 The
adamantane backbone is a rigid and bulky scaffold that causes restricted conforma-
tional rotations that produce turn-like structures. Therefore it presents a compelling
target for organocatalysis in reactions known to require rigid turn structures.88,89 α-
Amino acids with adamantyl side chains have also been synthesised but will not be
considered here.90,91
Synthesis of aminoadamantanecarboxylic acid
Synthesis of the amine moiety of Aca has been described following several similar
routes involving formation and then hydrolysis of an amide. These routes follow
the popular method of Ritter C-N bond formation, with electrophilic attack of a ni-
trile to the tertiary carbocation in the presence of strong acid (Scheme 1.40).92–94 The
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key step is formation of a tertiary carbocation, which proceeds via a bromide. The
bromide 1.66 is formed with a large excess of bromine, and is eliminated to give
the active carbocation. The acetonitrile adds to give the nitrilium ion 1.67 which be-
comes the amide 1.68 after addition of a water molecule. The amide is hydrolysed
under acidic conditions to give the amine as the hydrochloride salt 1.69.
SCHEME 1.40: Synthesis of Aca using the Ritter reaction via the bro-
mide 1.66. (i) Br2. (ii) MeCN. (iii) H2O. (iv) Aq. HCl.
Schreiner et al. developed a method that avoided the use of excess bromine through
formation of a radical carbocation (Scheme 1.41).87 Starting with adamantane-1-car-
boxylic acid 1.70, Schreiner’s route generates the carbocation 1.71, by reaction with
a mixture of nitric acid and sulfuric acid.95 These produce the radical carbocation
by single electron transfer from the adamantane derivate to NO2+.96 The reaction
occurs selectively at the tertiary position as this is the more stable radical cation. The
reaction then rejoins the Ritter process with acetonitrile adding to give the acetamide
1.72 after the addition of water. The free amine can be obtained by acid hydrolysis
of the amide. This route gives the best yields when the substrate contains either
carboxylic acids as this increases the solubility in the reaction medium; and/or alkyl
groups that help stabilise the radical carbocation. This methodology can be used to
form other amino adamantanes.
A further method developed by Schreiner et al. uses phase transfer catalysis to gener-
ate the halide 1.73 prior to the formation of the carbenium ion (Scheme 1.42).87 Ritter
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SCHEME 1.41: Nitrosonium ion-induced carbocation route to Aca. i)
HNO3, H2SO4. ii) MeCN. iii) H2O. iv) HCl.
protocol with the carbocation formed by the nitrosonium ion bears the acetamide
1.74. Finally the carboxylic acid 1.72 is formed by a Koch-Haaf type reaction with
formic acid generating carbon dioxide in situ. The carbon dioxide attacks the tertiary
carbocation formed by the bromide; addition of -OH from water gives the carboxylic
acid 1.62.
SCHEME 1.42: Phase transfer catalysed synthesis of Aca. i) NaOH,
CHI3, tetra-N-butylammonium bromide, ultrasound, ii) a. NOBF4,
MeCN, –50 to –15 °C, b. H2O, iii) a. H2SO4, HCO2H, b. H2O, iv) 8 M
HCl.
Although the oxidative route using the nitrosonium species is more efficient for the
formation of 1.62, the halide-based methods are more versatile and allow a broader
scope of R-groups and side chains to be accessed. Side chain functionalisation can
be desirable in the chemistry of peptides, so the less appealing halogenation route is
still very useful. Whichever method is used, chiral products are racemic and may be
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resolved by selective recrystallisation of diastereomeric salts formed from quinine.87
Adamantane amino acid peptides
Peptide couplings between Aca units may be performed by using traditional pep-
tide couplings reagents such as HBTU (Scheme 1.43); or solid phase peptide synthe-
sis.87,91,97
SCHEME 1.43: Peptide coupling between two Aca units. i) HBTU,
DIPEA
Schreiner’s group went on to develop a series of organocatalysts based on Aca-
containing peptides. These will be discussed in Section 1.4.4. Schreiner’s array of
peptide multicatalysts illustrate the power of using peptides in order to easily alter
the functionality of the molecule through use of different amino acids. The variety
of functionality available in natural amino acids gives scope to alter catalytic func-
tion, solubility, and conformational control simply by introducing a different amino
acid residue.98 The modular nature of the chain of amino acids and well-developed
peptide coupling chemistry allows this ease of elaboration.
1.3 Asymmetric organocatalysis
The demand for chiral compounds is ever-increasing, due to their biological im-
portance, their utility in industry, and their remarkable structures. Of the many
approaches available for synthesis of chiral compounds, asymmetric catalysis is at-
tractive because of its efficiency. Traditionally, chiral catalysts were organometal-
lic complexes, or biologically derived enzymes. Both of these have shortcomings.
Metal-containing complexes are often sensitive to air and may not be compatible
with many solvents, or with harsh reaction conditions. They tend to be specific for
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a small set of substrates. Enzymes must either be synthesised, which is a significant
challenge considering the molecular weight of even the smallest of these biologi-
cal polymers; or extracted from a biological source. Like organometallic catalysts,
enzymes are sensitive to reaction conditions, particularly temperature, pH, and or-
ganic solvent. Organocatalysts, composed of small molecules with no metal atoms
complexed, hold the advantage of being more stable to reaction conditions, with
generally lower toxicities than organometallic compounds.
Arguably the first organocatalysts were 4-dimethylaminopyridine (DMAP) in Steg-
lich esterification or piperidine in Knoevenagel condensation; however these are not
asymmetric catalysts.99,100 The first asymmetric organocatalyst emerged in the 1970s
with Hajos and Parrish’s discovery of proline-catalysed Robinson annulation: now
called the Hajos–Parrish–Eder–Sauer–Wiechert reaction due to the contributions of
many chemists to the investigation of scope and mechanism of this useful aldol re-
action.101 Their work described the proline-catalysed stereoselective intramolecular
aldol reaction of ketone 1.75 to give alcohol 1.76 in quantitative yield and 93% ee
(Scheme 1.44).
SCHEME 1.44: Hajos and Parrish’s proline-catalysed asymmetric
Robinson annulation. i) 3 mol % L-proline.
Amino acids with primary amines were found to have lower stereoselectivity; pro-
line’s secondary amine in a 5-membered ring has a more rigid conformation and
increases stereoselectivity. The reaction mechanism has been proposed to proceed
via an enamine intermediate.102
The versatility of organocatalysts in asymmetric catalysis have been recognised more
recently. The last 20 years have seen a huge explosion in this area and it would be
infeasible to discuss its entire scope. Interested readers are directed to the reviews
by Taylor and Jacobsen, Schreiner, Seayad and List, and Dalko and Moisan.103–106
Some pioneering organocatalysts will be mentioned briefly but more attention will
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be paid to those with resemblance to amino acids and peptides. Since amine-based
organocatalysts follow either standard enamine or iminium catalytic mechanisms
they have the advantage of being more general for types of functional group: exam-
ples of each mechanism are discussed in the sections to follow.
1.3.1 Early asymmetric organocatalysis
Two distinct areas start quite early in the growth of organocatalysis. These can
broadly be termed Brønsted acid catalysis and Lewis base catalysis.107
Brønsted acid catalysis
Acids were known to be useful as non-chiral catalysts before interest in chiral ver-
sions became apparent, inspired by the prevalent motif of proton transfer in enzy-
matic catalysis.103 One of the first asymmetric examples is Jacobsen’s urea or thiourea
imines for the asymmetric Strecker reaction, a reaction which is useful for forming
highly enantiopure amino acid precursors.108 These catalysts were discovered by ac-
cident: Jacobsen included a control experiment without metal and found the ligand
gave better results than the complex.109 Jacobsen’s catalysts displayed impressive
enantioselectivity and substrate range, with the thiourea 1.77 giving the best enan-
tioselectivity (Scheme 1.45).
SCHEME 1.45: An example of Jacobsen’s thiourea/imine catalysts in
asymmetric Strecker reaction. i) Trimethylsilyl cyanide, 2 mol % 1.77,
then TFAA.
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In thiourea 1.77, the active site of the catalyst is the N-H bonds of the thiourea as seen
in the simplified transition state in Figure 1.46. Replacing the oxygen of the urea in
initial catalysts (not shown) with a sulfur increased the stereoselective power of the
catalyst because thiourea protons are more acidic. Both thiourea protons hydro-
gen bond with the imine in cis-configuration as the only essential points for catalyst
activity. This points the large group on the imine carbon away from the catalyst,
allowing for this catalyst’s broad substrate scope for aldimines since this group does
not interact strongly with the catalyst; ketimines on the other hand are not ideal sub-
strates for this reaction since their additional R group is too big to occupy the space.
The HCN addition occurs over the cyclohexane ring, inducing S configuration in the
product.
FIGURE 1.46: Transition state of Strecker reaction catalysed by 1.77
Lewis base catalysis
Lewis base catalysis is less well-defined, covering a range of processes like Den-
mark’s activation of silicon Lewis acids with phosphoramides, to nucleophilic cata-
lysts such as carbenes used in the Stetter reaction.110,111
It would be remiss to discuss early examples of Lewis base asymmetric organocat-
alysts without mention of MacMillan’s well-known imidazolidinone catalysts, for
example 1.78. They were first shown to be effective in a Diels-Alder reaction, fol-
lowed by an array of other reactions including Friedel-Crafts alkylation, variants of
the Michael addition, and α-halogenation (Scheme 1.47).112–117 The beauty of these
catalysts is that they offer a general strategy to promote many reactions. The cata-
lysts may act in either the enamine or iminium catalytic mechanisms.
Jørgensen’s diphenylprolinyl silyl ethers (for example, 1.79) are an example of chi-
ral secondary amine compounds that will catalyse a number of different reactions
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SCHEME 1.47: MacMillan’s imidazolidinone catalysts in (from top to
bottom) Diels-Alder reaction, Friedel-Crafts reaction, α-fluorination,
and intramolecular Michael addition. i) 20 mol % 1.78, HCl; ii)
20 mol % 1.78, TFA; iii) a) 20 mol % 1.78, dichloroacetic acid, N-
fluorobenzenesulfonimide, b) NaBH4; iv) 5 mol % 1.78, HCl.
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of carbonyl compounds (Scheme 1.48), such as the α-functionalisation of aldehy-
des and the epoxidation of α,β-unsaturated unsaturated aldehydes.118–120 They are
also widely used in the Michael addition and its variants, including aza-Michael
additions, with some examples in the literature detailing elegant syntheses using
these catalysts in cascade reactions, installing as many as four stereocentres concur-
rently.121–123
SCHEME 1.48: Jørgensen’s diphenylprolinyl silyl ether catalyst in
(from top to bottom) α-amination, epoxidation of α,β-unsaturated un-
saturated aldehydes, and aza-Michael addition. i) 10 mol % 1.79; ii)
10 mol % 1.79, H2O2; iii) a) 20 mol % 1.79, b) NaBH4.
An exemplar of a cascade reaction using Jørgensen’s diphenylprolinyl silyl ether
catalyst is the total synthesis of (+)-Conicol 1.86, where it installs four stereocen-
tres in a one-pot, two-step reaction in 55% total yield with >99% ee (Scheme 1.49).
Jørgensen’s catalyst 1.80 enabled the installation of these stereocentres from achiral
substrates. This is a cascade reaction of four steps: (oxa-Michael)-Michael-Michael-
aldol. The first step in the cascade is tandem oxa-Michael addition of a phenol oxy-
gen of (E)-2-(2-nitrovinyl)benzene-1,4-diol (1.81) to 3-methylbut-2-enal (1.82), and
Michael addition of the resultant enamine species 1.83 to the α,β-unsaturated nitro
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group. The next step was addition of 4,4-dimethoxybut-2-enal 1.85 to the same reac-
tion vessel for a tandem Michael-aldol condensation. The Michael addition occurs
between the α-nitro carbon of 1.84 and 4,4-dimethoxybut-2-enal; the aldol reaction
occurs between the aldehyde of 1.84 and 4,4-dimethoxybut-2-enal.
SCHEME 1.49: An example of Jørgensen’s diphenylprolinyl silyl ether
catalyst in the synthesis of (+)-Conicol in a cascade reaction. i) 20 mol
% 1.80, HOAc.
4,4-Dimethoxybut-2-enal was chosen to represent the final ring’s three-carbon syn-
thon since Hong et al. found using crotonaldehyde led to the formation of an unsta-
ble α,β-unsaturated cyclic ketone later in the synthetic pathway which aromatised to
form a phenol; the dimethoxy compound gave a more stable intermediate. The suc-
cessful crotonaldehyde Michael-aldol reaction was remarkable since its γ-H could
have caused γ-amination side reactions. This synthetic strategy lends itself to di-
verse products based on the central three-ring skeleton which is found in many nat-
ural products being studied for biological activity. Two variants were synthesised in
Hong et al.’s study.123
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1.3.2 Enamine catalysis
The difference between enamine and iminium catalysis for an asymmetric amine cat-
alyst hinges on whether the nucleophile or the electrophile is activated. For enamine
catalysis, the nucleophile is activated via an initial iminium species. The enamine
intermediate forms because of the increased C-H acidity in the iminium-enamine
equilibrium.
Many amine catalysts proceed through the enamine catalysis mechanism.124 Scheme
1.50 shows the mechanism in an enamine aldol reaction catalysed by proline or a
proline derivative such as Jørgensen’s catalysts (Schemes 1.48 and 1.49). This mech-
anism is the same with small variances for all enamine-route catalyses. The first step
is formation of the enamine B through nucleophilic attack from the amine A to the
carbonyl carbon. This step proceeds via an iminium intermediate C but here, the
next step proceeds via the enamine species. The nitrogen lone pair reforms the C=N
double bond D and the enamine double bond acts as the nucleophile to attack the
electrophilic atom. In the aldol reaction, this is the carbonyl carbon; in the Michael
addition, this is the 4-position. The resultant iminium species is hydrolysed to form
the product E and the regenerated amine catalyst A.
1.3.3 Iminium catalysis
In iminium catalysis, the electrophile is activated. As shown in Scheme 1.51 the
first step is the same and the amine catalyst A will form an iminium species B with
the carbonyl group. This charged species increases the electrophilicity of the carbon
atom. The nucleophile C attacks the electrophilic carbon, which has been activated
by the iminium formation. Hydrolysis of the iminium intermediate D allows forma-
tion of the product and catalyst regeneration.125,126
Michael addition is shown in the iminium catalysis exemplar. It is an important reac-
tion catalysed by many chiral amines and may undergo either enamine or iminium
catalysis depending on the reagents. The iminium route prevails when the Michael
acceptor (the α,β-unsaturated substrate) is an enal as opposed to a nitrile or nitro, for
instance.
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SCHEME 1.50: Enamine-type mechanism of organocatalytic reac-
tions.
SCHEME 1.51: Iminium-type mechanism of organocatalytic reactions.
EWG = electron-withdrawing group.
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1.3.4 Proline in enamine mechanism of catalysis
Proline itself has been employed as a Lewis base asymmetric organocatalyst and
was found to show stereoselectivity in a remarkable number of reactions, includ-
ing crossed aldol coupling, Mannich reactions, and Michael additions.105,127–130 All
these proline-catalysed reactions are thought to proceed via an enamine intermedi-
ate. Scheme 1.52 shows an example of an aldol reaction between acetone 1.87 and
4-nitrobenzaldehyde 1.88.
SCHEME 1.52: List’s proline-catalysed asymmetric aldol reaction. i)
L-proline. Other aromatic substrates gave similar yields and selectiv-
ities (62-94% yield, 60-77% ee).
Proline 1.32 could undergo side reactions with an aromatic aldehyde, for instance,
condensation 1.89 and decarboxylation giving an azomethine ylide 1.90. The ylide
can undergo a further reaction with a further molecule of 4-nitrobenzaldehyde 1.88,
generating a 5-membered heterocycle 1.91 by 1,3-dipolar cycloaddition (Scheme 1.53).131,132
This can be avoided by using acetone as a solvent in a 1:4 mixture with DMSO, giv-
ing a large excess of acetone to outcompete side reactions.
SCHEME 1.53: 1,3-Dipolar cycloaddition side reaction between pro-
line and 4-nitrobenzaldehyde.
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1.3.5 Trans-4,5-methano-L-proline in iminium mechanism of catalysis
Hanessian and coworkers found trans-4,5-methano-L-proline (1.92) was a more stere-
oselective catalyst in conjugate addition of symmetrical nitroalkanes to 2-cycloal-
kenones than L-proline.126 In the addition of 2-nitropropane 1.94 to 2-cyclohexenone
1.93, trans-4,5-methano-L-proline gave 1.95 with a yield of 92% with 99% ee, while
using L-proline as a catalyst gave 83% yields with 89% ee under the same conditions
(Scheme 1.54). Here, the catalysis mechanism is the iminium route (Scheme 1.51).
The base additive, trans-2,5-dimethylpiperazine, forms a salt with 2-nitropropane.
2-Cyclohexenone forms the iminium species with the catalyst’s amine. The piper-
azinium nitronate anion adds to the activated iminium species selectively in an anti-
configuration with respect to the carboxylic acid group of the catalyst, giving the
R-form of the product. It is unclear why the bicyclic catalyst is superior to proline
but it is thought that the extra rigidity improves selectivity.
SCHEME 1.54: Trans-4,5-methano-L-proline-catalysed addition of
2-nitropropane to 2-cyclohexenone. i) 10 mol % 1.92, trans-2,5-
dimethylpiperazine.
Peptide catalysts are capable of performing all of the above and more. Some exam-
ples will be discussed in the next section.
1.4 Peptide organocatalysis
It has been established that asymmetric organocatalysis is a broad and growing area
of research. Since the work presented in this thesis is focused on peptide catalysts,
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the scope and function of peptide organocatalysts will be explored here in more
detail.
Proteins perform a wealth of functions in living systems. They can be molecular
transporters, structural support, intra- and extra-cellular communicators, and cata-
lysts. All these functions, and many more besides, are carried out by combinations
of the same twenty or so natural amino acids. That Nature gets such variety of
function from such a small number of building blocks is a result of how they are
linked together and then the shape these macromolecules adopt. There is a strong
structure-function relationship in biological polymers.
A protein is a polymeric macromolecule that comprises a linear chain of amino acids
linked through amide bonds, which are specifically called peptide bonds when re-
ferring to the amide linkage between two amino acids. This is the primary structure.
Local areas of shape and specific conformations arise due to weak intramolecular
and intermolecular interactions, particularly hydrogen bonding between C=O and
N-H groups on the peptide backbone. The conformation of a protein’s peptide chain
is a vital component of its function. This is the secondary structure. Further levels
of protein structure are: tertiary structure, which is the three dimensional shape of a
protein, stabilised mainly by hydrophobic interactions, and ionic bonds, hydrogen
bonds, and disulfide bridges between the R groups of the amino acid residues; and
quaternary structure, stabilised in much the same way as tertiary structure, with in-
teractions between two separate peptide strands. These levels of protein structure
are less relevant to this project which deals only with short peptides.
The conformation of a protein’s peptide chain is a vital component of its function.
Many secondary structural motifs exist but a common conformational motif found
in proteins, and in the active sites of many enzymes, is the β-turn (Fig. 1.55). The
β-turn is a sharp four-residue hairpin shape in the chain, stabilised by hydrogen
bonds, which induces a change in direction of the peptide strand.
Enzymes were discovered to be proteins in the early 1900s and early examples of
synthetic peptide catalysts were published in the 1980s: for example, Juliá et al.’s
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FIGURE 1.55: Hydrogen bonding in a β-turn.
polyalanine 1.96 and polyglutamates (Scheme 1.56).133 The study of enzymes catal-
ysis was more popular, with examples such as pig liver esterase being very useful,
and is an ongoing area of compelling research.134–138 Research activity on peptide
organocatalysis was specialised to a small number of groups until the explosion of
interest in asymmetric organocatalysis and, in particular, the discovery of proline as
an efficient asymmetric catalyst with diverse applications.
SCHEME 1.56: Juliá et al.’s pioneering polyalanine peptide for asym-
metric catalytic epoxidation of chalcone. (i) 80 mol % 1.96, H2O2,
NaOH.
Enzymes are proteins that catalyse the reactions of an organism’s metabolism - often
asymmetrically and with site specificity, as well as excellent efficiency. It follows,
then, to seek to mimic the structures and functions of enzymes to produce catalysts
capable of performing with high yield and enantioselectivity. Enzymes themselves
can be difficult to work with, being sensitive to the reaction environment and diffi-
cult to obtain and purify in high yield. Their specificity, an advantage in nature, can
be a limitation to a chemist, as only a limited number of substrates can be used. Fur-
ther, the complexity of an enzyme means that producing its mirror image, allowing
synthesis of either enantiomer of the product, is challenging. Proteins are often too
long or too sensitive to be practical; single amino acids by themselves are too lim-
ited: peptides strike a happy medium. Short peptides, or oligopeptides, are relatively
easy to synthesise by established peptide synthesis protocols. Accordingly, synthetic
peptide sequences have seen increasing use in asymmetric catalysis.
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1.4.1 Miller’s peptide organocatalysts
Undoubtedly the leader in this field is Miller and coworkers. Their studies on peptide-
based asymmetric catalysts have opened the doors for the outpouring of new pep-
tide catalysts being discovered, and has covered numerous transformations includ-
ing acyl transfer among many others.40
Early studies modified common physiological processes. A prime example is the de-
velopment of acyl transfer catalysts that mimic many metabolic reactions and were
modified to allow the desymmetrisation or kinetic resolution of alcohols. Desym-
metrisation alters a symmetrical compound to remove a symmetry element, such
as mono-acylation of a pro-chiral alcohol, to give one enantiomer of the product.139
This is useful when done stereoselectively.
Miller’s work started with tripeptides containing modified histidine residues, and
found that increasing length of the peptide chain up to 8 amino acid residues created
catalysts with well-defined shape due to intramolecular hydrogen bonding.40 This
increases the stereoselectivity of the catalyst. Octapeptides that mimic the β-hairpin
turn (Fig. 1.57) motif also exhibit greater selectivities than those which do not.
FIGURE 1.57: Miller’s octapeptides for asymmetric acylation; 1.97 ex-
hibiting β-hairpin turn; 1.98 does not have the β turn.
Compounds 1.97 and 1.98 differ only in the chirality at the proline residue. In 1.97
the D-proline residue, which forces the twist with its 5-membered ring and disrupts
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hydrogen bonding, is integral in the formation of the β-hairpin conformation. Com-
pound 1.98 is identical to 1.97 except for the inclusion of L-proline instead of D-
proline, and is less rigid and does not exhibit the β-turn conformation; its substrate
selectivity is lower and performs the kinetic resolution with lower stereoselectivity.
For the kinetic resolution of (±)-N-(2-hydroxycyclohexyl)acetamide (Scheme 1.58),
turn-containing 1.97 had a krel of 51 with a conversion of 50%, which translates
to an ee of approximately 90%; compared to non-turn-containing 1.98’s krel of 7
with conversion of 46%. The imidazole of the π-methyl histidine residue captures
the acetic anhydride; in the turn-containing 1.97, hydrogen bonding between the
peptide and oxygen and nitrogen of the substrate induce an enantiomer-specific
transition-state hydrogen bonding interaction which accelerates the reaction rate of
the (R,R)-enantiomer.
SCHEME 1.58: Asymmetric acylation of (±)-N-(2-
hydroxycyclohexyl)acetamide. i) Ac2O, 2 mol % 1.97 or 1.98.
Using combinatorial chemistry and the inclusion of both L- and D-amino acids, fur-
ther octapeptide sequences were prepared and screened in acylation resolution re-
actions.140 While 1.97, above, gave good selectivity with limited examples of amide-
functionalised alcohols, the search was for a more general acylation catalyst. Iter-
ative combinatorial peptide library preparation allowed synthesis of a large num-
ber of potential catalysts that could quickly be screened to find the candidates most
likely to perform well as asymmetric catalysts.
Indeed, the best peptide, 1.99, gave good krel for the kinetic resolution for a variety
of racemic alcohols. Predictably, greater selectivity was observed for more sterically
bulky substrates. The best example is shown in Scheme 1.59. The group performed
structural and modelling analysis after the fact to determine reasons for this peptide
sequence’s good performance and found certain residues to be responsible for the
lowered conformational variability thought to increase stereoselectivity. This exam-
ple shows one benefit of using peptides as catalysts: their highly functionalised side
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chains offer the possibility to tune regioselectivity and activity simply by altering an
amino acid residue.
The N-terminal π-methyl histidine residue contains the imidazole nucleophile that
activates the acyl reagent. The C-terminal isoleucine residue replaced residues with
less sterically bulky R-groups in less selective catalysts; this suggests conformational
proximity between the N- and C-terminus residues during the transition state. The
fourth residue is a trityl histidine which is shared between the peptides with greatest
activity; it is thought that π stacking with the aryl rings of the substrate enhances se-
lectivity. The two t-butyl ethers provide hydrogen bonding donors for the substrate
to position it.
SCHEME 1.59: Miller’s peptide 1.99 in acylation for kinetic resolution
of alcohols. i) 2.5 mol % 1.99, Ac2O.
Having found success mimicking nature, Miller began to investigate reactions that
are rarer in nature or require metalloenzymes. One of these was regio- and stereose-
lective epoxidation of polyenes. For this transformation, Miller’s peptides consisted
of a peracid-derivatised aspartic acid residue as the catalytic moiety.141 Small alter-
ations to the peptide structure were also found to be important for efficient epox-
idation. Studying the effect of peptide length, a shortening from trityl-protected
asparagine 1.101 to a methyl ester 1.100 (Scheme 1.60) produced a significant de-
crease in regioselectivity and stereospecificity. 1.100 produced 1.104 with 62% ee and
4.2:1 site specificity while 1.101 catalysed the reaction with ee of 86% and 13:1 site
1.4. Peptide organocatalysis 49
specificity.
SCHEME 1.60: Epoxidation catalysed by Miller’s peptide catalysts
1.100 and 1.101. (i) 10 mol % peptide catalyst, 10 mol % HOBt, 10
mol % DMAP, DIC, H2O2.
This terminal region containing the trityl asparagine residue in 1.101 is involved in
stabilising conformations of the peptide that increase both stereo- and regioselec-
tivity. This is evidenced by the 1H NMRs of the two peptides; 1.101 has sharper
peaks indicating less conformational freedom. According to their model, the hy-
droxyl group of the substrate participates in hydrogen bonding that directs it to
present the face of the bond that is epoxidised to the peracid-activated aspartic acid
residue that carries out the epoxidation. Several possible hydrogen bonding sites
are possible as suggested by ROESY NMR spectra which determines through-space
interactions. One option is with with two backbone carbonyl oxygens; Henbest and
others have shown that the hydroxyl group may interact solely with the peracid; or
it may be a mixture of these two hydrogen bonding modes (Fig. 1.61).142–144
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FIGURE 1.61: Possible intermolecular hydrogen bonding interactions
stabilising transition state in epoxidation of polyenes.
1.4.2 Wennemers’ peptide organocatalysts
Small peptides with the sequence Pro-Pro-Xaa-NH2 (where Xaa is a generic acidic
amino acid with various functionality and modification) have been used by Wen-
nemers’ group in asymmetric catalysis of Michael addition of aldehydes to nitro-
alkenes including demanding disubstituted nitrostryenes.145 The sequence (D-Pro-
Pro-Glu-NH2) 1.105 was screened along with all its diastereomers and gave the best
yield and stereoselectivity in Michael addition between butanal 1.106 and trans-β-
nitrostyrene 1.107 (quantitative conversion, 50:1 dr (syn/anti), and 97% ee for (S,R)-
1.108, Scheme 1.62).
Introduction of a fourth amino acid residue gave little increase in yield and no
change in stereoselectivity.146 More important was the conformation of the two pro-
line residues, which due to their tertiary amide bond, force a turn-like structure.147
In the ground state, the tripeptide has a hydrogen bond between the terminal pro-
line residue’s amine proton and the glutamic acid side chain’s carboxylate oxygen.
This induces the amide bonds of both proline residues to prefer the cis configura-
tion that creates the turn-like structure. Formation of the enamine with the Michael
donor substrate releases the carboxylic acid of the glutamic acid side chain from its
hydrogen bond with the N-terminus proton; this carboxylic acid then serves as a
proton donor for the incoming nitroalkene and guides the substrate to form the syn
product.
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SCHEME 1.62: Wennemers’ tripeptide in asymmetric Michael addi-
tion of butanal to trans-β-nitrostyrene. i) 5 mol % 1.105.
Iterative design changes in the catalysts optimised them to perform in aqueous con-
ditions: here, addition of alkyl groups helps the catalyst mirror the hydrophobic en-
vironment of enzyme active sites.148 Without this alteration, the tripeptide catalyst
must be used in dry solvents since excess water interferes with reaction rate. The
alkyl chain permitted the formation of an emulsion in aqueous solvent. Michael ad-
ditions between aldehydes and nitroalkenes were performed with very good yield
and chemoselectivity: the peptide catalysts favour the conjugate addition over the
homo-aldol reaction. Peptide 1.109 (Fig. 1.63) gave >95% yield and 91% ee for the
reaction above (Fig. 1.62).
FIGURE 1.63: Wennemers’ alkylated tripeptide catalyst 1.109.
1.4.3 Reymond’s aryl peptide dendrimers
Conformational stability of peptide catalysts has been shown to be important for
catalyst selectivity and activity. Even small peptides contain numerous functional
groups and their conformation is difficult to predict. In Miller’s combinatorial li-
braries of peptides (above), only the conformation of the effective catalysts was de-
termined. Knowing the conformation of a successful peptide, it would be interesting
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to know if a structure with fixed shape could be introduced that would allow ratio-
nal design of a peptide catalyst with inbuilt conformational rigidity that has similar
catalytic power.
Reymond’s group looked at constricting conformational freedom using 3,5-diam-
inobenzoic acid as a rigid backbone unit on which branching amino acid chains
were coupled.149 They used a combinatorial approach to build branched peptides,
allowing the screening of a variety of similar peptides in an ester hydrolysis reaction
(Scheme 1.64).150
The peptide dendrimer shown (1.110) had good activity in the ester hydrolysis (kcat/kuncat
= 4,000) and stereoselectivity (74% ee). The figure shows a simplified cartoon of
the peptide dendrimer’s structure; the two branches extending from the central 3,5-
diaminobenzoic acid scaffold have the same structure and linkages, and the two
halves of the dendrimer joined by the cysteine-cysteine disulfide bridge are identi-
cal.
SCHEME 1.64: Ester hydrolysis catalysed by Reymond’s peptide den-
drimers. (i) 10 mol % 1.110, pH 6 buffer.
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They found that catalytic activity increased when their peptide was built on a more
rigid backbone. They hypothesised that rigidity inhibited folding, making the con-
formation more open and allowing the substrate to access the active site. This is
another example of kinetic resolution and the mechanism involves two histidine
side-chains, one acting as the nucleophile activating the acyl group; the other acts as
a general base. The selectivity is mediated by electrostatic interactions between the
aspartate anions presented on the surface of the peptide dendrimer and the quino-
lium cation. A decrease in selectivity is observed when a single amino acid residue
is altered in the peptide, which suggests additional interactions within the peptide
which influence stereoselectivity. Further studies or modelling would help elucidate
exact interactions.
1.4.4 Schreiner’s peptide organocatalysts
Schreiner’s work with an adamantane-containing amino acid (Aca, see Section 1.2.4)
is another example of the utility of a rigid backbone element in peptide catalysts.
Schreiner’s research has revealed that changing the amino acids attached to the cen-
tral adamantane unit allows a broad scope of reactions to be promoted.151–153
Dakin-West reaction
An Aca-containing peptide catalyst from Schreiner’s group performed the first enan-
tioselective Dakin-West reaction (Scheme 1.65).151 The Dakin-West reaction is often
used for the conversion of an amino acid to a keto-amide. The catalyst 1.111 con-
tains the methyl histidine residue common to all Schreiner’s Aca catalysts with its
imidazole side chain, as well as a cyclohexylalanine residue, which was important
for forming the catalytic binding pocket to provide stereocontrol. The catalyst gives
enantioselectivity with a range of aryl and alkyl substrates that is on par with other
organocatalytic decarboxylative protonations, with moderate to good yields.
In the first step of the reaction mechanism (Scheme 1.66), the amino acid is N-
acylated to give 1.112, which then forms a mixed anhydride 1.113, with two equiv-
alents of the acetic anhydride. Cyclisation gives the oxazolone 1.114, which is de-
protonated to give the resonance-stabilised enolate 1.115. The enolate oxygen is
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SCHEME 1.65: Enantioselective Dakin-West reaction catalysed by
Schreiner’s Aca-containing peptide 1.111. i) 10 mol % 1.111, DCC,
Ac2O. ii) AcOH. R = aryl, alkyl, H.
acetylated and this O-acyl species 1.116 undergoes Steglich esterification catalysed
by 1.111 to give 1.117. Acetic acid opens the oxazolone ring to give 1.118 and the
transacylation of acetic acid gives the β-ketoacid 1.119. Upon deprotonation by the
methylimidazole group of 1.111, 1.119 is decarboxylated, forming the enolate 1.120,
and then reprotonated to give the methylketo-acetamide 1.121.
The catalyst is proposed to be active at two points in the reaction mechanism.154
The methyl histidine acts as a Lewis base for the acetyl transfer on 1.116, and as a
Brønsted base in the final protonation. The reaction is usually non-stereoselective,
giving the product as a racemate because of intermediates 1.115 and 1.120. The
methylimidazole moiety by itself is not basic enough to deprotonate the oxazolone
1.114, and using an external base in the reaction reduces enantioselectivity of the fi-
nal step. DCC was used as an additive because it furnishes the cyclised oxazolone
with a good reaction rate, and assists in the subsequent deprotonation. Since its side
product, dicyclohexylurea (discussed in Section 3.3.3), does not act as a base, it did
not interfere with the final protonation step’s enantioselectivity.
The adamantane catalyst performed the final protonation of 1.120 enantioselectively,
affording the enantioenriched product 1.121. The S-product is favoured due attrac-
tive interactions between the catalyst and substrate during the final deprotonation,
decarboxylation and the ensuing stereoselective protonation. Hydrogen bonding in-
teractions between the substrate’s amide proton and the catalyst’s cyclohexylalanine
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SCHEME 1.66: Mechanism of the Dakin-West reaction.
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residue’s carbonyl oxygen, and the enolate oxygen of the substrate binding with the
amide proton of cyclohexylalanine residue, bring the α-carbon close to the proto-
nated imidazole of the π-methyl histidine (Fig. 1.67). This proximity and additional
dispersive interactions between the cyclohexyl rings on the substrate and catalyst
lead to preferential protonation from one face to give the S-product.
FIGURE 1.67: Stabilising interactions in the transition state of
organocatalysed Dakin-West reaction.
Peptide multicatalysts
Multicatalysts are molecules that contain several active sites within one catalyst.
They differ from molecules such as bifunctional catalysts in that their sites act in-
dependently of each other. By allowing the catalysis of multiple reactions in a single
vessel they permit complexity to be built quickly. Peptides are suited to this because
it is easy to add discrete functionality and then separate these groups along the pep-
tide chain. Schreiner’s Aca-containing peptides are particularly appropriate for this
purpose due to the functional group separation introduced by the adamantane scaf-
fold.
An example of Schreiner’s multicatalysts combined two known catalytic groups on
a constrained peptide backbone: multicatalyst 1.122 combines (2,2,6,6-tetramethyl-
piperidin-1-yl)oxyl (TEMPO) for oxidation of aldehydes; and a π-methyl histidine
to promote acyl transfer (Scheme 1.68). Compound 1.122 is added in the first step
of the one-pot reaction and catalyses reactions in both steps. First it desymmetrises
the meso-diol 1.123 by selectively acylating one hydroxyl group, then oxidises the re-
maining alcohol to form the aldehyde 1.124 and prevent intramolecular acyl shift.98
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As per the previous discussion of kinetic resolution (Section 1.4.1), the importance
of removing the unreacted enantiomer is obvious; the prevention of intramolecular
acyl shift ensures the selectivity of the desymmetrisation is not wasted by racemisa-
tion after the fact. The best yield and stereoselectivity was found for cis-cyclooctane-
1,2-diol 123, as smaller products suffered from a fast-acting Baeyer-Villiger oxidation
with m-CPBA.
SCHEME 1.68: One-pot desymmetrisation and oxidation of 1.123 by
Schreiner’s peptide catalyst 1.122. i) 5 mol % 1.122, Ac2O. ii) Bu4NBr,
mCPBA.
Expanding on Miller’s work with oligopeptides in kinetic resolution of chiral al-
cohols, their inclusion of an Aca residue solved several problems. The bulky hy-
drocarbon group prevented the peptide self-associating, increased its affinity for or-
ganic solvents, and promoted hydrophobic interactions in the transition state (Fig-
ure 1.69).97 The cyclohexyl amino acid’s side chain increases lipophilicity, which had
previously been shown to increase selectivity of the catalyst.89 Molecular modelling
sought to explain the role of adamantane in the catalyst’s increased efficiency: it was
predicted that adamantane held an important C=O group in correct conformation
for hydrogen bonding with the cyclic diol. The carbonyl group acted as a hydro-
gen bond acceptor and was important for stereoselective receipt of the substrate.
Additionally, London dispersion forces (hydrophobic interactions) between the acyl
adduct and the cyclohexyl side chain stabilised the catalytic pocket formed upon
association of the diol.
By varying the order reagents are added to the reaction, the above histidine-TEMPO
multicatalyst 1.122 could be made to facilitate an even more efficient variant of this
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FIGURE 1.69: Predicted catalytic binding pocket of Schreiner’s pep-
tide 1.122 in acyl transfer.
transformation. The order of each reaction was reversed so that the catalyst oxidised
an aldehyde and which formed an anhydride in situ. This anhydride participated in
the enantioselective acylation reaction. This one-pot oxidative esterification allowed
the kinetic resolution and the resolution of meso diols; additionally it represented an
alternative route to ester formation.155 The combined multicatalyst gave the same
products as the two catalysts individually, with only slightly lower ee. Shown in
Scheme 1.70, the reactions catalysed by the π-methyl histidine-containing peptide
(step i) and TEMPO (step ii) separately gave 1.125 (46%, 81% ee) and 1.126 (43%,
88% ee); catalysed by 1.122 (added in step i) gave 1.125 (43%, 73% ee) and 1.126
(41%, 73% ee) in a one-pot reaction.
Schreiner’s research with these multicatalysts has shown that they are amenable to
other kinetic resolutions simply by altering the amino acid residue added to the cen-
tral adamantane core. By adding a dicarboxylic acid, in addition to the histidine
residue, a multicatalyst that promoted alkene epoxidation followed by ring opening
then the familiar acyl transfer could be created. Cyclohexene 1.128 was first epox-
idised, reacted and resolved, to give (R,R’)-1.129 with 35% yield and 60% ee and
(S,S’)-1.125 with 34% yield and 92% ee (Scheme 1.71).43,44 Other alkenes gave simi-
lar yields and selectivities. This is a remarkable reaction considering three separate
reactions are promoted by the same catalyst.
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SCHEME 1.70: Schreiner’s multicatalyst 1.122 employed in kinetic
resolution of diol 1.125 with oxidative esterification. i) 5 mol % 1.122,
pyridine, t-BuOCl, ii) rac-1.125, DIPEA.
SCHEME 1.71: Schreiner’s dicarboxylic acid/histidine peptide cata-
lyst in epoxidation and enantioselective acyl transfer. i) 5 mol % 1.127,
H2O2, DIC; ii) H2O, N2H4 ·H2SO4; iii) Ac2O, DIPEA.
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1.4.5 Prolinamide BINAM derivative organocatalyst
A more well-known motif is the binaphthyl backbone found in many ligands and
catalysts. Nájera has used (Sa)-1,1’-binaphthyl-2,2’-diamine (BINAM) as a rigid back-
bone that constrains the conformation of the resulting peptide.156,157 Proline-function-
alised BINAM 1.18 was used to promote the aldol reaction.38 The sterically-hindered
BINAM introduced axial chirality into the molecule and allowed stereochemical con-
trol of the alcohol product. Here, the backbone is not an amino acid, but a diamine,
with both proline residues coupled through their carboxylic acids. It is included in
the review as an interesting example of an organocatalyst that harnesses the catalytic
power of amino acid residues. Proline is a popular catalytic moiety for aldol conden-
sation; it was combined with BINAM, which is a scaffold that provides rigidity and
steric bulk, as well as a chiral platform that the substituents can be arranged about.
In one example of the aldol reaction (Scheme 1.72), acetone was used as the nucle-
ophile (R1 = H) and 2-phenyl-2-oxoacetate (R2 = Ph, R3 = Me) as the aldol acceptor,
or electrophile. When (Sa)-BINAM-L-prolinamide was the catalyst, the yield was
>90% and the chiral tertiary alcohol had 15-32% ee of the R isomer; (Sa)-BINAM-D-
prolinamide produced >90% yields of the S isomer with 55-60% ee. A range of other
alkyl and aryl derivatives was tolerated in the reaction, giving the desired products
with good yield and enantioselectivities: up to 95% and 92% ee. Some more chal-
lenging derivatives with R1 = CH2Cl or CH2SCH3 gave lower yields of 60% and 20%,
respectively; these substrates are less reactive nucleophiles. An alkyl β-ketoester (R2
= Et) reacted with lower enantioselectivity; possibly due to lower difference in steric
hindrance between the Re and Si intermediates because of the less bulky ethyl group.
The diastereomers of the catalyst gave different results. From molecular modelling
calculations, it appears that the amino acid controls enantioselectivity while BINAM
improves arrangement of the substrates. The axial chirality introduces a spatial ar-
rangement that favoured formation of the S isomer’s transition state due to steric
hindrance between the substrate and the binaphthyl portion of the catalyst.
The above examples of asymmetric peptide organocatalysts show the importance of
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SCHEME 1.72: Nájera’s BINAM prolinamide catalyst in aldol re-
actions between ketones and β-ketoesters. i) 20 mol % 1.18,
ClCH2CO2H.
structural or conformational restriction (or both) on catalyst performance and stere-
oselectivity, regardless of the type of reaction. Merely a brief overview of the pos-
sibilities afforded by peptide catalysts has been given. The rapidly growing field of
peptide organocatalysis has developed broad avenues into a variety of useful reac-
tions. The array of functionality and well-established chemistry for peptide synthe-
sis makes it an attractive field for further study.
1.5 Michael addition
The Michael addition is a generic term that now refers to the nucleophilic addition of
methylene nucleophile to an activated α,β-unsaturated compound, which has been
widely used as a source of C-C bond formation (Scheme 1.73). It is another term
for conjugate addition. Depending on the substrates and catalysts used the Michael
addition may be used for the stereoselective introduction of chiral centres. For the
research discussed in this work, a control experiment was required to test our new
catalysts. Michael addition was chosen because it has been well studied, and would
allow us to gain insight into catalyst behaviour and alter reaction conditions with
known variables.
The Michael addition was first described by Arthur Michael in the late 19th century
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SCHEME 1.73: Generic Michael addition. R1 and/or R2 are electron-
withdrawing groups. The base B: abstracts a proton from the methy-
lene hydrogen. R3 is an electron-withdrawing group that causes reso-
nance stabilisation such as a carbonyl, nitrile, sulfone or nitro group,
activating the alkene.
as the addition of the enolate of an aldehyde or ketone to the β carbon of an α,β-
unsaturated carbonyl compound. Since then, the definition of the Michael reaction
has broadened from its original specification to include unsaturated compounds that
contain other electron-withdrawing groups, such as nitriles and nitro groups like
trans-β-nitrostyrene (Section 1.3, Scheme 1.62); and also any 1,4-addition to an α,β-
unsaturated carbonyl compound, rather than only aldehydes; for instance the aza-
Michael reaction refers to the addition of a nitrogen nucleophile (Schemes 1.74 &
1.75); and thia-Michael addition involves addition of sulfur to the Michael acceptor
(Scheme 1.76).158–161
SCHEME 1.74: Takasu et al.’s aza-Michael addition to form tetrahy-
droisoquinoline 1.131 with asymmetric organocatalyst 1.130. i) 20
mol % 1.130, MeOH.
An example of an intramolecular aza-Michael reaction is the asymmetric organocat-
alytic synthesis of tetrahydroisoquinoline 1.131 by Takasu et al.158 This reaction was
completed in ”green” conditions, with only the organocatalyst required as reagent
and methanol and water as solvents. The opposite enantiomer of the product was
produced by changing the two 2-methyl groups of the catalyst for a t-butyl sub-
stituent.
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SCHEME 1.75: Phase-transfer-catalysed asymmetric aza-Michael ad-
dition in synthesis of Letermovir 1.133. i) K3PO4; ii) 5 mol % 1.132,
K3PO4.
Similar reactions can be catalysed by many different catalysts. The next is an exam-
ple of phase transfer catalysis in an aza-Michael addition in the synthesis of Leter-
movir (1.133, Scheme 1.75). In this reaction, toluene was used in place of alcoholic
solvents to suppress background cyclisation of the guanidine, which is catalysed
by Brønsted acids. The phase transfer catalyst 1.132 benefited from the inclusion of
electron-deficient -CF3 groups which increased performance; >99% ee was achieved
by recrystallisation of 1.133 as the di-p-toluoyl-(S,S)-tartaric acid salt.
An example of thia-Michael addition is the addition of thiol 1.136 to conjugated car-
bonyl compounds 1.135 catalysed by iron(III)-salen complex 1.134 (Scheme 1.76).
Regioselectivity for δ-addition over β-addition was enhanced by adding sterically
bulky groups at the iminyl carbons.
Michael additions are useful for synthetic chemistry since they are a gentle approach
to forming C-C bonds with β-functionalisation while controlling both regio- and
stereoselectivity. The Michael addition has been used for, for example, stereoselec-
tive installation of cyclic aldehydes in the total synthesis of the cardiotonic steroid
precursor cardenolide 1.137, with the catalyst Cu(OTf)2 providing stereochemical
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SCHEME 1.76: Iron(III)-salen complex catalysed asymmetric and re-
gioselective thia-Michael addition. i) 10 mol % 1.134, AgBF4.
control of the addition (Scheme 1.77).162
SCHEME 1.77: Michael addition in enantioselective synthesis of
steroid precursor cardenolide 1.137. i) 50 mol % Cu(OTf)2.
Nagorny and coworkers suggested Cu(OTf)2 induced formation of the major di-
astereomer via the transition state shown in Figure 1.78. The incoming nucleophile
attacks from the face which causes the least allylic strain, with the benzoyl group
facing away.
Another example of Michael addition used in natural product synthesis is in the
formation of key intermediate 1.139 in the synthesis of lycoposerramine-Z 1.140 by
intramolecular Michael addition.163 Lycoposerramine-Z is an alkaloid, isolated from
club mosses in the Lycopodium family, with possible acetylcholinesterase-inhibitory
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FIGURE 1.78: Cu(OTf)2 as asymmetric catalyst in Michael addition in
synthesis of 1.137.
activity for treatment of Alzheimer’s disease. The BINOL-phosphoric acid 1.138
catalysed the Michael addition with good enantioselectivity (Scheme 1.79, 65% yield,
>99:1 dr).
Metal complexes such as copper triflate (Scheme 1.77) and complexes of many other
transition metals including aluminium, manganese, nickel, and scandium were de-
veloped in stereoselective syntheses.164–169 In contrast, organocatalysts offer the ad-
vantage of being able to be used in the presence of water, instead of under anhydrous
conditions, as is the case for most metal complexes. In some cases the presence of
water can even enhance yield or stereoselectivity.170 Due to the utility of the Michael
addition in synthesis, there is still demand for new catalysts that improve either
yield, selectivity, functional group tolerance, substrate applicability, have milder or
greener reaction conditions, or a combination of any or all of the above.
While organocatalysts such as the phosphoric acid shown in Scheme 1.79 are also
used, most organocatalysis of Michael additions usually involve an amine catalyst.
Amine catalysis occurs in one of two main mechanisms that start with creation of a
covalent bond between the amine nitrogen of the catalyst and one of the substrates:
enamine activation and iminium activation, depending on whether the nucleophile
or electrophile is activated. Examples of both mechanisms are presented in Section
1.3.
Peptides feature heavily in the literature on asymmetric organocatalysis of Michael
additions. Proline-derived catalysts, including proline itself are also good Michael
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SCHEME 1.79: Asymmetric intramolecular Michael addition in the
synthesis of lycoposerramine-Z with chiral phosphoric acid 1.138. i)
20 mol % 1.138.
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addition catalysts. Wennemers’ oligopeptide catalysts (see Section 1.4.2) are excel-
lent catalysts of Michael addition between alkyl aldehydes and β-nitrostyrene, giv-
ing good yield and selectivity. The suggested mechanism of stereoselectivity in these
cases is hydrogen bonding between the enamine catalyst/Michael donor and the ni-
trate of the Michael acceptor holding the transition state in conformation such that
the addition of the Michael donor and the loss of proton occur syn to each other.
1.6 Conclusion
Examples discussed in this chapter illustrate just a small fraction of the utility of pep-
tides in asymmetric organocatalysis. The orientation of active groups in a catalyst
plainly impacts its stereoselectivity. [2.2]Paracyclophane offers a convenient scaffold
for arranging chemical moieties in 3D space. Therefore, the aim of this project was
to investigate new planar chiral amino acids incorporated into peptides, where we
could control the placement of substituents in space and determine if altering the
active moieties’ position and distance relative to each other affected the catalyst’s
stereoselectivity.
The three chapters to follow each discuss one of the aims of the project:
1. To develop a convenient synthetic route to a [2.2]paracyclophane-centred amino
acid;
2. To develop coupling methods for incorporating this amino acid into small pep-
tides with natural amino acids; and
3. To investigate these small peptides’ activities as organocatalysts.
Chapter 2 discusses the first aim: to synthesise a [2.2]paracyclophane amino acid.
The first target was to develop a scalable synthesis of 4-amino[2.2]paracyclophane-
13-carboxylic acid 1.141 (Fig. 1.80). The devised route should allow easy access, give
one regioisomer, and ideally allow for resolutions of the planar chirality.
Chapter 2 discusses the second aim: to incorporate 1.141 into small peptides. The
ideal peptide coupling conditions should be high-yielding with the challenging [2.2]para-
cyclophane derivative, and prevent racemisation of the amino acids.
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FIGURE 1.80: 4-Amino[2.2]paracyclophane-13-carboxylic acid 1.141
Chapter 3 discusses the third aim: to use the synthesised peptides as organocata-
lysts to investigate their activity in a stereoselective Michael addition. The small
peptides’ efficacy could be measured against other peptide catalysts in similar reac-
tions. [2.2]Paracyclophane’s unique properties were hypothesised to impact on the






A note on nomenclature
The definition of an amino acid is variable and depends greatly on context. Com-
mon usage dictates that amino acid refers to the 20 or so naturally occurring amino
acids coded by DNA. Many variations and modifications exist in nature, and even
more small molecules containing both amine and carboxylic acid moieties have been
created in vitro. These, too, can be considered amino acids and may be incorpo-
rated into amide-linked polymers, or peptides. The [2.2]paracyclophane-centred
compound that this work is focused on will be described as a pseudoamino acid,
for clarity. It is not naturally-occurring, and strictly speaking it does not contain an
amine but is better described as an aniline derivative. This, coupled with the steric
bulk and unusual electronic properties of [2.2]paracyclophane change its behaviour
in synthesis and reactivity. Thus, peptides containing a pseudoamino acid become
pseudopeptides, after Pearson’s naming of similar anthranilic acid-containing com-
pounds 2.1 (Fig. 2.1).171
For brevity, the [2.2]paracyclophane-derived pseudoamino acid 2.3 that is the fea-
ture of this project will be referred to as Pca, following similar naming conventions:
by the Heinze group and Barišić group (among others), using Fca with ferrocene
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FIGURE 2.1: Pearson’s pseudopeptide 2.1 and analogous [2.2]paracy-
clophane pseudopeptide 2.2.
2.463,64 and Schreiner’s adamantane-derived Aca 2.598 (Fig. 2.2). The pseudo-geminal
4-amino[2.2]paracyclophane-13-carboxylic acid synthesised in this thesis will be re-
ferred to simply as Pca, with other regioisomers given a descriptive prefix. For exam-
ple, 4-amino[2.2]paracyclophane-12-carboxylic acid (2.6) will be called pseudo-ortho
Pca. Pca-containing peptides will be referred to in the usual fashion for chemistry
literature, by their three-letter codes, from N-terminus to C-terminus.
FIGURE 2.2: Unnatural cyclic amino acids.
2.1 Project scope
Asymmetric organocatalysis using small peptides as the catalyst is a young and ex-
citing field of research, but many parts of its utility and control of stereoselectivity
are found by trial and error using combinatorial methods, rather than specific de-
sign from known mechanistic principles. Much is known about the effect of specific
peptide sequences on reaction rate and selectivity, but the effect of conformation is
less explored.172 For instance, in the peptide-catalysed Michael addition introduced
in Section 1.5, how does spatial orientation between the amine and the proton donor
affect stereoselectivity? Wennemers’ study of Michael addition with nitroalkenes
(discussed in Section 1.4.2) demonstrates the importance of the proton donor’s in-
teraction with the catalytic intermediate.147
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[2.2]Paracyclophane offers a unique opportunity to investigate this question. Its
rigid, bulky structure provides a scaffold around which functional groups can be
arranged in space with precision. Thus, we can manipulate the distance and an-
gle of these functional groups from each other in order to investigate how these
factors may influence stereoselectivity in the Michael addition. By controlling the
relative position of functional groups (ortho, pseudo-geminal, pseudo-ortho (Fig. 2.3))
on the [2.2]paracyclophane decks, the separation of functionality is reasonably well-
defined and its influence on stereoselectivity can be investigated.
FIGURE 2.3: Left to right: ortho, pseudo-geminal, and pseudo-ortho
substitution of Pca.
As illustrated in the literature review, there is significant interest in conformation-
ally restricted and planar chiral amino acids and peptides (using cyclic, polycyclic
or organometallic backbones) and their use in catalysis, materials, and medicinal
chemistry. In restricting conformational freedom, [2.2]paracyclophane forms a turn-
like motif common to many asymmetric organocatalysts (and also found extensively
in nature). In the first report of Pca by Pelter in 1997 there was mention of its β-turn
mimicking potential (Fig. 2.4).173 However, there have been no subsequent reports
regarding its properties in the intervening 20-plus years. Perhaps a reason for this
is the difficulty in producing the desired compound in reasonable quantity. This
project is an opportunity to find an efficient synthetic route to Pca and to explore a
small area of its potential use.
FIGURE 2.4: A β-turn-like conformation.
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2.2 Literature syntheses of [2.2]paracyclophane-centred pseudo-
amino acids
One of the selling points of [2.2]paracyclophane is the wealth of options available for
controlled installation of functional groups. There are many conceivable [2.2]para-
cyclophane-centred pseudoamino acids (or Pca) (for instance, ortho, pseudo-geminal,
pseudo-ortho (Fig. 2.5)) with fascinating possibilities: but none have been studied
in this type of chemistry. The closest example is Pelter’s preliminary work with the
synthesis of these compounds and their proposed, but never fulfilled, investigation
into their β-turn-like configuration.173
FIGURE 2.5: Substitution patterns for disubstituted [2.2]paracyclo-
phane.
The combination of [2.2]paracyclophane’s useful properties also contributes to some
of the problems encountered in synthesis. Some of the challenges associated with the
production of [2.2]paracyclophane derivatives include low solubility, side-product
formation, and difficulty separating regioisomers, enantiomers and diastereomers.
[2.2]Paracyclophane’s steric bulk can also inhibit reactions.
With this in mind, a good starting place would be the ortho-Pca. The configuration of
the carboxylic acid and amine groups resembles the successful catalysts of Pearson
(Fig. 2.1). This configuration, however, is synthetically troublesome. Obstacles the
Rowlands group have encountered in the synthesis of ortho-substituted [2.2]para-
cyclophane amines include instability of the products resulting in decomposition,
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and poor reactivity of these ortho-substituted compounds.20,174 The N-phenyl ortho-
substituted Pca was synthesised previously but the primary amine was never ob-
tained.174
2.2.1 Pseudo-ortho [2.2]paracyclophane amino acid synthesis
The pseudo-ortho Pca 2.6 is the next obvious choice as many good ligands are based
on this configuration;22,175,176 but at the initiation of this project we thought the
chemistry would be too long. One described route (Scheme 2.6)177 starts with di-
bromination of [2.2]paracyclophane 2.7,178 which always gives a mixture of products
with the pseudo-para 2.8 and pseudo-ortho 2.9 predominating. A useful quantity of
pseudo-ortho isomer 2.9 can be obtained by the thermal isomerisation of the less sol-
uble pseudo-para derivative and separation by recrystallisation based on their sol-
ubilities. The route then involves the multi-step formation of the bromo-oxazoline-
[2.2]paracyclophane 2.10, palladium-catalysed formation of the amine 2.11, and fi-
nally oxazoline hydrolysis to give the carboxylic acid. This route did have the ad-
vantage of achieving resolution of the planar chirality by the inclusion of the enan-
tiomerically pure oxazoline, which gave diastereomers that were easily separable.
2.2.2 Pseudo-geminal [2.2]paracyclophane amino acid synthesis
Pelter’s 1997 synthesis of Pca also included a shorter, but very low-yielding synthesis
of the pseudo-ortho pseudoamino acid 2.6. Therefore, pseudo-geminal Pca 2.3 was
chosen as the initial target planar chiral pseudoamino acid for this project, since it
appeared, on paper, to be the easiest to synthesise. The discussion of its synthesis
that follows might show that looks can be deceiving.
The first strand of this project was development and optimisation of a synthetic route
to pseudo-geminal Pca. Several groups, including our own, have previously reported
syntheses of this compound (or protected versions thereof).
Pelter’s first reported synthesis from the late 1990s (Scheme 2.7) started with forma-
tion and protection of the carboxylic acid 2.12 to the methyl ester 2.13.173,179,180 The
nitration was found to be particularly problematic, giving very low (<15%) yield;
additionally the substitution is not regioselective, giving a mixture of three or more
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SCHEME 2.6: Ma et al.’s synthesis of pseudo-ortho 4-
amino[2.2]paracyclophane-12-carboxylic acid. i) Fe, Br2. ii)
triglyme, heat (4 repetitions). iii) n-BuLi, CO2. iv) a. SOCl2, L-valinol
b. PPh3, CCl4. v) benzhydrylideneamine, Pd-DPPF. vi) 6 M aq. HCl,
THF. vii) aq. HCl.
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compounds with different substitution patterns. Basic ester hydrolysis and hydro-
genation complete this route to the pseudo-amino acid 2.3.
SCHEME 2.7: Pelter’s first synthesis of pseudo-geminal Pca. i) AcCl,
AlCl3. ii) KOBr. iii) CH2N2. iv) HNO3, H2SO4. v) KOH, EtOH. vi)
H2, Pd-C.
In 2000, Pelter’s group reported another synthesis by an altogether different route
employing an oxazoline to protect the carboxylic acid from attack during halogen-
metal exchange (Scheme 2.8).181 The highest yielding, most convenient synthesis
of the oxazoline involved a five-step sequence starting with bromination; a Grig-
nard formation and addition to carbon dioxide gave the carboxylic acid 2.12; amide
formation via the acyl chloride; a second, pseudo-geminal bromination; and finally
cyclisation of the β-hydroxy amide amide to the oxazoline gave the precursor 2.15.
The second bromine is converted to lithium by halogen-metal exchange and then
to a second carboxylic acid 2.16 with addition of carbon dioxide. Finally, the amine
2.17 is formed by a Curtius rearrangement and the oxazoline protecting group is re-
moved to give Pca 2.3. The amide directs the second bromination to the pseudo-gem
position. Although lengthy, the reported overall yield for this route is 45%.
Ma’s synthesis (Scheme 2.9) of oxazoline substituted [2.2]paracyclophanyl imidazo-
[1,5-a]pyridinium triflates included synthesis of Pca as a means of testing absolute
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SCHEME 2.8: Pelter’s pseudo-geminal Pca synthesis via an oxazoline.
i) Br2, Fe. ii) a. Mg, CO2. iii) SOCl2, 2-amino-2-methylpropan-1-ol.
iv) Et3N, PPh3, CCl4. v) n-BuLi. vi) CO2 then aq. acid. vii) , a. SOCl2
b. NaN3/acetone c. toluene, heat d. aq. KOH. viii) 6 M HCl.
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stereochemistry by plane-polarised light rotation.177 It followed largely the same
route as Pelter’s oxazoline route; except the amine was formed from the carboxylic
acid using different conditions. It first creates the diastereomeric oxazoline species
2.18, a masked carboxylic acid. Carboxylic acid formation on the pseudo-geminal
position by halogen-metal exchange then transformation with DPPA completes the
amine formation. This route boasts the advantage of the oxazoline synthetic interme-
diate being easily resolved by column chromatography, separating the two diastere-
omers, which after oxazoline cleavage afforded the carboxylic acid, enantiomerically
pure.
SCHEME 2.9: Ma’s pseudo-geminal Pca synthesis via an oxazoline. i)
Br2, Fe. ii) a. Mg, CO2. iii) a. SOCl2, L-valinol. b. PPh3, CCl4 iv)
n-BuLi then CO2. v) DPPA. vi) Aq. HCl.
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2.3 Syntheses of 4-amino[2.2]paracyclophane-13-carboxylic acid
in this work
The first route to pseudo-gem Pca investigated in this project was based on chemistry
being performed in the Rowlands group. This oxime methodology is adapted from
previous work detailing a one-pot oxime oxidation of an aryl aldehyde to the hy-
droxamic acid, then Lossen rearrangement to give the amine.20,182–184 A second route
which formed the amine by nitro reduction was developed in response to difficulties
with the former method. These syntheses both started from [2.2]paracyclophane 2.7,
a compound that is available cheaply in large quantities.
2.3.1 Chiral resolution
Resolution of the planar chirality of the [2.2]paracyclophane backbone was attempted
at several synthetic stages. Resolution before coupling to an amino acid or peptide
is possible, and has been shown to work well by Bräse and others; we considered
it might be more expedient to resolve the [2.2]paracyclophane backbone at a later
stage.51 The closer to the end of a synthetic route a resolution is performed, the fewer
total synthetic steps must be completed if both stereoisomers are desired. Addition
of an L-amino acid leads to the formation of diastereomers and it was anticipated
that these might be separable by standard flash chromatography.
2.3.2 Oxime methodology
At first, refinement of the oxime methodology was attempted (Scheme 2.10). This
route is short and elegant, with the amine 2.21 formed in two steps from the formalde-
hyde 2.19 by a Lossen-type rearrangement via oxime 2.20. The methyl carboxylate
acts as the directing group for the formation of the pseudo-geminal isomer.
Friedel-Crafts acylation
The first synthetic step was the direct synthesis of [2.2]paracyclophane-4-carboxylic
acid 2.12 by a Friedel-Crafts reaction between [2.2]paracyclophane and oxalyl chlo-
ride (Scheme 2.11). This avoided bromination followed by halogen-metal exchange
and addition to carbon dioxide used in the syntheses described above.
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SCHEME 2.10: Oxime route for Pca synthesis. i) a. AlCl3,
(COCl)2, b. chlorobenzene, H2O. ii) a. (COCl)2, DMF, b. MeOH.
iii) CH3OCHCl2, TiCl4. iv) NaOAc, NH2OH ·HCl. v) a. hy-
droxy(tosyloxy)iodobenzene, b. NaOH.
The Friedel-Crafts acylation forms [2.2]paracyclophane-4-(2-chloro-2-oxoacetyl) 2.22,
a remarkably stable keto-acid chloride, which may be isolated from the reaction mix-
ture without decomposition.185 The keto-acid chloride undergoes decarbonylation
upon heating, yielding the acyl chloride 2.23 which can be hydrolysed to the car-
boxylic acid 2.12 by the addition of water. Methanol can be added instead to directly
form the methyl ester, however it was found that a mixture of the desired product,
the carboxylic acid and unreacted [2.2]paracyclophane was observed; using water to
quench the reaction gives only carboxylic acid and starting material.
This step is a known reaction, but not widely used.186 In the course of this project,
the reaction was problematic, giving the acid in variable low to moderate yields, and
separation from the starting material by column chromatography was far from satis-
factory. The first step requires careful exclusion of water from the reaction vessel and
many steps were taken to remove any water present in the system. These included
flame-drying glassware; running the reaction under an argon balloon and cycling
the argon atmosphere with vacuum three times before addition of reagents; driving
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SCHEME 2.11: Friedel-Crafts acylation of [2.2]paracyclophane.
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off any residual water on reagents with heat under vacuum; and transferring the
large volume of solvent to the reaction vessel via cannula rather than syringe. These
did not seem to improve the efficiency of the reaction, which hardly ever gave above
30% yield.
Instead of forming the methyl ester directly after formation of the oxo-acyl chloride
intermediate in the previous step, the methyl ester was formed by activating the
carboxylic acid with oxalyl chloride and DMF to form the acyl chloride, which was
isolated by removing the solvent to dryness under reduced pressure (Scheme 2.12).
SCHEME 2.12: Acyl chloride formation with oxalyl chloride and cat-
alytic DMF.
The acyl chloride formation occurs first by generating the Vilsmeier reagent 2.26
from oxalyl chloride and DMF. The DMF performs nucleophilic attack on the C=O
of oxalyl chloride through its oxygen of the oxalyl chloride C=O forming the tetra-
hedral intermediate 2.24. The C=O double bond reforms and a Cl– is ejected. The
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chloride ion attacks the electrophilic C=N double bond of 2.25. CO, CO2, and Cl– are
generated along with the iminium species 2.26. This highly electrophilic intermedi-
ate is now attacked by the -OH of the carboxylic acid. The iminium reforms, ejecting
a chloride ion, which then attacks at the carboxylic acid’s electrophilic carbon. The
tetrahedral intermediate reforms the C=O bond, reforming the DMF catalyst, and
leaving the acyl chloride 2.23.
The acyl chloride was then reacted with methanol to form the desired methyl ester
(Scheme 2.13).
SCHEME 2.13: Methyl ester formation from acyl chloride.
Reiche formylation
The aldehyde 2.19 was then formed using Reiche formylation conditions.187 These
conditions have been used extensively in [2.2]paracyclophane chemistry for substi-
tution specifically at the 13- (pseudo-geminal) position when there is an electron-
withdrawing group in place at the 4-position.186,188,189 This step was high-yielding
with good purity, as found in the literature. The only drawback with these condi-
tions is the use of TiCl4 which requires careful handling since it exothermically forms
hydrogen chloride upon contact with water and other weakly basic solvents. This
reaction is well-established as a carbon-carbon bond forming method in cyclophane
chemistry due to their electron-rich nature making them a suitable substrate.51,190,191
The mechanism of the Reiche formylation begins with generation of the electrophile
from 1,1-dichlorodimethyl ether. Nucleophilic attack from the 13-carbon to the chloro-
methyl carbocation 2.27 of the substrate gives the Wheland intermediate 2.28. Gen-
erally in Reiche formylation, in the next step a chloride ion abstracts a proton, restor-
ing aromaticity. In the [2.2]paracyclophane system, the ester on the opposing ring
abstracts this proton. A further chloride ion is ejected and a molecule of water adds
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to the oxonium electrophile 2.29. The hemiacetal 2.30 is protonated at the acetal
oxygen, making methanol a good leaving group. Finally, the aldehyde product is
deprotonated 2.19 (Scheme 2.14).
SCHEME 2.14: Reiche formylation of 4-formyl[2.2]paracyclophane
2.13.
The rate-determining step in electrophilic aromatic substitution is usually the initial
step which destroys aromaticity. In this formylation, the proton abstraction seems
to be the rate-determining step. The transannular effect could be thought of as sta-
bilising the carbocation through resonance, but more important is the ability to re-
move the proton. This is illustrated by the fact a nitrile group in the same position
does not direct addition to the pseudo-gem position as it is linear and the lone pair
has the wrong orientation. The methyl ester on the opposite deck assists in proton
abstraction and directs the substitution to the pseudo-gem position. The regiospeci-
ficity may also be enhanced by the TiCl4 coordinating with the oxygen atoms of
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the 1,1-dichlorodimethyl ether and methyl [2.2]paracyclophane-4-carboxylate.187,192
This aligns the substrate for attack from the 13-position of [2.2]paracyclophane and
increases the electrophilicity of the substrate, and hence gives pseudo-gem substitu-
tion.
Limiting the equivalence of the alkylating reagent (1,1-dichlorodimethyl ether) to
1.05-1.10 helps prevent over-alkylation. Additionally, the steric bulk of the ethy-
lene bridges of [2.2]paracyclophane may help prevent additional aryl carbons being
derivatised. This reaction was found to give the best results on smaller scales (up to
5 g): larger scale syntheses than this had a lower yield and decreased purity. This
may be simply because inert technique was more difficult on larger scales. Larger
flasks are more difficult to evacuate of atmospheric water completely and it is more
likely that larger quantities of reagents or solvents will retain residual water after
drying. This residual water would quench the reagents before they react with the
[2.2]paracyclophane.
The regiochemistry of formylation was confirmed by 1H NMR spectrum of the formy-
lated product, 13-formyl[2.2]paracyclophane-4-carboxylic acid 2.19 (Fig. 2.15 and
Fig. 2.16). The peak pattern of the aromatic protons is consistent with a 4,13-substi-
tution pattern on [2.2]paracyclophane, and can be observed in the spectra of pseudo-
geminal compounds throughout this work.
FIGURE 2.15: 1H NMR spectrum of 2.19.
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FIGURE 2.16: 13-Formyl[2.2]paracyclophane-4-carboxylic acid 2.19.
The H5 and H12 protons are assigned to the overlapping peaks at 7.07 ppm with J
= 2.4 Hz, indicative of meta coupling. H8 and H15 are the doublets at 6.64 and 6.61
ppm with J = 7.8 Hz. This is the ortho coupling; the para coupling with H5 and H12 is
not present. H7 and H16 are the last pair of aromatic protons seen in the spectrum as
the two overlapping dd peaks at 6.7 ppm with J = 5.7, 2.0 Hz, indicative of their ortho
and meta coupling partners, respectively. This peak coupling pattern is indicative of
pseudo-gem substitution.
Oximation
The oximation using hydroxylamine hydrochloride was undemanding, using hy-
droxylamine hydrochloride, with NaOH to remove the hydrochloride salt. In this re-
action, hydroxylamine condenses with the aldehyde, forming the resonance-stabilised
oxime (Scheme 2.17). This reaction proceeded in high yield and purity.
Oxime rearrangement to amine
The final step was one-pot oxidation-rearrangement of the oxime to the amine via
the hydroxamic acid. This used Koser’s reagent and then NaOH. This is presumed
to involve a Lossen-type rearrangement.
Originally, the plan was to go directly to the amine. The expected reaction was
initially Beckmann rearrangement without competition from fragmentation to form
the nitrile; followed by basic amide hydrolysis (Fig. 2.18).193 However, isolation of
the hydroxamic acid intermediate suggested a different mechanism.
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SCHEME 2.17: Hydroxylamine condensation with 2.19, affording
oxime product 2.20.
SCHEME 2.18: Mechanism for proposed Beckmann rearrangement to
form amine.
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The first stage of this mechanism is oxidation of the oxime to the hydroxamic acid,
mediated by Koser’s reagent 2.31.182,184,194 Koser’s reagent, or hydroxy(tosyloxy)-
iodobenzene (Fig. 2.19), is a useful hypervalent iodine reagent for oxidation as an
alternative to heavy metal reagents.
FIGURE 2.19: Koser’s reagent 2.31.
The oxime oxygen attacks the iodine and displaces tosic acid. Rearrangement expels
Ph(OH)I, giving the intermediate 2.32, which is deprotonated to give the nitrile ox-
ide 2.33. The nitrile oxide undergoes nucleophilic attack by the OH- generated from
the Koser’s reagent. Tautomerisation results in the hydroxamic acid 2.34 (Scheme
2.20).
SCHEME 2.20: Oxime rearrangement to hydroxamic acid mediated
by Koser’s reagent.
A modified Lossen rearrangement using base with no external activating reagent
was employed to form the amine from the hydroxamic acid.183 The apparent path-
way involved firstly the generation of a small quantity of the isocyanate 2.36 which
then participated in a chain reaction which furnished the final amine (Scheme 2.21).
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SCHEME 2.21: Proposed mechanism for Lossen-type rearrangement
to amine via an isocyanate.
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First, the isocyanate reactive intermediate is generated from reaction of two hydrox-
amic acid molecules to give the O-acylhydroxamate 2.35, which rearranges to form
the isocyanate 2.36 and a molecule of the corresponding carboxylic acid. This dif-
fers from traditional Lossen rearrangement where an activating agent, such as tosyl
chloride, is required to make the hydroxyl group into a good leaving group, allow-
ing conversion of the hydroxamic acid to the isocyanate.
Further, in a standard Lossen rearrangement, hydrolysis of the isocyanate requires
water, but here, the reaction has a higher yield in anhydrous conditions, since the
isocyanate must react with more hydroxamic acid. The formed isocyanate enters
the chain reaction cycle and is attacked by the hydroxamic acid. This dimer under-
goes rearrangement to produce carbon dioxide, one molecule of the amine, and one
molecule of the isocyanate; the latter of which goes on to complete another chain
reaction cycle.
The reaction did not behave as predicted through the Beckmann rearrangement, in-
stead proceeding via the hydroxamic acid, causing yield and purity issues. The yield
was highly variable, ranging from less than 10% to a maximum of 53%, with very
poor purity. Column chromatography was inconsistent at affording the pure prod-
uct. The hydroxamic acid intermediate could be isolated in high yield and purity,
indicating that the problematic step of the reaction was the Lossen-type rearrange-
ment. Other members of the Rowlands group found acceptable results forming 4-
amino-13-bromo[2.2]paracyclophane 2.37 with 65% yield in the final hydroxamic
acid rearrangement (Scheme 2.22).20
SCHEME 2.22: Synthesis of 4-amino-13-bromo[2.2]paracyclophane
2.37. i. Koser’s reagent then NaOH.
It is possible that intramolecular hydrogen bonding between the hydroxamic acid
and carboxylate substituents on the two opposing faces of paracyclophane prevented
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the rearrangement from proceeding. Other problems included hydrolysis of the es-
ter and involvement of the acid. Synthesis of the monosubstituted 4-amino[2.2]pa-
racyclophane via the oxime, to avoid interference of other functional groups did not
improve the yield of the oxime rearrangement. Difficulties were encountered by
other members of the Rowlands group in the synthesis of similar molecules, so the
roadblock at this final step meant development of an alternative route to Pca was
valuable.
Ester hydrolysis
The first route to Pca concluded with hydrolysis of the methyl ester. A methyl ester
was employed as a protecting group in the oxime methodology for synthesis of Pca.
Several conditions for hydrolysis of this ester according to Scheme 2.23 were tested
and are listed in Table 2.1.
SCHEME 2.23: Ester hydrolysis of Pca-OMe 2.21 to Pca 2.3.
Basic ester hydrolysis occurs by a hydroxide ion attacking the carbonyl electrophile
to form the tetrahedral carbon intermediate. The carbonyl C=O bond is restored, and
with loss and gain of a proton, the alkyl protecting group leaves as the correspond-
ing alcohol: here, methanol (Scheme 2.24). Formation of the carboxylate drives the
equilibrium to favour the products.
SCHEME 2.24: Basic ester hydrolysis mechanism.
Previously our group used the conditions in the first entry of Table 2.1: 0.067 M
3:1 MeOH/H2O, 5 eq. KOH, at 50 °C as reported.195 They were found to return
approximately 20% of the material as the methyl ester as determined by 1H NMR.
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This could be avoided by running the reaction either at reflux in the same solvent
mixture (entry 2) or at 50 °C in 3:1 EtOH/H2O (entry 3), which both gave the desired
free carboxylic acid with only trace amounts of the appropriate returned ester. Using
ethanol as solvent improved the solubility of the starting material, pushing more of
the ester to be hydrolysed. The ratio of 3:1 EtOH/H2O at 50 °C was deemed most
desirable since it required a lower energy input.
Solvent system Temperature Product yield Returned ester
3:1 MeOH/H2O 50°C 60% 20%
3:1 MeOH/H2O reflux 80% 0%
3:1 EtOH/H2O 50°C 90% 0%
TABLE 2.1: Conditions tested for ester hydrolysis of Pca-OMe 2.21.
All reactions used 5 eq. of KOH, and solvent was used at 0.067 M for
the substrate.
2.3.3 The nitro group methodology
The oxime methodology for synthesis of Pca was discarded after several attempts at
the oxime rearrangement failed or could not be purified. Additional problems were
encountered in yield and purity of the initial carboxylic acid formation. For these
reasons, developing a more straightforward and easy to execute synthetic route
seemed more efficient. It took much longer than anticipated to optimise this new
methodology. However, the nitro methodology performs better, giving moderate
yield with high purity, and takes only four steps to obtain Pca. The four steps give
Pca in 34% and increases to 47% when considering returned starting material.
This method used simpler transformations that had more potential for optimisation
and to be scaled up to allow for production of a large quantity of this key material.
First, nitration 2.38 of [2.2]paracyclophane installed the amine precursor. This was
followed by formylation 2.39 of the opposing face; then oxidation of the aldehyde to
the carboxylic acid 2.40; and finally reduction of the nitro to the primary amine 2.21,
as summarised in Scheme 2.25.
Both the nitro group or the acid can participate in the transannular effect and direct
to the pseudo-gem position so either functional group might be appended first. It
was advantageous to form the carboxylic acid second since it introduces solubility
issues; and its acid-base properties could be utilised for purification of the material.
92 Chapter 2. Synthesis of 4-amino[2.2]paracyclophane-13-carboxylic acid
SCHEME 2.25: Nitro route for synthesis of Pca. i) HNO3, H2SO4. ii)
TiCl4, CH3OCHCl2. iii) KMnO4. iv) Zn, NH4Cl.
Further, at the outset of the development of this method, the nitration was the largest
unknown due to the variance and poor performance of conditions used in [2.2]para-
cyclophane chemistry; this step’s success or failure would determine the viability of
this synthetic route.
This route, as with the previous oxime methodology, includes methyl ester protec-
tion of the carboxylic acid. In the nitro methodology, the carboxylic acid does not
need to be protected since the nitro reduction proceeds well with the carboxylic acid
unprotected. However, protection of the carboxylic acid was necessary for elabora-
tion of the amine in the completed Pca. The methyl ester protection gave the product
in high yield wherever it was carried out in the synthetic route (Scheme 2.26). A con-
venient place in the route to complete it was before reduction of the nitro group to
the primary amine.
Nitration
The route starts with nitration by electrophilic aromatic substitution. This route was
not considered as the first choice due to inconsistency in the literature yields, and
previous difficulty in the Rowlands lab with nitration of [2.2]paracyclophane com-
pounds. [2.2]Paracyclophane can be considered as an electron rich aromatic system
and is prone to multiple reactions or nitrations under standard conditions. Pelter’s
nitration conditions using 1:1 sulfuric acid and nitric acid at room temperature gave
a very low yield and generated side products with multiple points of nitration.173
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FIGURE 2.26: Methyl ester protection of carboxylic acid in nitro
methodology. i) a. SOCl2 b. MeOH.
Paradies et al. describe a nitration of [2.2]paracyclophane in harsh conditions with
heating.196 In these conditions, glacial acetic acid rather than sulfuric acid is used to
generate the nitronium electrophile. Even employing rigorous temperature and time
control, the authors report at best a 30% yield. This result was replicated, however
these conditions always produce a large proportion of side products and the reaction
procedure could perhaps best be described as finicky, with challenging purification.
While giving some limited success, these conditions were discarded in favour of de-
velopment of more gentle, controlled conditions. Sulfuric and nitric acid were used
as in Pelter’s nitrations, here in the stoichiometry of 4 and 2 equivalents respec-
tively; however the reaction was performed at low temperature (0°C). Important for
the success of this reaction was using dichloromethane and the solvent at low tem-
perature. Dichloromethane has acceptable solubility of [2.2]paracyclophane at (0°C).
These conditions were favoured because the formation of side products was slower,
allowing the reaction to be run overnight. Even under these conditions a black, tar-
like substance was formed. It was essential that the reaction mixture was decanted
from this tar otherwise the work-up became difficult. An emulsion would form that
prevented a good yield being obtained.
These conditions gave higher yield, usually between 80 - 90%, with the side products
able to removed using column chromatography or recrystallisation. The difference
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in yield is probably due to the lower reaction temperature simply slowing the for-
mation of undesirable products such as multiply-nitrated [2.2]paracyclophane.
The mechanism of all the methods described above is the same: an electrophilic aro-
matic substitution. The acetic or sulfuric acid generates the nitronium ion 2.42, a
good electrophile. [2.2]Paracyclophane attacks to generate the arenium ion inter-
mediate 2.43, from which the conjugate base of the initial acid abstracts a proton
and aromaticity is restored (Scheme 2.27). We believe problems arise when over-
nitration, oxidation or skeletal rearrangement of [2.2]paracyclophane occurs under
these still harsh conditions.
SCHEME 2.27: Nitration of [2.2]paracyclophane.
Formylation
The Reiche formylation used in the oxime methodology was also employed with
good results here. No optimisation was required. This reaction proceeded well on
4-nitro[2.2]paracyclophane 2.38 (Scheme 2.28) with yields averaging 80%. Even with
the strongly electron withdrawing nitro group, [2.2]paracyclophane can still be con-
sidered a good nucleophile on the non-substituted deck. The product 2.39 was easily
purified using column chromatography. These conditions are discussed in more de-
tail in Section 2.3.2.
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SCHEME 2.28: Formylation of 4-nitro[2.2]paracyclophane.
Resolution of 4-nitro-13-carboxy[2.2]paracyclophane
Reversible imine formation between a chiral amine and the 4-nitro-13-carboxy[2.2]-
paracyclophane was investigated to determine the suitability for resolution of the
RP- and SP- stereoisomers at this step in the synthesis. Imine formation between
(S)-1-phenylethylamine 2.44 and the aldehyde group of 4-nitro-13-carboxy[2.2]para-
cyclophane 2.39 was easily performed and using (S)-1-phenylethylamine gave the
product as a mixture of diastereomers, (RP,S)-2.45 and (SP,S)-2.45, which if sepa-
rated, could undergo imine hydrolysis to yield the title compound in enantiomeri-
cally pure form (Scheme 2.29). While the imine formation was successful and reso-
lution by recrystallisation of the imine was proven possible, the recrystallisation was
unreliable, and therefore this method of resolution was not used.
SCHEME 2.29: Synthesis of 2.45.
[2.2]Paracyclophane compounds tend to readily solidify due to their limited solubil-
ity and rigid structure with strong ability for π-π interactions that encourage uniform
packing. 1-Phenylethylamine has been used as a resolving agent in similar cases,
such as the mono-aldehyde 4-carboxy[2.2]paracyclophane.51,197
The best recrystallisation conditions for the imine were dissolving in hot toluene
with slow cooling to -18°C; however it did not produce crystals suitable for X-ray
crystallography. [2.2]Paracyclophane derivatives tend to produce needles or long,
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flat crystals that are difficult to examine with X-ray crystallography. All but the
largest needle-shaped crystals are difficult to align in the X-ray beam.
One diastereomer of the product could be crystallised from the crude reaction ma-
terial (Scheme 2.29). The mother liquor is enriched in the other diastereomer. This
was seen in the proton NMR spectrum of imine 2.45 before crystallisation, and after:
two peaks at 8.36 and 8.23 ppm are seen for the C(H)=N proton, each relating to one
diastereomer, in the unresolved imine’s spectrum; the crystals’ spectrum shows only
one peak. The mother liquor’s 1H NMR contains the two peaks but is enriched in
the other peak (Fig. 2.30). Without X-ray crystallography data it proved impossible
to determine which diastereomer is which.
FIGURE 2.30: The C(H)=N peak region on the 1H NMR spectrum
of 2.45. Bottom to top: unresolved mixture of diastereomers (blue);
crystals of pure diastereomer (red); enriched mother liquor (green).
An additional problem was that ideal conditions that reliably produced crystals
were difficult to deduce since the compound was equally likely to form an oil as
a solid after work up. If there was too much solvent remaining in the oil, crystals
would not form using any method. Trituration did not improve the outcome.
The crude imine product could not be purified using silica gel chromatography since
the acidity of the silica was sufficient to cleave the imine. In fact, one method of
cleaving the imine after resolution of the diastereomers used in this project was stir-
ring the compound in a thin silica/CH2Cl2 slurry. This method was devised after
observing significant cleavage of the imine after attempted purification of 2.45 on a
silica gel column and is also used in the literature.197
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Cleavage of the imine after separation of the diastereomers afforded enantiopure or
enantioenriched (in the case of the diastereomer that remained in the mother liquor)
(RP)-2.39 and (SP)-2.39. These enantiomers are identical to most forms of analysis
(NMR, mass spectrometry, IR); chiral HPLC on an OD-H column can distinguish
between the enantiomers.
This method for resolving the enantiomers of the [2.2]paracyclophane derivative
was not favourable since we could not find conditions to reliably crystallise the com-
pound.
Aldehyde oxidation to carboxylic acid
There are a wealth of options for oxidation of an aldehyde to a carboxylic acid: from
the reagents familiar from undergraduate chemistry courses, like Cr(IV) species (chro-
mate or dichromate salts), Cu(II) salts (Benedict’s and Fehling’s reagents) and KMnO4;
to sodium chlorite and hypochlorite, orthoperiodic acid, potassium peroxymono-
sulfate, aerobic oxidation and others.198–203 While it is a textbook reaction, it is not
necessarily that easy in practice, as was proven here.
Oxidation by potassium permanganate was initially avoided due to harsh condi-
tions and problems other Rowlands group members had encountered. As the ni-
tration had shown, [2.2]paracyclophane and the nitro derivative are not as robust
as we expected under strongly oxidising conditions. Concerns about its interference
with other functional groups were raised in similar [2.2]paracyclophane compounds
as observed by an intern working in our group.204 For this reason, and since such a
wealth of options exist for oxidising an aldehyde to a carboxylic acid, we screened a
variety of other reagents first.
Pinnick oxidation conditions were chosen first, since it is a mild method that does
not interact with other functional groups and is effective with sterically hindered
compounds (Scheme 2.31).198 These conditions met a small initial success, yielding
approximately 5% (as measured by NMR spectroscopy) of the carboxylic acid. This
was unrepeatable on following attempts with the same conditions, and no attempts
at varying conditions were successful. Solvents tested were DMSO/H2O, and also
MeCN/H2O which enabled the reaction to be run cooler than room temperature;
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and increasing the equivalence of the reagents all resulted in no increase in conver-
sion to the desired carboxylic acid.
SCHEME 2.31: Pinnick oxidation of 2.39.
The reaction mechanism is detailed in Scheme 2.32: First the aldehyde 2.39 is proto-
nated and the chlorite attacks the aldehyde’s carbonyl carbon. The tetrahedral inter-
mediate rearranges 2.46 in a 5-membered transition state to oxidise the aldehyde to
the carboxylic acid 2.40 and reduce the chlorine atom to hypochlorous acid.
SCHEME 2.32: Oxidation mechanism of aldehyde 2.39 using Pinnick
conditions.
2-Methyl-2-butene is present in excess as a chlorine scavenger (Scheme 2.33): its
C=C undergoes addition from the HOCl, removing the generated HOCl from the
reaction mixture. This prevents hypochlorite from participating in side reactions
with the chlorite that hinder the aldehyde oxidation.
SCHEME 2.33: 2-Methyl-2-butene as chlorine scavenger.
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On the small scale this reaction was attempted (<100 mg) it is possible that mea-
suring inaccuracy meant that less than the 1.75 molar equivalents necessary of 2-
methyl-2-butene were present to halt the formation of the chlorine dioxide that im-
pedes oxidation. The container of 2-methyl-2-butene present in the lab was also over
20 years old and may have degraded upon storage. As other oxidants, listed below,
did not work it is possible that either the electron withdrawing nitro group hinders
oxidation, or that the sterically challenging pseudo-gem aldehyde cannot be easily
attacked and hence slows oxidation.
Nonetheless, alternative conditions for oxidation of the aldehyde by NaClO2 were
investigated, using TEMPO with NaClO as a catalyst.205 Although these conditions
were designed for oxidising primary alcohols to the carboxylic acid, since they quickly
convert the intermediate aldehyde to the carboxylic acid, they are commonly used
for this oxidation and are suitable for the purpose of the required transformation.206,207
In a similar vein, NaClO oxidation catalysed by TEMPO and KBr was investigated,
both in aqueous solvent and in a two-solvent system with phase-transfer catalyst
(Starks’ catalyst).208 These conditions all returned only starting material.
Potassium peroxymonosulfate (KHSO5) in DMF, conditions previously shown to
perform well with aromatic aldehydes with an electron withdrawing group,202 were
also used and found to be ineffective with 4-nitro-13-carboxy[2.2]paracyclophane.
An oxidation of 4-acetyl[2.2]paracyclophane to the carboxylic acid reported by Richards
et al.209 using hyperbromite was also ineffective. It appears that in the latter case, the
nitro substituent interferes with the oxidation since Richards’ oxidation was on the
monosubstituted acetyl compound.
It was clear that the oxidation of 2.39 was more challenging than we had originally
envisaged. Seeking further options, potassium permanganate was tested as an oxi-
dant and found to be suitable in this case. Oxidation occurred to give 2.40 with 65%
yield along with recovery of 30% starting material. This makes the yield 95% with
respect to recovered starting material. We suspected that the incomplete reaction of
the starting material could be due to either the reduced manganese reagent reacting
with remaining KMnO4; or that the acetone solvent was itself being oxidised by the
KMnO4. Evidence for the latter was the smell of acetic acid detected during work
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up. Steps to counteract the incomplete reaction of the substrate included the addi-
tion of HCl to the reaction mixture to increase the oxidising potential; adding further
equivalents of KMnO4 part-way through the reaction time; and using t-BuOH as sol-
vent instead of acetone. Unfortunately, these all proved ineffective. The best course
of action was to collect the returned starting material and repeat the reaction.
The reaction mechanism is assumed to proceed in the usual manner for a KMnO4
oxidation (Scheme 2.34).210,211 Water attacks the C=O electrophile, giving the hydrate
2.47. One oxygen atom attacks the permanganate, then proton transfer oxidises the
tetrahedral carbon to give the carboxylic acid 2.40.
SCHEME 2.34: Oxidation of aldehyde 2.39 using KMnO4.
While this methodology gave the desired product, the work-up could be problem-
atic with the metal waste causing turbidity which can disguise the aqueous/organic
solvent interface. This could be minimised by filtering the crude reaction mixture to
remove the solids. However, this decreased the yield of the product from approxi-
mately 60% to 30%, which was probably simply due to incomplete extraction of the
product from the retained solids during filtration. A better alternative to expedite
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work-up was using a straight-walled separating funnel, rather than a round shaped
funnel, which allowed the layers to settle much faster. Addition of an acid to the re-
action mixture at the start of the reaction did not increase conversion of the starting
material to the product.
The inclusion of a carboxylic acid allows acid/base extraction protocol to remove
any impurities, and isolate unreacted starting material. In fact, this step is so effec-
tive at delivering the pure compound that the previous two nitration and formyla-
tion steps can be completed without further purification, and the crude 4-nitro-13-
formyl[2.2]paracyclophane may be used in this reaction. The acid/base work up de-
livers pure 4-nitro[2.2]paracyclophane-13-carboxylic acid with good yield (Scheme
2.35).
SCHEME 2.35: Acid/base work up procedure for aldehyde oxidation.
The purification involved the following steps: first the solvent is removed from the
crude organic extract since it contains a large volume of acetone which can inhibit
complete separation of the starting material and product in the next step. The solids,
containing a mixture of the aldehyde starting material, the carboxylic acid, retained
impurities from previous steps, and their side products, are partitioned between
EtOAc and 2 M aqueous NaOH with vigorous stirring. The EtOAc layer contains
the unreacted aldehyde starting material, and may be concentrated to recover it. The
aqueous layer contains the sodium carboxylate salt of the desired product, which
may be retrieved by acidifying the solution to around pH 2-3 with HCl. The car-
boxylic acid precipitates from solution and can be collected by filtration or organic
102 Chapter 2. Synthesis of 4-amino[2.2]paracyclophane-13-carboxylic acid
extraction of the aqueous phase. Filtration may give a slightly purer product than
extraction but at the cost of lower yield.
Resolution of 4-toluenesulfonylamido[2.2]paracyclophane-13-carboxylic acid
A possible method for resolution of [2.2]paracyclophane carboxylic acid derivatives
that was considered was recrystallisation of diastereomeric salts. Due to difficulties
recrystallising the desired compound discussed below, this method of resolution
was not developed further.
Members of the Rowlands group used cinchonine 2.49 to form a salt with the car-
boxylic acid of N-tosyl Pca 2.48 (Scheme 2.36).20,212 Since tosylation of the amine
was not part of the synthetic pathway, this method for resolution added an extra
two steps: tosylation and then deprotection. There were also concerns about the
ease of cleavage of the tosyl group from the nitrogen. Despite these apprehensions,
resolution of N-tosyl Pca by recrystallisation of the cinchonine salt was trialled as
a possibility, since this resolution would also as a model for the Pca system. Re-
crystallisation conditions would be expected to be comparable between Pca and its
N-tosyl derivative.
According to previous work in the Rowlands group, crystallisation of the salt was
attempted using minimal hot acetone. The cinchonine in stock was not soluble in
acetone, nor was the salt formed in these experiments. Using methanol instead of
acetone produced satisfactory results. The salt 2.50 formed with high yield and pu-
rity and one diastereomer of the salt crystallised with hot methanol. The salt was
neutralised with hydrochloric acid and the resultant 4-toluenesulfonylamido[2.2]pa-
racyclophane-13-carboxylic acid was >99.9% enantiopure. The yield of this experi-
ment is low but could be improved by optimisation of the protocol. The experiment
was run at a small scale (100 mg), and the amount of transfer loss at this scale was
significant. In the starting material the two enantiomers were present in 1:3 ratio
due to use of previously enantioenriched material.
This result was confirmed by HPLC. Enantiomer A has a retention time of 13.232
minutes on an AD-H column running 80:20 hexane/i-PrOH @ 1 mL/min and enan-
tiomer B has a retention time of 17.506 minutes. No crystal structure was obtained
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SCHEME 2.36: Resolution of 2.48 by crystallisation of the cinchonine
salt. i) MeOH. ii) crystallisation and collection of the crystals. iii) HCl.
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so the absolute configuration of the enantiomers is not known.
Successive crystallisations would produce an enriched mother liquor; however if
both enantiomers of 2.50 were required perfectly enantiopure it might in theory be
possible to achieve this by also running the same crystallisation method with the
pseudo-enantiomer of cinchonine, cinchonidine 2.51 (Fig. 2.37). With the same stere-
ochemistry in the piperidine cyclic system, the compound is often used to achieve
resolution of the opposing enantiomer to cinchonine.
SCHEME 2.37: Cinchonidine.
Resolution of 4-nitro[2.2]paracyclophane-13-carboxylic acid
Following the success of using chiral alkaloids to separate the diastereomers of other
[2.2]paracyclophane carboxylic acids, cinchonine was used as a resolving agent for
4-nitro[2.2]paracyclophane-13-carboxylic acid 2.40 (Scheme 2.38).
SCHEME 2.38: Attempted resolution of 2.40 with cinchonine.
However, no crystals of this compound could be formed from conditions tested: sol-
vents tested were acetone and methanol, with both hot recrystallisation and slow
evaporation tested for each. The pseudo-enantiomer of cinchonine, cinchonidine,
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was also tested but no success was found in crystallising this salt either. Since few
crystallisation conditions were tested, it is quite possible that this is a viable route.
Resolution at this stage was abandoned since no progress was made after some time
and we suspected after formation of pseudopeptides with Pca and natural amino
acids, the diastereomeric compounds might be easier to resolve by column chro-
matography or recrystallisation.
Nitro reduction to amine
Aryl nitro reduction is another transformation that is documented with a large num-
ber of reagents described in the literature - to name just a few: catalytic hydrogena-
tion (on Pd or Pt), hydrazine, Fe/H+, Sn(II) and Na2S. The reduction has been
described in the [2.2]paracyclophane literature, as well, with reagents employed
including Adam’s catalyst (Pt(IV) oxide) and Pd-C catalysed hydrogenations and
Fe/HCl.173,196,213–217 However, none of the described methods have resulted in such
an unusual compound that is both an electron rich aniline analogue or a bidentate
aryl pseudoamino acid.
Previously, the Rowlands group has used iron with hydrochloric acid to reduce
4-bromo-13-nitro[2.2]paracyclophane, so these conditions were considered a good
starting point for the reduction of 4-nitro[2.2]paracyclophane-13-carboxylic acid 2.40.215
While these conditions gave the desired product, the yield was an unattractive 50%.
Worse, the reaction produced a mixture of amino acid and a significant amount (ap-
proximately 20%) of a side product: the methyl or ethyl ester of the carboxylic acid,
depending on the alcoholic solvent used. The alcoholic solvent was required due to
solubility issues. While the ester is easily hydrolysed using basic ester hydrolysis
conditions, other concerns lead to a search for more appropriate means of reduc-
ing the nitro group to an amine. These concerns were that high pH raised safety
concerns when the reaction was performed at larger scales, and made neutralisation
time consuming and increased the volume of the aqueous phase; and that solubility
of the product is low in most common laboratory solvents, which, combined with
dilution of the aqueous phase, made extraction of the product from the bulk reaction
mixture during work up laborious and inefficient.
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Reduction using tin and hydrochloric acid had similar problems as the iron con-
ditions; in addition, separation of the product from the residual tin was difficult.
Thus, the product could not be analysed by NMR spectroscopy, due to the presence
of the paramagnetic tin which causes peak broadening. The quality of the spectrum
may have been further deteriorated by coordination of the ions to the [2.2]paracy-
clophane compound.
As a result we decided to screen other reductions. Reducing conditions with sodium
borohydride and nickel(II) chloride produced no reaction.218
Catalytic hydrogenation,219 another method for the reduction of nitroarenes that
uses palladium on charcoal also produced some initial success with traces of product
but the yield could not be improved much. Addition of an acid, such as hydrochlo-
ric acid, to the reaction mixture increased the yield from 30%, since amines have the
tendency to adsorb to the palladium catalyst. Acidification causes the lone pair on
the nitrogen to be unavailable for adsorption. This method had the advantage of an
easy work up: merely filtration over celite. However, the reaction was slow and took
over 16 hours at 50 °C, which is much longer than usual for a catalytic hydrogena-
tion. The extended reaction time resulted in the formation of side products that we
suspect are cleavage of the ethylene bridges of [2.2]paracyclophane.
Zinc activated with ammonium chloride was found to be a milder reduction that
produced less side product, giving <5% methyl ester.220 This zinc reduction pro-
ceeds by the following mechanism, where the ammonium chloride is the acid and
zinc is the electron donor (Scheme 2.39).
A N-O- oxygen is protonated by ammonium chloride. Zinc donates two electrons,
one at a time, to the positively charged nitrogen atom, creating a negative charge
on the unprotonated oxygen, which is then protonated by another molecule of am-
monium chloride. An oxygen is further protonated to the positively charged state,
making a good leaving group. Expulsion of the water molecule creates the proto-
nated nitroso compound 2.52. Single electron transfer (from zinc) to the nitrogen
gives the free radical 2.53. This is quenched by a further single electron transfer
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FIGURE 2.39: Reduction of the aryl nitro group to the amine with zinc
and ammonium chloride.
and subsequent protonation of the nitrogen atom, giving the intermediate hydrox-
ylamine 2.54. Protonation of the -OH moiety allows water elimination. Two final
single electron transfers and then nitrogen protonation forms the amine. The change
in formal charge of the nitrogen from +4 to -2 requires 3 equivalents each of zinc and
ammonium chloride.
These conditions were favourable compared to the conditions using iron and hy-
drochloric acid, or catalytic hydrogenation; the yield was acceptable at 65-80%, and
very little side product formation occurs. The literature example of this reduction on
2-nitroazobenzene runs for only 2 hours, where reduction of nitro[2.2]paracyclophane
derivatives required overnight heating. [2.2]Paracyclophane’s slower reaction time
could be due to its bulkiness and decreased reactivity of the nitrogen.
Filtration of the crude reaction mixture yields a mixture of the desired product and
the remaining ammonium salts. This crude material matches the pure amine by
TLC, 1H NMR and mass spectrometry analysis; however the reaction yield is in-
flated to over 100%. The salt is easily removed by washing the crude solid with
water.
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The small amount of methyl ester side product was deemed acceptable, especially
since amine derivatives of [2.2]paracyclophane make purification by chromatog-
raphy difficult, with many compounds co-eluting despite retention factor gaps of
greater than 0.3; they also tend to streak or even remain at the top of the silica. Since
silica is acidic it can bond to the basic amines on the compound and inhibit their elu-
tion. In the case of 4-amino[2.2]paracyclophane-13-carboxylic acid, the compound
may form a zwitterion that is highly attracted to silica and does not elute smoothly.
It is also possible that the compounds exhibit intermolecular hydrogen bonding so
are not cleanly separable. Additionally, removal of the methyl ester was often un-
necessary since most synthetic pathways involved formation of the methyl ester.
Since the 4-amino[2.2]paracyclophane-13-carboxylic acid product is problematic to
purify by column chromatography due to its tendency to adhere to the silica and
streak down the column, attempts were made to purify at this step by recrystallisa-
tion. No suitable solvent system was found. This compound is remarkably insoluble
in most solvents, with DMSO and DMF the only solvents which allow full dissolu-
tion.
Methyl ester protection of the carboxylic acid
As discussed above, methyl ester protection of the carboxylic acid can occur at sev-
eral points in the synthesis of Pca. The most effective method is largely the same
as in the oxime methodology: acyl chloride formation in neat thionyl chloride, then
reaction with dry methanol (Scheme 2.40). Other ester protection methods that were
trialled included acyl chloride formation with oxalyl chloride and an interesting set
of conditions involving oxone (KHSO5); these were not used since they gave less
complete conversion to the ester or were more time-consuming.




An updated route to 4-amino-13[2.2]paracyclophane-carboxylic acid (Pca) was de-
veloped and optimised (Scheme 2.41). The synthetic route comprises four steps with
an overall yield of 50%. This compares with previous routes which had yields be-
tween 7% and 45% for 6 - 7 steps. The synthetic route is as follows: first, [2.2]para-
cyclophane is nitrated. Then, formylation gives the pseudo-geminal aldehyde. The
aldehyde is oxidised, furnishing the carboxylic acid. The nitro group is reduced to
the amine, giving Pca.
FIGURE 2.41: Optimised route for synthesis of Pca. i) HNO3, H2SO4.
ii) TiCl4, CH3OCHCl2. iii) KMnO4. iv) Zn, NH4Cl. v) a. SOCl2 b.
MeOH.
Protection of the carboxylic acid is required for further elaboration of the N-terminus
of Pca. The carboxylic acid may be protected with methyl ester formation either
before, or after reduction of the nitro group to the amine, with little effect on the
overall yield of the synthesis of Pca-OMe.
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Resolution of the planar chiral enantiomers was attempted at two steps, with neither
deemed satisfactory (Scheme 2.42). In both cases, recrystallisation of the formed
diastereomeric compound or salt was problematic. Resolution of diastereomers was
instead achieved for some compounds once coupled to natural amino acids: see
Chapter 3.
FIGURE 2.42: Diastereomer formations for attempted resolution by






3.1 Pseudopeptide design rationale
Pseudo-geminal Pca was selected as the isomer for the [2.2]paracyclophane-modified
amino acid around which small peptides would be assembled (Fig. 3.1), since it was
predicted to be the easiest to make (see Section 2.2).
FIGURE 3.1: Model peptide structure design.
At the N-terminus of the model Pca pseudopeptide 3.1 (outlined in blue in Fig. 3.1),
we require a proline residue since its formation of a nucleophilic enamine from many
aldehydes and ketones is a key factor in many organocatalytic reactions. The pref-
erence is for the proline residue to be directly coupled to the Pca residue so that we
have increased control of the conformation through greater rigidity and less confor-
mational freedom (3.2). A “linker” residue might also be included between these
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two residues, in the sequence Pro-Xaa-Pca (3.3) (Fig. 3.2) but this might dilute the
influence of the Pca.
FIGURE 3.2: Examples of potential peptide structures with variations
at the N-terminus.
The C-terminus’ particular amino acid residue is less important (red outline in Fig.
3.1); we require a proton source for the catalysis mechanism and hope to hydrogen
bond one or more components of the reaction. Any amino acid would suffice in
providing a carboxylic acid for this purpose. This provides an opportunity to vary
the residue at the C terminus to vary the spatial position of the carboxylic acid, the
stereochemistry, and the bulk of the residue. Our goal was to alter these variables
and study the difference in catalytic selectivity between carboxylic acid moieties at
different lengths or orientations from the Pca scaffold.221 This variation could be
achieved by comparing Pca peptides with C-termini residues of, for instance, aspar-
tic acid (3.4) and glutamic acid (3.5) (with their α-carboxylic acid groups protected);
another amino acid with its α-carboxylic acid (in syntheses in this project, pheny-
lalanine (3.6) and valine were extensively used for their ease of characterisation);
and the carboxylic acid of Pca itself (3.7) (Fig. 3.3).
The two chains extending from the Pca residue’s C- and N-termini should interact
to control conformation - and effectively control secondary structure. They may also
position reaction substrates. Our hypothesis was that [2.2]paracyclophane would
provide an advantageous platform for controlling conformation of catalysts and
studying the effects thereof in asymmetric organocatalysis. Effectively, it would be a
β-turn mimic.
In the following sections each type of coupling reagent will be discussed as it is
first mentioned, or where most relevant, with its mechanism of action. In other
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FIGURE 3.3: Examples of potential peptide structures with variations
at the C-terminus.
synthetic routes it will be referenced briefly, with additional discussion focussing
on particular information relevant to that substrate and any characteristics that may
affect the coupling conditions. Interested readers are referred for further reading
to an excellent review by Albericio and El-Faham, which covers the “letter soup”
of peptide coupling reagents available to a chemist and influenced the choice of
reagents.78
3.2 Coupling studies with [2.2]paracyclophane analogues
Before synthesis of 4-amino[2.2]paracyclophane-13-carboxylic acid was complete,
studies of amide couplings using analogues of the compound were conducted. The
reason for this was we anticipated that couplings of aniline derivatives would be
more challenging than alkyl amines due to delocalisation of the nitrogen lone pair
and, in our case, the increased bulk of the Pca framework. Three analogues were
studied: o-toluidine 3.8, anthranilic acid 3.9, 2,6-diaminotoluene 3.10 (Fig. 3.4).
We anticipated this would aid in uncovering peptide coupling conditions for the
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more complicated [2.2]paracyclophane system, and troubleshoot any initial prob-
lems found.
FIGURE 3.4: Pca analogues.
2,6-Diaminotoluene was included in this study both as an analogue of a [2.2]paracy-
clophane aniline for peptide coupling studies; and since resultant peptides might be
further modified to become potential asymmetric organocatalysts themselves. 2,6-
Diaminotoluene has two amine groups ortho to a methyl group. The presence of the
methyl group simulates the steric and electronic effects of the ethylene bridges of
[2.2]paracyclophane, creating an electron-rich and sterically hindered aryl ring. The
two amines in close proximity to each other are obvious spots for functionalisation
to create a binding pocket for organocatalysis. The central methyl group might be
oxidised to a carboxylic acid, providing a chiral proton donor that would catalyse
numerous useful reactions. Examples of this system were seen in papers by Pearson
for aldol reactions, and Moriyama for Friedel-Crafts reactions.222,223 Two electron
withdrawing amide functionalities on the 2,6-diaminotoluene scaffold assist to in-
crease acidity of the benzoic acid in the catalyst but the main cause of the increased
acidity is their hydrogen bonding with the carboxylic acid. A version with protected
amino acids coupled instead of achiral elements would have the potential advan-
tage of chirality, possibly permitting stereoselectivity (Fig. 3.5). We supposed that
we could make a chiral version while learning about aromatic peptide coupling con-
ditions.
FIGURE 3.5: Example 2,6-diaminobenzoic acid peptide derivative of
2,6-diaminotoluene as Brønsted acid catalyst.
Except where noted, coupling tests were performed using N-protected valine as the
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coupling partner, since the isopropyl unit is easy to spot in 1H NMR. The -CH proton
is split by the two -CH3 groups to give a characteristic septet and the two methyl
groups stand out from the other protons in our molecules.
3.2.1 Reactions of o-toluidine
The first couplings were performed on o-toluidine 3.8, the mono-amine analogue
of 2,6-diaminotoluene. Initial conditions involved attempted coupling via either
the N-hydroxysuccinate ester or the acyl chloride but these were unsuccessful. N-
Hydroxysuccinimide (NHS) along with dicyclohexylcarbodiimide (DCC) or diioso-
propylcarbodiimide (DIC) to make the N-hydroxysuccinimide ester of N-pivaloyl-
protected valine was unsuccessful; so the coupling did not proceed in this case due
to failed activation of the carboxylic acid.
Fortunately, the acid could be activated as the hydroxybenzotriazole ester which per-
mitted coupling of N-pivaloyl valine 3.11 to o-toluidine 3.8. 1-Ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC) and hydroxybenzotriazole (HOBt) with 4-dimethylaminopy-
ridine (DMAP) were used to form the activated ester 3.12 (Scheme 3.6). These con-
ditions were successful, however the resultant amides 3.13 were not of interest for
further study. A discussion of common carbodiimide coupling reagents, as trialled
in this coupling, follows in section 3.2.2.
SCHEME 3.6: Coupling of N-pivaloyl valine to o-toluidine via benzo-
triazole ester. i) EDC, HOBt. ii) o-toluidine, DMAP.
The success of the latter set of coupling reagents suggested that we had found appro-
priate coupling conditions for Pca. This optimism was proven unfounded since they
were not successful in other systems. This might be due to the electron-donating
nature of the methyl substituent of o-toluidine increasing the reactivity of its aniline
nitrogen enough to allow coupling where Pca-OMe’s nitrogen is deactivated by the
methyl ester and steric hindrance.
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3.2.2 Coupling reagent: carbodiimides
A common set of coupling reagents (also discussed in Chapter 1, Section 1.2) for
other unnatural amino acids are carbodiimides as dehydrating agents, alone or with
HOBt, HOAt or analogues to promote coupling.224–226 Popular carbodiimide cou-
pling reagents include N,N’-dicyclohexylcarbodiimide (DCC), N,N’-diisopropylcar-
bodiimide (DIC), and N-ethyl,N’-dimethylaminopropylcarbodiimide (EDC) (Fig. 3.7).
FIGURE 3.7: Carbodiimide coupling reagents, left to right: DCC, DIC,
EDC.
Carbodiimides react with the carboxylic acid of an amino acid 3.14 to form the acti-
vated O-acylisourea species 3.15. The coupling proceeds via several different inter-
mediates (Scheme 3.8, from left to right): the formation of an anhydride 3.17 with
a further molecule of amino acid R1-CO2H; direct coupling with the N-terminus of
the new amino acid to form the desired product 3.18; and, in the case of an activated
carboxylic acid that is the C-terminus of a peptide chain of at least 2 amino acids,
formation of an oxazolone 3.19. The side product in each case is urea derivative
3.16.
The oxazolone (3.19) route is undesirable since it will produce a racemic product
under mildly basic conditions (Scheme 3.9) via the resonance-stabilised oxazolonium
ion 3.20.227
The N-hydroxybenzotriazole (HOBt) and similar benzotriazole derivatives (Fig. 3.10)
function to prevent the unreactive N-acylurea 3.21 side product that may form from
the O-acylisourea 3.15 (Scheme 3.11); an additional benefit is decreased racemisation
of the amino acid by preventing intramolecular reaction forming the oxazolone.228
1-Hydroxy-7-azabenzotriazole (HOAt) and derivatives also gain from the interac-
tion between the aza-N and the carbonyl of the coupled carboxylic acid, increasing
reactivity (Fig. 3.12).
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SCHEME 3.8: Carbodiimide peptide coupling mechanism.
SCHEME 3.9: Racemisation mechanism in oxazolone route.
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FIGURE 3.10: Example benzotriazole derivative additives. Left to
right: 1-hydroxybenzotriazole (HOBt), 1-hydroxy-7-azabenzotriazole
(HOAt).
SCHEME 3.11: Formation of N-acylurea isomer.
The N-hydroxy additives interact in the carbodiimide reaction by substituting with
the O-acylisourea formed between the carboxylic acid and the carbodiimide reagent.
The deprotonated N-hydroxy derivative attacks the carbonyl electrophile, substitut-
ing the urea derivative and forming the ester, which is slightly less reactive but less
prone to isomer formation (Scheme 3.13). This reaction occurs more quickly than the
N-acylurea formation.
3.2.3 Reactions of anthranilic acid
Anthranilic acid 3.9 was an interesting test subject since it was a single-ring mimic
of the target centre compound of this project as it contained both an amine and a
carboxylic acid group. The electron-withdrawing nature of the carboxylic acid in
this molecule deactivates the aniline further which is relevant for peptide coupling
to the N-terminus of Pca, since although the functional groups may be on different
aromatic rings, transannular electronic communication between the rings still causes
a similar effect. As such it was hypothesised that this compound would be a more
FIGURE 3.12: Neighbouring group effect in HOAt.
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SCHEME 3.13: Benzotriazole additives in peptide coupling with car-
bodiimides.
accurate test compound for couplings before moving on to the more synthetically
expensive Pca.
Attempts to repeat the successful EDC/HOBt conditions were met with little suc-
cess. No reaction was observed. The next attempted conditions were acyl chloride
formation with Et3N which also failed (Scheme 3.14). It is suspected that anthranilic
acid’s carboxylic acid group interfered with the couplings. Ultimately, it was de-
cided that the model studies were not helpful. Conditions are highly substrate spe-
cific so screening Pca itself seemed more efficient.
SCHEME 3.14: Attempted coupling conditions between N-pivaloyl
valine and anthranilic acid’s nitrogen atom. i) a. EDC, HOBt. b. an-
thranilic acid, DMAP; ii) a. DMF, (COCl)2. b. anthranilic acid, Et3N.
3.2.4 Reactions of 2,6-diaminotoluene
Several attempts were made at coupling amino acids to form a diamide 3.22 from 2,6-
diaminotoluene 3.10. Making a mixed anhydride with 2 equivalents each of ethyl
chloroformate and either N-pivaloyl valine or Boc-valine, was unsuccessful, with
not even mono-coupling occurring (Scheme 3.15). Increasing the stoichiometry of
the N-pivaloyl valine or the Et3N did not help.
Most amino acids were available in N-protected form if required; otherwise Boc pro-
tection was performed with Boc2O (Scheme 3.16).
Acyl chloride formation with POCl3 produced only trace amounts of the mono-
coupled product 3.23; most of the material was returned starting material (Scheme
3.17).
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SCHEME 3.15: Attempted coupling between N-protected valine and
2,6-diaminotoluene. i) NMM, EtOCOCl.
SCHEME 3.16: Boc protection of amino acids.
SCHEME 3.17: Attempted coupling between N-pivaloyl valine and
2,6-diaminotoluene via acyl chloride. i) POCl3.
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Using the successful peptide coupling conditions from the tests with o-toluidine
(EDC, HOBt, DMAP), only mono-amide coupling occurred to give 3.23 in 50% yield;
using microwave irradiation did not alter this. Other sets of reagents, combined
with microwave irradiation, also only produced the mono-coupled product. These
reagents included: TBTU, in concert with HOBt and DIPEA; and DCC with NHS
and DMAP (Scheme 3.18). Aminium-uronium salts such as TBTU are discussed in
the section to follow.
SCHEME 3.18: Attempted coupling between N-pivaloyl valine and
2,6-diaminotoluene with peptide coupling reagents. i) a. EDC, HOBt.
b. anthranilic acid, DMAP; ii) a. TBTU, HOBt. b. anthranilic acid,
DIPEA; iii) a. DCC, NHS. b. anthranilic acid, DMAP.
Attempts were made to couple an activated amino acid to the remaining aniline
moiety on the purified product of single addition 3.23. N-Pivaloyl valine activated
by anhydride formation with ethyl chloroformate failed to give any reaction; neither
did the previously successful conditions of EDC and HOBt with DMAP (Scheme
3.19).
SCHEME 3.19: Attempted coupling of N-pivaloyl valine to 3.23. i) a.
EtOCOCl. B. 3.23, NMM; ii) a. EDC, HOBt. b. 3.23, DMAP
Even coupling a simple acyl chloride in the form of N-pivaloyl chloride still gave
no reaction (Scheme 3.20). This was worrying with regards to future pseudopeptide
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coupling prospects.
SCHEME 3.20: Attempted coupling to N-pivaloyl chloride to 3.23. i)
NaOH.
Based on TLC and 1H NMR and mass spectra evidence, coupling one amino acid
was possible using standard peptide synthetic methods. They indicated consump-
tion of the starting material 3.23, and formation of a new amide product. However,
forming the second peptide bond, either in concert with the first coupling, or as
a separate step after successful mono-amide formation, was a more difficult task.
Steric hindrance from the methyl group and bound amino acid undoubtedly inhibits
this coupling. Additionally, the amide group is somewhat electron withdrawing and
may lower reactivity of the second aniline such that a further peptide or amide cou-
pling is no longer possible.
In the brief studies conducted on this subject, no successful route to the twice-coupled
2,6-diaminotoluene was found. 2,6-Diaminotoluene was used as a model for inves-
tigating coupling conditions for Pca, which has only one aniline group, so this was
not necessarily a problem. However, a secondary aim of this strand of research was
to develop the twice-coupled products themselves as catalysts, and in this respect,
this strand of research was a failure. The continuing failure of the desired reaction is
indicative of future problems that would be encountered in forming peptides with
Pca.
3.2.5 Coupling reagent: aminium-uronium salts
Aminium-uronium salt reagents include TBTU and HATU, analogues of HOBt and
HOAt, respectively (Fig. 3.21).
These reagents may be used independently, without other activating agents like car-
bodiimides (Scheme 3.22), but may have a tertiary base (such as DIPEA or Et3N)
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FIGURE 3.21: Aminium-uronium salt peptide coupling reagents.
Left: N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-




SCHEME 3.22: Peptide coupling mechanism with TBTU.
They are named aminium-uronium salt reagents because they may exist in either
the uronium (O-linked) or aminium (N-linked) form: crystallographic data shows
TBTU exists in the aminium isomeric form, which is slightly less reactive. A sub-
stoichiometric quantity of these reagents is often used to avoid reaction of the uro-
nium with the amine to form a guanidine, which caps the amino acid and prevents
coupling with the appropriate carboxylic acid (Scheme 3.23).229
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SCHEME 3.23: Undesirable guanidino derivative formation.
3.3 Coupling amino acids with 4-amino[2.2]paracyclophane-
13-carboxylic acid
3.3.1 Synthesis of Pca-Phe
Couplings to the C-terminus of Pca were investigated first. The carboxylic acid is
formed before the aniline group; and we expected coupling to the carboxylic acid
would be facile. Phenylalanine was chosen as the amino acid that was coupled to
Pca and the synthetic route to Pca-Phe 3.26 is summarised in Scheme 3.24.
SCHEME 3.24: Pca-Phe synthetic scheme. i) a. SOCl2. b. L-
phenylalanine. ii) Zn, NH4Cl.
Coupling L-phenylalanine with 4-nitro[2.2]paracyclophane-13-carboxylic acid 3.24
In the nitro methodology for Pca synthesis (Section 2.3.3), a convenient point to form
a peptide bond at Pca’s C-terminus is after oxidation to form the carboxylic acid,
giving 4-nitro[2.2]paracyclophane-13-carboxylic acid 3.24. Here, the nitro group is a
masked amine, protecting the nitrogen from side reactions and avoiding the solubil-
ity problems associated with the amine.
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Amide coupling between the carboxylic acid on [2.2]paracyclophane and a natural
amino acid was achieved by activation of the carboxylic acid. An effective activation
method was formation of an acyl chloride (Scheme 3.25). Thionyl chloride and oxa-
lyl chloride were both effective means of activating the carboxylic acid and forming
the subsequent peptide bond. Phenylalanine was used as the natural amino acid
here due to its visibility on TLC plates with no requirement for a visualising agent.
SCHEME 3.25: Phenylalanine coupling to [2.2]paracyclophane car-
boxylic acid 3.24 via acyl chloride 3.27. i) SOCl2 or DMF, (COCl)2.
i) L-phenylalanine, NaOH.
The acyl chloride formation with oxalyl chloride is akin to that detailed in Section
2.3.2. With thionyl chloride, the mechanism proceeds as follows: the nucleophilic
carbonyl oxygen of the carboxylic acid attacks the sulfur of thionyl chloride. The
S=O bond is restored, ejecting the chloride ion. The chloride ion now attacks the
carbonyl electrophile and then the chlorosulfite leaves, forming sulfur dioxide and
chloride. The chloride deprotonates the carbonyl oxygen, leaving the acyl chloride
and HCl (Scheme 3.26).
SCHEME 3.26: Acyl chloride formation mechanism with thionyl chlo-
ride.
Although acyl chloride formation is discouraged in peptide chemistry due to pos-
sibility of racemisation (see section 3.3.3), with Pca this is not a concern as there is
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no stereocentre that can be racemised by deprotonation. Normal amino acids have
a relatively acidic α-hydrogen that, in acyl chlorides, can be deprotonated to give a
ketene with destruction of the stereocentre.
Other examples of coupling with a natural amino acid’s amine via acyl chloride ac-
tivation of the coupling partner’s carboxylic acid suggest using high equivalents of
the amino acid.230 This helps prevent side product formation by outcompeting other
reactions that could occur such as quenching of the acyl chloride with water before
it has a chance to react with the desired amine.
Resolution of diastereomers of Pca-peptides
Since peptide couplings were always performed with L-amino acids to racemic mix-
tures of the appropriate [2.2]paracyclophane compounds, the resultant peptides are
diastereomers (Fig. 3.27). Since diastereomers no longer have essentially exactly the
same physical behaviours such as solubility, and intramolecular hydrogen bonding,
this allowed the possibility of separation by silica column chromatography with-
out further modification. Recrystallisation is also a popular method of separation of
diastereomers but was not achieved for these peptides in my hands.
FIGURE 3.27: Diastereomers of Pca-containing dipeptide.
TLC analysis was a quick method of testing the compounds in different solvent sys-
tems to check for separation of diastereomers. With careful application of appropri-
ate column chromatography technique, compounds with an Rf difference of as low
as 0.05 may be at least partially separable. This usually involves measures such as
increased column length and/or volume of silica gel; low eluent polarity; running
the column very slowly as a gravity column; and taking very small fractions. This is
time consuming but can deliver the desired compounds in small quantities.
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Resolution of 4-nitro[2.2]paracyclophan-13-(amido-Phe)
Resolution of the two diastereomers could be achieved by column chromatography
eluting with 1:1 hexane/EtOAc with 1% acetic acid. The separation was always
incomplete, but fractions of each diastereomer could be isolated. In fact, in the more
concentrated fractions of the slower-eluting diastereomer, crystals of (RP,S)-3.25 (Fig.
3.28) crashed out of solution.
FIGURE 3.28: (RP,S)-3.25.
Crystals obtained were found to be enantiopure, assuming that the Phe stereocentre
is fixed, and were of good enough quality to be X-rayed (Fig. 3.29).
FIGURE 3.29: X-ray crystal structure of (RP,S)-3.25.
X-ray crystallography correlation to 1H NMR spectra allowed for stereochemical at-
tribution of the diastereomers using 1H NMR spectra (Fig. 3.30). This could be
achieved by looking at the NH-CO proton resonance, which appears as two dou-
blets at 7.97 and 7.91 ppm in the mixture of diastereomers. A sample of 3.25 from
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the same crystals that provided the X-ray crystal structure has only one of the dou-
blets, at 7.97 ppm. Given the X-ray crystal structure shows this diastereomer to be
(RP,S)-3.25, the (RP,S) diastereomer must have the amide proton peak at 7.71 ppm.
FIGURE 3.30: H NMR spectra of 3.25. Bottom (blue): (RP,S)-3.25; top
(red): mixture of diastereomers.
The full 1H NMR spectrum shows many more sets of peaks exhibit shifted peaks
between the diastereomers: for instance the [2.2]paracyclophanyl Ar-H at 7.22 and
7.13 ppm. The 1H NMR spectrum of the mixture of diastereomers shows some peaks
with integrals of around 0.5, indicating they are part of a pair of peaks, one for each
diastereomer, and that the diastereomers are present in about 1:1 ratio.
Nitro reduction to give Pca-Phe
As new conditions for reduction of the nitro group in 4-nitro[2.2]paracyclophane-13-
carboxylic acid were optimised (see Section 2.3.3), they were applied to reduction of
the phenylalanine amide 3.25. The iron/hydrochloric acid and catalytic hydrogena-
tion conditions for Pca synthesis both gave similar results for this reduction: moder-
ate yields with problematic work up and/or side product formation. Providentially,
the zinc/ammonium chloride conditions also gave good yield in high purity for the
nitro reduction of 3.25 to furnish Pca-Phe 3.26 (Scheme 3.31).
Resolution of the reduced Pca-Phe pseudopeptide (Fig. 3.32) was also possible, how-
ever a larger proportion of the two diastereomers eluted concurrently, and the usual
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SCHEME 3.31: Reduction of nitro group to give Pca-Phe. i) Zn, NH4Cl
concerns with column chromatography of amines (see section 2.3.3) made this a
more taxing column to run.
FIGURE 3.32: Pseudo-dipeptide 3.26.
Amines are problematic in column chromatography and [2.2]paracyclophane amines
tend to stick to the silica gel. We suspect either oxidation or polymerisation of the
aniline is occurring.
Coupling to the N-terminus of Pca-Phe
The dipeptide was synthesised with good yield and was easily purified by column
chromatography. The next step was to see if we could couple the dipeptide with an
amino acid at Pca’s N-terminus to furnish the first of our desired tripeptides (Scheme
3.33). It was anticipated to be a difficult endeavour, with the Phe residue and its
peptide bond to Pca further decreasing the nucleophilicity of the Pca-N, and the
additional steric bulk also hindering reactivity. No coupling conditions that were
tested were successful in coupling an amino acid to the N-terminus of Pca-Phe.
Mixed anhydride formation was tested with two reagents: ethyl chloroformate and
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SCHEME 3.33: Attempted coupling of amino acid to Pca-Phe’s N-
terminus. R = L-amino acid residue.
isobutyl chloroformate. Several base additives were trialled as well: Et3N, N-meth-
ylmorpholine, and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The base is required
in the formation of the activated mixed anhydride species, where it deprotonates
the carboxylic acid. DBU was tested as it is a volatile amine base which allowed us
to avoid water in the work up. We suspected that the product might be lost in an
aqueous work up. This did not help the reaction succeed, and ultimately no com-
bination of these reagents we tested successfully coupled Pca-Phe to Boc-L-proline.
Mixed anhydride formation with chloroformate reagents is discussed below.
Another coupling condition that was trialled for this coupling was HOBt with TBTU
and DIPEA. The final set of conditions used were DCC and NHS, which were also
unsuccessful.
The route was terminated because we could not couple an amino acid to the N-
terminus due to a combination of low reactivity and steric bulk, as well as possible
interactions from the carboxylic acid on the C-terminus. Unfortunately no condi-
tions were found for forming our desired tripeptide through this route so we moved
on to testing coupling conditions to the Pca-N on Pca by itself.
Coupling reagent: chloroformates
For all the peptide coupling chemistry described in this chapter, the key is transform-
ing the -OH into a leaving group. Every coupling, including making acyl chlorides,
essentially varies only differs in how dehydration or the removal of OH is achieved.
Thus, the mixed anhydride approach effectively allows us, in its desired route, to
remove -OH in the form of CO2. In the undesired route it results in displacement of
an acid and formation of a simple carbamate (Scheme 3.34).
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SCHEME 3.34: Peptide bond formation (A) from mixed carbonic an-
hydrides and carbamate formed from side reaction (B).
Chloroformates such as ethyl chloroformate and isopropyl chloroformate (Fig. 3.35)
are used in concert with a tertiary amine base to form a mixed anhydride (Scheme
3.36).
FIGURE 3.35: Chloroformate peptide coupling reagents. Left: ethyl
chloroformate 3.28; right: isobutyl chloroformate 3.29.
SCHEME 3.36: Mixed anhydride formation mechanism with ethyl
chloroformate and N-methylmorpholine.
Care must always be taken to avoid carbamate formation (Scheme 3.34).231,232 Pre-
cautions include keeping the reaction cool, using only one equivalent or a slight
deficiency of chloroformate reagent, adding the amine coupling partner separately
after anhydride formation, and increasing the steric bulk of the alkyl portion of the
chloroformate reagent to slow attack at the wrong carbonyl.
3.3.2 Peptide coupling to the N-terminus of Pca
Natural amino acids being coupled by their carboxylic acid group to the aniline of
Pca were N-protected in order to prevent side reactions. The most common pro-
tecting group used was tert-butoxycarbonyl (Boc), since it was easily and cleanly
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removed under acidic conditions. The Boc group is compatible with most methods
of amide couplings, and Boc-protected amino acids are readily commercially avail-
able.
While coupling to the C-terminus of Pca was facile, for couplings to the N-terminus,
normal peptide and amide coupling conditions mostly proved unsuccessful, as will
be discussed below. While anilines may successfully undergo amide and peptide
couplings with several sets of conditions as detailed above and in the research of
others,233 Pca displayed remarkable lack of reactivity and failed to couple under any
of these conditions.
Common peptide coupling conditions tend to use a combination of reagents: one
dehydrating and one that becomes an activated leaving group. Using the correct
combination is vital. Most research groups tend to settle on one set of conditions
that is most efficient for their application and in their hands. The highly substrate-
dependent nature of peptide coupling conditions means that the combination re-
quired for one compound may be completely ineffective for similar compounds.
These common coupling reagents all act to convert the hydroxyl moiety into a leav-
ing group which activates the carboxylic acid, increasing its reactivity. None activate
the nitrogen. In Pca, the nitrogen is the issue. It is very poorly nucleophilic and only
formed amide or peptide bonds in certain, strong conditions which may be unsuit-
able for use with natural amino acids. It would be interesting to see if in a different
regioisomer of Pca, with a different relationship between the NH2 and CO2Me on
[2.2]paracyclophane, the reaction would be any different.
It seems that with the Pca nitrogen, even with the most reactive activated carboxylic
acids, is simply too unreactive for most peptide coupling conditions and requires
either to be made more reactive itself, or an even harsher carboxylic acid activation
that may not be suitable for use with natural amino acids since they are sensitive to
racemisation.
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3.3.3 Attempted synthesis of Pro-Pca
Since we could not find conditions for forming a tripeptide by coupling the N-
terminus of Pca-Phe with a third amino acid, the next approach was to focus on
the more problematic peptide coupling with the aniline nitrogen of Pca first. Then,
after finding successful conditions for this challenging reaction, we could focus on
the easier coupling to Pca’s carboxylic acid (Scheme 3.37).
SCHEME 3.37: Proposed synthetic scheme for tripeptide synthesis
starting with Pca-OMe.
This route began with the synthesised Pca-OMe from the nitro methodology (see
Section 2.3.3). The carboxylic acid of the [2.2]paracyclophane was protected with a
methyl ester when coupling to amine of the paracyclophane in order to remove any
influence the acid would have on the reaction.
Coupling Boc-L-proline to Pca-OMe
The first step for this pathway was to couple an amino acid to Pca-OMe. Before we
discovered successful conditions, we investigated a number of other routes which
returned only starting material due to the poorly-reactive aniline on Pca.
The aniline itself is unreactive because of the strong electron-withdrawing effect of
the conjugated π-electron system. The nitrogens of aniline compounds tend to be
unreactive; in [2.2]paracyclophane they are troublesomely so. The lone pair of the
nitrogen is delocalised over the aryl ring it is bonded to, decreasing the nitrogen’s
nucleophilicity. In Pca the electrons are further withdrawn by the communication
between the two rings of paracyclophane by the shared π system (Scheme 3.38).
Since the two aromatic rings of [2.2]paracyclophane sit within each others’ van der
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Waals radii, the transannular electronic effect means that the lone pair on the nitro-
gen effectively can participate in resonance with two aryl rings and is less reactive.
SCHEME 3.38: Nitrogen lone pair participation in aromatic resonance
in Pca-OMe.
The low reactivity is probably also further hindered by the steric effect of the nearby
ethyl bridges joining the two rings, even though these groups would be electron-
donating and in theory increase the nitrogen’s reactivity; and by the lower deck.
In addition, the steric hindrance is exacerbated by placing the ester or acid in the
pseudo-gem position, directly beneath the amine. It is also possible that this enforces
an interaction between the nitrogen lone pair and the π* antibonding orbital of the
ester, which would also decrease its reactivity (Fig. 3.39). This is similar to the sec-
ondary orbital effect which induces endo selectivity in Diels-Alder reactions.234,235
Figure 3.39 also shows the limited approach caused by the sterically congested sys-
tem. It is not the case that the [2.2]paracyclophane-amine is the same as aniline; it
behaves quite differently, as demonstrated in this thesis.
FIGURE 3.39: Orbital overlap in Pca-OMe.
Previous work by the Rowlands group has highlighted this component’s poor reac-
tivity;20 for example, tosylation of methyl 4-amino[2.2]paracyclophane-13-carboxylate
3.30 occurs only in 49% yield, with the rest of the material being unreacted starting
material, even with strong base (NaH) under reflux (Scheme 3.40). This usually un-
complicated procedure’s difficulty here illustrates the low reactivity of this aniline.
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SCHEME 3.40: Tosylation of methyl 4-amino[2.2]paracyclophane-13-
carboxylate 3.30. i) NaH, TsCl, reflux in THF.
The poorest reactivity in an amino[2.2]paracyclophane species our group has ob-
served was in the ortho-bromo species, 4-amino-5-bromo[2.2]paracyclophane 3.32.20
Nearly all elaborations of the amine were fruitless, yielding only the starting mate-
rial. These transformation attempts included various alkylations, reductive amina-
tions, and acylations with anhydrides or acyl chlorides. Only one derivative was
ever made and that involved formation of the diazonium salt with NaNO2 then
coupling with morpholine to give the triazene compound 3.33 (Scheme 3.41). The
bromo group in the starting material withdraws electrons, further removing electron
density from the already deactivated aniline nitrogen.
SCHEME 3.41: Synthesis of triazene 3.33. i) HBF4, NaNO2. ii) mor-
pholine.
Many peptide coupling conditions were tested in this coupling. The first was mixed
anhydride formation, where the natural amino acid was either Boc-proline or N-
pivaloyl valine; EtOCOCl was tested as the reagent with Et3N as the base (discussed
in Section 3.3.1). These conditions with both amino acids were unsuccessful, re-
turning only starting material. We thought that the amino acid might be forming a
carbamate with the ethyl chloroformate instead of the desired mixed anhydride, so
we also tested the coupling of N-pivaloyl valine to Pca-OMe with i-BuOCOCl. Its
increased bulk would hinder carbamate formation. However, this reagent was also
ineffective. No carbamate was isolated.
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The following sections discuss several peptide coupling conditions that were trialled
in coupling Boc-Pro to Pca-OMe.
Coupling reagent: imidazoles
Carbonyldiimidazole (CDI, Fig. 3.42) is a useful reagent that forms from the acylim-
idazole active ester. It generates an imidazole molecule so that no additional base is
required to form the peptide bond (Scheme 3.43).236
FIGURE 3.42: Carbonyldiimiazole.
SCHEME 3.43: Active ester formation with CDI showing generation
of an imidazole molecule.
We first separately formed the acylimidazole ester with Boc-valine to ensure that the
active ester was being formed.237 This reaction was successful, so we moved on to
the one-pot reaction with the active ester formed in situ and then, in theory, react-
ing with Pca-OMe.238 This was not successful, returning only the Pca-OMe starting
material, even when the two steps were performed separately. The same conditions
with Boc-proline as the amino acid also failed.
When no reaction was seen in couplings to Pca with CDI, external bases including
K2CO3, NaOH, and NaH were added to the reaction conditions, with no improve-
ment in outcome. Additional tests were run coupling Boc-valine with proline to
check the CDI reagent was still good; and with the amine on aniline with CDI to
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test the efficacy of CDI with aromatic amines (Fig. 3.44). These couplings were suc-
cessful, so the problem is with Pca’s additional bulk and π electron participation of
nitrogen’s lone pair.
SCHEME 3.44: Boc-valine coupling with aniline. i) a. CDI. b. aniline.
Coupling reagent: acyl chlorides
In peptide synthesis, acyl chlorides tend to be avoided for their propensity to form
numerous side products, including hydrolysis back to the parent acid and incompat-
ibility with some protecting groups like Cbz, and racemisation at the α-carbon.239,240
Due to these severe limitations, acyl halide activation of chiral amino acids was
found to be inappropriate. As discussed later in Section 3.3.7, we found that acyl
chloride formation may be milder with respect to racemisation than the literature
suggests. It is imperative that racemisation of incoming enantiopure amino acids
does not occur in order to avoid introduction of another set of diastereomers. In any
case, this does not change the fact that acyl chloride activation did not work for this
amide formation, even with the inclusion of a base such as NaH.
Acyl chloride formation with oxalyl chloride and DMF on Fmoc-proline was looked
into following conditions from Evindar and Batey.233 These conditions were not suc-
cessful for Pca, with the desired product not forming, and the Fmoc carbamate ad-
ditionally being cleaved. Cooling the reaction mixture to 0 °C for acyl chloride for-
mation, then using NaH with the Pca-OMe and heating the reaction, did not aid this
reaction.
One acyl chloride-activated amide coupling that was successful was between Pca
and N-pivaloyl chloride in the presence of n-BuLi (Fig. 3.45).241 These conditions
were run to check that amide bond formation with Pca’s nitrogen was possible at all.
The combination of strong base and acyl chloride was necessary but these conditions
did not translate to amino acid coupling. The acyl chloride of Boc-glycine did not
couple to Pca in the same conditions.
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SCHEME 3.45: Pivaloyl amide formation with Pca. i) a. n-BuLi, -78
°C. b. N-pivaloyl chloride.
Fluorination was not tested for couplings in this project; however, given the poor
results with acyl chloride activation, it is likely that the acyl fluoride would not have
be a strong enough activator to couple an amino acid to the nitrogen of Pca.
Coupling reagent: N-hydroxysuccinimide in the synthesis of Pro-Pca
During this project it was observed by a colleague that coupling could be achieve in
a simpler system, 4-amino[2.2]paracyclophane 3.51 (Scheme 3.46).
SCHEME 3.46: Amide coupling between Boc-proline 3.52 and 4-
amino[2.2]paracyclophane 3.51. i) DCC, NHS. ii) 3.51.
This result was repeated and the discovery was carried forward to determine if the
reaction would still proceed on Pca-OMe 3.30. Small scale experiments confirmed its
success and a small amount of Boc-Pro-Pca-OMe 3.54 was prepared (Scheme 3.47).
This discovery was made toward the end of this project so the opportunity was not
available to try it on other systems or with any other amino acids.
Active esters formed from reagents such as N-hydroxysuccinimide (Fig. 3.48), which
generates a hydroxamic acid ester, act as all the other reagents described, to make
the carbonyl carbon more susceptible to attack from the amine by turning to -OH
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SCHEME 3.47: Peptide coupling between Boc-proline and Pca-OMe.
i) DCC, NHS. ii) 3.30.
into a good leaving group.242 These activated esters have the advantage of being
shelf-stable.
FIGURE 3.48: N-Hydroxysuccinimide (NHS).
Carbodiimides may be used as pre-activating reagents to aid in formation of these
active esters; and NHS in combination with DCC was found to be an effective set of
coupling conditions for peptide synthesis with Pca.
The coupling reaction with DCC and NHS proceeds as follows (Scheme 3.49). First
the O-acylisourea 3.55 forms between the carboxylic acid on Boc-proline and DCC.
The carboxylic acid protonates the carbodiimide and the carboxylate ion attacks the
protonated carbodiimide giving the O-acylisourea.
The mechanism of the O-acylisourea formation can be seen in Section 3.2.2. DCC is a
low-melting point solid and thus easily transferred by gently heating the container;
and in winter, any glassware used handling it.
The NHS then substitutes to form the succinate ester 3.56. Formation of the urea is
the driving force for this reaction. The urea derivative formed by the substitution
is predictably insoluble and may be removed from the prepared succinate ester by
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SCHEME 3.49: Peptide coupling mechanism between Boc-proline and
Pca-OMe using DCC and NHS.
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performing two or three successive recrystallisation steps, filtering off the solid dicy-
clohexylurea and concentrating the filtrate containing the active ester. When added
to the reaction mixture, Pca’s nitrogen forms the amide bond with nucleophilic at-
tack to the succinate ester carbonyl, giving NHS and Boc-Pro-Pca-OMe 3.54.
A literature search did not suggest that NHS with DCC are necessarily good con-
ditions for peptide couplings with anilines. More common coupling conditions for
these relatively unreactive nitrogens are HOBt and EDC or the host of other reagents
we had tried with the Pca analogues (Section 3.2). NHS was not a common activating
agent for these compounds. As to why these conditions are successful in Pca’s case,
one possibility is that the succinate is a comparatively small moiety compared to the
benzotriazole derivatives and reduces steric hindrance on the coupling, occurring
between two already quite bulky compounds. Perhaps the carbonyl groups on the
succinate moiety participate in hydrogen bonding with the aniline and carboxylic
acid hydrogens (Fig. 3.50), resulting in increased reactivity in something akin to the
neighbouring group effect seen in azabenzotriazoles due to the spatial position of its
7-N.228
FIGURE 3.50: Possible neighbouring group effect between Pca-OMe
and Boc-Pro-OSu.
Important for the success of this reaction are the exclusion of water from the solvent
and atmosphere; DCC is a dehydrating agent so its presence in excess probably con-
tributes to the success of these reaction conditions. Some variability was seen in the
yield of this reaction, with the worst yield being from a large scale (3 g) coupling
which only gave 200 mg of the product with the rest of the substrate being returned
starting material and a mixture of side products. Possible reasons for this poor re-
sult could have been low solubility of the starting material leading to the starting
material crashing out of solution; or incomplete exclusion of air and water from the
reaction vessel. It was noted that the rubber septum used to cap the reaction vessel
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was degraded and may have been leaky.
The success of this reaction can be confirmed by certain changes in the 1H NMR of
the compound: the peak at 5.26 ppm which was assigned to H-5 in the Pca-OMe (Fig.
3.51) starting material has shifted downfield, due to the presence of the amide com-
pared to the aniline (Fig. 3.52). This proton is now more deshielded. The remaining
aryl peaks also experience a downfield shift compared to the starting material. Of
course, the presence of amide N-H protons for the peptide and Boc-group moieties
as well as peaks corresponding to the proline alkyl groups at the appropriate inten-
sities also indicate this successful coupling.
FIGURE 3.51: Boc-Pro-Pca-OMe, numbered.
FIGURE 3.52: Proline coupling to Pca (blue, bottom) compared with
the Pca starting material (red, top) aryl region.
3.3.4 Attempted synthesis of 4-methylamino[2.2]paracyclophane-13-carb-
oxylic acid
During the course of research, alternatives to true peptide couplings between Pca
and other amino acids were attempted. Reduction of the oxime to the methylamine
substituent 3.45 might have been an acceptable compromise for the aryl amine, since
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the aryl amine was so difficult to form and couple to other amino acids (Scheme
3.53).
SCHEME 3.53: Proposed oxime reduction to methylamine 3.45. i) Zn,
HCl.
We hypothesised that part of the difficulty in forming the aryl amine was the lower
electron density on the final nitrogen. Separating it from resonance with the aryl
ring with a methylene group might have alleviated this issue and if the alkyl amine
would couple better. The alkyl amine might be more nucleophilic, as seen in the
glycine residue. However, oxime reduction with zinc and HCl was unsuccessful,
and due to time constraints other chemoselective reductions were not attempted.
3.3.5 Attempted coupling of Boc-proline derivatives to Pca
Reductive amination
Following from the attempted oxime reduction to the primary amine, different types
of bonds were explored. A small drawback is that these bonds would lack the struc-
tural and electronic properties of the amide bond.
An alternative coupling method to produce a peptide analogue is reductive amina-
tion of the formyl carbonyl group of a reduced natural amino acid such as prolinal
(3.46, Scheme 3.54).
SCHEME 3.54: Proposed reductive amination with Boc-prolinal 3.46.
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This route was attractive since imine formation at [2.2]paracyclophanyl amines has
been performed in the Rowlands group before with benzaldehyde. Anilines are par-
ticularly susceptible to reductive amination. As mentioned, a drawback is that this
compound would lack the amide functionality at the nitrogen of Pca. Loss of the car-
bonyl would affect conformation and hydrogen bonding potential of the compound.
While we wanted the compounds to be as close to an amide as possible, considering
how hard the amide coupling had been we were prepared to try alternative options
to move the project forward.
As a test, we tried reductive amination with benzaldehyde which was high-yielding
(Scheme 3.55). This reaction has the benefit of the product being highly crystalline
and able to be isolated in high yield and purity by recrystallisation.
SCHEME 3.55: Reductive amination of Pca with benzaldehyde.
Reductive amination of an aldehyde proceeds by the following mechanism: first the
imine or iminium is formed in a series of reversible reactions (Scheme 3.56).
SCHEME 3.56: Imine formation mechanism.
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The carbonyl oxygen is protonated. Nucleophilic addition to the carbonyl by the
amine nitrogen and loss and gain of a proton gives the hemiaminal intermediate
3.47. Elimination of a water molecule gives the imine 3.48. The imine may be isolated
at this point. The protonated iminium species is reduced giving the secondary amine
3.49 (Scheme 3.57).
SCHEME 3.57: Reduction of the imine to complete reductive amina-
tion.
Initially, we believed the reaction between Pca and Boc-L-prolinal had been success-
ful. Proton NMR of the crude reaction mixture revealed that the aldehyde proton
of Boc-L-prolinal was greatly diminished in integration compared to the remaining
prolinyl peaks; small shifts in the aryl peaks of [2.2]paracyclophane also suggested
the imine formation was successful. Unfortunately the NMR spectrum was not clear
and attempts to purify the imine failed. The compound did not crystallise under
similar conditions that resulted in the formation of benzaldehyde imine. Where the
benzyl imine could be purified by recrystallisation by cooling to 4°C overnight; the
prolinyl imine was a liquid which could not be recrystallised in the same manner,
even when cooling to -18°C. Column chromatography was impaired by imine cleav-
age under the mildly acidic environment of silica gel. Instead, the prolinyl imine
was prepared for reduction (or storage) by running the material through an alumina
plug to remove any traces of acid or moisture which might cleave the imine, and
imine reduction was attempted on the crude material.
However this imine could not be reduced in the same manner. Other reduction
conditions with catalytic hydrogenation or sodium cyanoborohydride were also un-
successful. The issue with this transformation could have been either the Pca not
reacting with Boc-L-prolinal to form the imine; or that the reduction was unsuccess-
ful. The evidence for formation of the imine is somewhat tenuous, with the main
data point backing this up being the disappearance of the CHO peak of prolinal.
The two reaction steps were performed separately, confirming the presence of the
146
Chapter 3. Synthesis of 4-amino[2.2]paracyclophane-13-carboxylic acid
pseudopeptides
supposed imine intermediate before adding the reducing agent; this test was also
unsuccessful, so the choice of reducing agent would not have interfered with imine
formation: for instance, by being too strongly acidic and protonating the amine sub-
strate, hindering imine formation.
It appears that imine formation was possible but that purification and reduction
were the issue. Reduction of this imine might be problematic due to the differences
in electronics and sterics between Boc-proline and benzaldehyde. Aryl amines are
more stable to purification yet more reactive due to conjugation. Alkyl imines are
electron-rich and thus cannot be reduced as readily because they are generally less
stable, easily undergoing tautomerisation to an enamine. Boc-proline is also consid-
erably more sterically demanding than the flat aromatic ring structure of benzalde-
hyde, which again decreases reactivity.
Substitution with prolinol derivatives
Another alternative that was N-alkylation with an appropriately activated deriva-
tive of Boc-prolinol (Scheme 3.58). While formation of the tosylate was possible it
failed to react. Again the low reactivity of the Pca nitrogen was at fault. A further
attempt with the bromide of prolinol failed; it was similarly unreactive in this sub-
stitution.
SCHEME 3.58: Proposed reaction between Boc-Pro-OTs 3.50 and Pca-
OMe 3.30.
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3.3.6 Deprotection of and attempted peptide coupling to Boc-Pro-Pca-OMe
Ester hydrolysis of the Boc-Pro-Pca-OMe dipeptide
After successful coupling of Boc-Pro to Pca-OMe using NHS and DCC, the next step
was hydrolysis of the methyl ester. An alternative method was required for com-
pounds that did not dissolve in mixtures of alcohol and water, in the conditions
developed for the ester hydrolysis on Pca-OMe in the oxime methodology (see Sec-
tion 2.3.2). Heating with 2 M ethanolic potassium hydroxide is a common method
for ester hydrolysis and the protected pseudopeptide 3.54 dissolved in EtOH with
heating.
Boc-Pro-Pca-OMe was very sensitive to these conditions, with both the methyl es-
ter and the amide bond between Pro and Pca being hydrolysed, yielding Pca 3.58;
the same result was found with the reaction run at 50 °C. At room temperature,
overnight approximately half the material was hydrolysed at the amide bond as well
as the ester (Scheme 3.59). Due to time constraints, we were unable to explore milder
conditions, such as conducting the reaction at lower temperature or attempting the
reaction with a weaker base.
SCHEME 3.59: Methyl ester cleavage of Boc-Pro-Pca-OMe.
Coupling attempts to Boc-Pro-Pca’s C-terminus
Due to time constraints only a limited number of conditions were attempted but we
had hoped it would be easier considering the success described in Section 3.3.1. We
chose first the mild and, to this point, most effective peptide coupling conditions
we had found, activating the carboxylic acid with DCC and NHS. When this activa-
tion was unsuccessful we also tried mixed anhydride formation with EtOCOCl and
NMM as the base. However, only starting material was returned.
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Frustratingly, having made a dipeptide, Boc-Pro-Pca, it now proved impossible to
add another amino acid to the C-terminus.
Boc cleavage of Boc-Pro-Pca
The Boc group of 3.57 was cleaved using 3:1 CH2Cl2/CF3COOH at room tempera-
ture to give the deprotected pseudopeptide 3.7.243 Acidic Boc cleavage occurs by the
following mechanism:244 the first step is protonation of the carbamate. The tert-butyl
cation 3.60 dissociates. The resulting carbamic acid 3.59 undergoes decarboxylation
to give CO2 and the free amine, which will be protonated due to the excess of acid
in the reaction mixture (Scheme 3.60).
SCHEME 3.60: Mechanism of Boc cleavage with TFA.
Some Boc cleavage conditions include a trapping agent for the tert-butyl cation since
it may react with the amine to produce unwanted side products, however in this case
it was not found to be necessary.
Resolution of Pro-Pca
Analysis of 2D spectra of this compound 3.7 (Fig. 3.61) indicated that the obtained
material was a single diastereomer, with L-proline and a single enantiomer of Pca.
It is not clear which of RP- or SP-Pca is present since a lack of crystals prevented
confirmation of configuration, and the 2D NMR spectra are sufficiently complicated
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FIGURE 3.61: Pro-Pca 3.7.
to make them difficult to completely assign. As can be seen in 1H NMR spectra of
diastereomeric compounds where both diastereomers are present (see Section 3.3.1),
often twin peaks are seen for certain protons (for instance, the amide protons at
around 8-9 ppm). No evidence of these can be found in the proton spectrum of this
compound (Fig. 3.62). Additionally, the split peaks normally seen in 2D spectra
where diastereomers are present are not seen for this product.
FIGURE 3.62: H NMR spectrum of 3.7.
The broad OH and NH peaks at 9.44 and 8.61 ppm indicate one (or more) of several
things is occurring: chemical exchange with the solvent; hindered rotation of the
molecule; and slow tumbling in the viscous solvent (DMSO).
It is not clear at which point in the compound’s synthesis this accidental resolution
occurred. There are many possibilities. The resolution could have occurred during a
reaction, where one diastereomer was faster or more energetically favoured to form.
It also could have occurred during work up if one diastereomer was more soluble
than another and was either removed during washing, or not taken up during ex-
traction. If there were a significant difference in Rf during column chromatography,
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one diastereomer could have been lost during purification.
Looking at the yields of the reactions from the point where the diastereomers were
formed, i.e. the coupling of Boc-L-proline, might illuminate where the resolution
occurred.
The peptide coupling had a yield of 42%, which could mean that only one enan-
tiomer of Pca-OMe reacted with Boc-Pro-OSu, or one of the diastereomeric products
was lost during work up. It could also simply be a low yield due to the challenging
nature of coupling to Pca’s nitrogen.
The ester hydrolysis had a low yield of 39% of the desired carboxylic acid, which
might have suggested that this is the step where resolution was occurring. However
the low yield of this step was due to the poor optimisation of the reaction, which
gave a mixture of starting material, desired product, and Pca. Thus it is not clear
if the resolution occurred at this step due to more selective hydrolysis of the ester
of one diastereomer; or if both diastereomers were equally poorly suited for these
reaction conditions.
The Boc cleavage gave a good yield of over 90%, so the resolution did not occur in
this step.
Synthesis of the mono-substituted 4-prolinamido[2.2]paracyclophane
The mono-substituted 4-prolinamido[2.2]paracyclophane was desired for our catal-
ysis tests to see the effect of the carboxylic acid or its absence. The synthetic route
was easily adapted from the nitro methodology, with nitration followed by reduc-
tion to the amine. Boc-L-proline was then coupled to the amine using the same con-
ditions with DCC and NHS to yield the amide 3.61 (Scheme 3.63).
3.3.7 Synthesis of Pro-Gly-Pca
Since established peptide formations were demonstrated to be largely incompatible
with the poor nucleophilicity of the Pca nitrogen, another method of constructing an
amide bond to a short alkyl group was considered. The failure to react with anything
except highly activated acyl chlorides and the concern about steric hindrance caused
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SCHEME 3.63: Synthetic scheme for mono-substituted 4-
prolinamido[2.2]paracyclophane from 4-nitro[2.2]paracyclophane. i)
Zn, NH4Cl. ii) DCC, NHS, Boc-L-proline.
by the [2.2]paracyclophane skeleton led us to consider adding a simple linker such
as glycine (3.34, Fig. 3.64).
FIGURE 3.64: Gly-Pca-OH 3.34, with its ethanamide moiety.
This would allow incorporation of a primary alkyl amine. This should be more
nucleophilic than an aniline nitrogen and less sterically encumbered. Additionally,
it would allow us to use much stronger electrophiles. Constructing a glycine residue
starting with a strong electrophile that would be capable of reacting with the very
poor nucleophile might be a way of circumventing Pca’s poor reactivity at its aniline.
With this in mind, we looked at coupling Pca to bromoacetyl bromide, a highly elec-
trophilic acylating reagent, that contains a handle for subsequent elaboration. The
terminal bromide could be transformed to an amine 3.37 via an azide 3.36 (Scheme
3.65). This has the benefits of constructing an amino acid by synthetic chemistry
where it was nigh impossible to couple one; and the resulting alkyl amine should be
far more reactive than the aniline, allowing coupling of further amino acids.
Synthesis of bromide 3.35
Bromoacetyl bromide was found to form an amide, coupling with the nitrogen of
[2.2]paracyclophane (Scheme 3.66), with remarkable yield and purity, considering
the previous difficulties in this amine’s reactivity.245,246 The product precipitates on
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SCHEME 3.65: Synthetic route to Gly-Pca-OMe. i) NaN3. ii) H2, 10%
Pd/C.
addition of water to the reaction mixture and can be obtained as an essentially pure
material by filtration.
FIGURE 3.66: Mechanism of formation of 3.35.
The acyl bromide amide formation proceeds by the nitrogen adding to the carbonyl
group. The bromide is eliminated and may remove a proton from the nitrogen,
giving the amide 3.35. The success of this reaction where acyl chlorides of proline
failed can be rationalised for two reasons: the bromide ion is a better leaving group
than chloride, increasing impetus to form the amide; secondly, bromoacetyl bromide
is a smaller, less sterically hindered compound compared to Boc-protected proline.
The α-carbonyl bromide is especially labile. The π* orbital of C=O and the σ* orbital
of C-Br blend and this lowers the energy of the LUMO, making it more prone to
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nucleophilic attack (Fig. 3.67).247 Since the bromide ion is a good leaving group,
substitution readily occurs.
FIGURE 3.67: Orbital diagram of the α-carbonyl bromide of 3.35
demonstrating the orbital blending.
The compound could be used without further purification, which was valuable since
the bromide was prone to degradation to the alcohol in the presence of any atmo-
spheric water over time. It is stable to storage under inert atmosphere at -18°C for a
short time (a few weeks).
Synthesis of azide 3.36
Bromide 3.35 could be transformed to the azide 3.36 using sodium azide. It is a sim-
ple SN2 substitution of the azide for the bromide (Scheme 3.68). Again the crude
product could be used without purification, as the azide formation proceeded pre-
dictably without formation of any side product; any remaining sodium azide or
sodium bromide did not hinder the next reaction.
SCHEME 3.68: Transformation of bromide 3.35 to azide 3.36.
Synthesis of amine 3.37
The azide could be reduced to the amine using one of several reducing agents. Phos-
phines (triphenylphosphine, trioctylphosphine) efficiently reduced the azide how-
ever the resulting phosphine oxides were difficult to separate from the product.
Reduction using a phosphine follows the Staudinger reduction mechanism (Scheme
3.69).248,249
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SCHEME 3.69: Reduction with triphenylphosphine following the
Staudinger mechanism.
It was considered that Staudinger ligation could be used at this step to form a tripep-
tide in the same step, however this method was not pursued for three reasons: the
glycine residue formed from the azide reduction was a desired compound in itself;
the required phosphinomethyl thiol was not readily available; and the phosphine
oxide would still need to be removed from the crude product, which is a notoriously
difficult operation.227,250,251
Because of difficulties in purification, hydrogenation over 10% palladium on carbon
was preferred (Scheme 3.70). The reaction proceeds to completion in less than an
hour and the pure product is easily separated from the reaction mixture by filtration
through celite.
FIGURE 3.70: Reduction of the azide to the amine.
Attempted resolution of Gly-Pca
The Gly-Pca 3.34 was obtained by ester hydrolysis of 3.37 (Fig. 3.71).
Resolution of the racemic 3.34 was attempted by forming an imine with a chiral alde-
hyde such as camphor (Scheme 3.72), for subsequent resolution by recrystallisation.
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However, no available chiral aldehyde was found to form an imine with Gly-Pca -
the reaction did not occur and only starting material was returned. Resolution by
salt formation with cinchonine as with 4-toluenesulfonylamido[2.2]paracyclophane-
13-carboxylic acid 2.48 (section 2.3.3) was also unsuccessful.
With the Gly-Pca dipeptide synthesised, the next step was to couple a more catalyt-
ically useful amino acid to the more reactive alkyl amine of the glycine residue. An
L-amino acid would create two diastereomers which might be easier to resolve, as
well.
Coupling of Pro to Gly-Pca
Our goal was to incorporate proline because of its role in catalysis for the reactions
that will be tested in this project. The amine of proline was protected to avoid un-
wanted side couplings with the Boc group since this protecting group is readily re-
moved using acid.
Using the mixed anhydride activation of Boc-proline’s carboxylic acid with isobutyl
chloroformate and DBU as the base successfully coupled the Boc-proline with Gly-
Pca-OMe. However, the crude product retained a number of side products and
reagents, which were difficult to remove during work up or using column chro-
matography, so better conditions were sought.
FIGURE 3.71: Gly-Pca 3.34.
SCHEME 3.72: Attempted imine formation between Gly-Pca and
camphor.
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Since NHS and DCC were successful conditions for couplings with Boc-proline else-
where in this project, these conditions were also tested. Boc-proline was coupled to
Gly-Pca-OMe 3.37 using NHS and DCC as activating agents in good yield (Scheme
3.73). The mechanism of action of these reagents is discussed in Section 3.3.3.
SCHEME 3.73: Coupling Boc-Pro-OSu 3.38 to Gly-Pca-OMe 3.39.
Purification of the protected pseudopeptide product 3.39 was achieved by flash col-
umn chromatography and a MeOH/CH2Cl2 mixture as eluent.
Deprotection of the Boc-Pro-Gly-Pca-OMe tripeptide
Deprotection of the methyl ester and the Boc group were trivial (Scheme 3.74).
SCHEME 3.74: Deprotection of tripeptide 3.39. i) KOH, heat. ii). TFA.
For hydrolysis of the methyl ester on the tripeptide 3.39, reflux with 2 M ethanolic
potassium hydroxide was too harsh; the ester was hydrolysed as well as the pep-
tide bond between Gly and Pca. Repeating the conditions at 50°C, produced more
favourable results with only the methyl ester being hydrolysed, albeit taking slightly
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longer, requiring about 24 hours to go to completion with no formation of the ethyl
ester from EtOH.
Other conditions resulted in a mixture of products containing the carboxylic acid
and the ester corresponding to the solvent alcohol. The reaction proceeded best if
the ester was dissolved in ethanol first, then ground KOH was added to the ester
solution; otherwise, the substrate did not completely dissolve and reaction would
not go to completion.
The 1H NMR shows significant broadening of some, but not all, of the peaks (Fig.
3.75).
FIGURE 3.75: 1H NMR of Boc-Pro-Gly-Pca.
The [2.2]paracyclophane aryl peaks, some alkyl peaks, and the Boc-group protons,
are well-resolved; this is because these protons are not in local environments experi-
encing slow rotation about those bonds. The amide protons, as for Pro-Pca (Section
3.3.6), are subject to this effect (Figure 3.76), as are some protons in the glycine and
proline residues.
FIGURE 3.76: Delocalisation of nitrogen lone pair causing hindered
rotation about the amide bond.
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The broadening effect is further exacerbated by the presence of two diastereomers,
which can make full interpretation of some pseudopeptide compounds difficult.
Peak broadening due to poor sample preparation, for instance presence of paramag-
netic ions, poorly-dissolved compound, or temperature or concentration gradients
across the sample, can be ruled out since all peaks would be affected in this case.
Coupling attempts to Boc-Pro-Gly-Pca’s C-terminus
After methyl ester deprotection, amino acid couplings to the C-terminus of the Pca
were attempted (Scheme 3.77).
SCHEME 3.77: Attempted couplings between pseudo-tripeptide 3.40
and natural amino acids.
Since this compound was easier to synthesise than Pro-Pca, more coupling condi-
tions could be tested. Attempts were made using the following sets of reagents:
mixed anhydride formation with either ethyl chloroformate or isobutyl chlorofor-
mate and DIPEA; active ester formation with DCC and NHS; activation with EDC
and HOBt; and finally acyl chloride formation using either cyanuric chloride or
thionyl chloride. As before with Pro-Pca (Section 3.3.6), none were successful: they
gave either returned starting material or a negligible amount of product - <3% as
measured by 1H NMR or mass spectrum peaks matching the product. On the small
scales these experiments were run on (<20 mg), this product was impractical to ob-
tain.
For many of the experiments it was unclear why no coupling was observed. But
with the case of an attempted coupling between phenylalanine’s N-terminus and
Pca’s C-terminus using ethyl chloroformate or isobutyl chloroformate, it was found
that the corresponding Pca ester was formed instead of the desired mixed anhydride
(Fig. 3.78).
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FIGURE 3.78: Isobutyl ester of Boc-Pro-Gly-Pca-OH.
The mass spectrum of the obtained product gave m/z = 600; the mass of this com-
pound is 577, so the sodium adduct gives 577+23=600. Additionally, the distinctive
isobutyl CH(CH3)2 multiplet is visible in the proton NMR spectrum of the product.
The isobutyl chloroformate may have decomposed and formed isobutanol, allowing
ester formation to be favourable over the mixed anhydride.
N-Hydroxy succinate ester activation of Boc-Pro-Gly-Pca’s carboxylic acid was tested
with its usual partner DCC. The active ester was isolated then added to phenylala-
nine. The presence of the active ester was confirmed by proton NMR and mass
spectrum. There was no reaction between the active ester and phenylalanine.
A carbodiimide activation with EDC ·HCl, stabilised by HOBt and including DMAP
as an additional basic catalyst was also unsuccessful.
While initially, harsher coupling conditions were avoided, as a last attempt, car-
boxylic acid activation was attempted using thionyl chloride or cyanuric chloride
(Scheme 3.79).
TLC analysis showed consumption of the starting material, however the amide prod-
uct was never formed. At first it was suspected that, due to steric hindrance, the
acyl chloride was slower to react and the presence of any water in the reaction mix-
ture would simply form the starting carboxylic acid. These are the same conditions
that worked in reasonable yield with 4-nitro[2.2]paracyclophane-12-carboxylic acid.
However, the use of anhydrous conditions with nitrogenous bases instead of aque-
ous sodium hydroxide did not improve the result.
For the formation of an acyl chloride with cyanuric chloride in the presence of a base
such as triethylamine, the mechanism begins with the displacement of a chloride
ion by the carboxylic acid. The chloride ion then attacks the carbonyl carbon and
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SCHEME 3.79: Coupling phenylalanine to the carboxylic acid of
[2.2]paracyclophane derivatives via the acyl chloride. i) a. SOCl2, b.
MeOH. ii) L-phenylalanine, aq. NaOH.
ejects the alcohol byproduct, giving the acyl chloride (Scheme 3.80). Again, just the
dehydrating or activating of the carboxylic acid part is changing.
SCHEME 3.80: Acyl chloride formation with cyanuric chloride.
Phenylalanine was used for these coupling attempts since we had already coupled
this amino acid to the C-terminus of Pca (Scheme 3.81). When initial coupling at-
tempts with phenylalanine failed, Phe-OMe was synthesised in order to prevent
the carboxylic acid of Phe interfering with the coupling, and to increase solubility
of the amino acid in solvents compatible with the Pca derivative. Phe-OMe was
synthesised according to methods from Shibata et al. using thionyl chloride and
methanol.252
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SCHEME 3.81: Attempted coupling of Phe-OMe to Boc-Pro-Gly-Pca-
OH.
The enantiomeric purity of the obtained Phe-OMe was checked using circular dichro-
ism (CD) spectrometry and found to be acceptable. Enantiomers give CD spectra
with equal amplitude but opposite sign; therefore the CD spectra for a racemate
would be flat. Since no reference CD spectrum was available for L-Phe-OMe, its CD
spectrum was compared with the starting L-phenylalanine and found to be compara-
ble in amplitude. This evidence suggests that even if a small portion of the material
had racemised, the bulk of the material remained stereochemically unaltered.
Since these conditions were found to maintain stereochemistry, the use of thionyl
chloride as a carboxylic acid activating reagent was used in other points of synthesis
where stereochemistry was at risk. Protection of the carboxylic acid did not aid pep-
tide coupling, even when using thionyl chloride as an activating reagent. Thionyl
chloride under most circumstances is an efficient coupling reagent so would be ex-
pected to give a positive result if coupling on this compound were possible.
To see if the bulk of the nucleophile was the issue we attempted to couple glycine
methyl ester (Scheme 3.82). When this was also unsuccessful we presumed that the
problem resided with the Pca derivative considering 4-nitro[2.2]paracyclophane-13-
carboxylic acid could be coupled under similar conditions (Section 3.3.1).
Boc cleavage of Boc-Pro-Gly-Pca
The Boc group was cleaved using 1:3 trifluoroacetic acid in dichloromethane at 0°C.
With this pseudopeptide 3.41 fully deprotected, another pseudopeptide to be tested
as a catalyst was prepared and ready for resolution of the diastereomers (Fig. 3.83).
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SCHEME 3.82: Attempted coupling of glycine to Boc-Pro-Gly-Pca-OH
3.40.
FIGURE 3.83: Pseudopeptide 3.41.
The proton NMR of the pseudopeptide product displays some interesting effects of
the compound’s structure. Variable temperature 1H NMR shows how the N-H peaks
of this compound start as several well-defined peaks and coalesce to an averaged
peak as the temperature increases (Fig. 3.84).
FIGURE 3.84: N-H region of the Pro-Gly-Pca spectrum in variable
temperature 1H NMR. Bottom to top: 298 K (blue), 328 K (red), 373 K
(green).
This is due to the faster tumbling of the amide bonds with the increased kinetic en-
ergy. It may also be affected by a decrease in intramolecular hydrogen bonding as
temperature increases, which would explain their shift upfield due to less deshield-
ing.
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Resolution of Pro-Gly-Pca
TLC analysis of the fully deprotected pseudopeptide 3.41 (Fig. 3.83) eluting with 5%
methanol in dichloromethane, when run twice gave two spots with an Rf difference
of 0.07 (0.32 and 0.39). Standard flash column chromatography failed to resolve the
diastereomers, but a gravity silica column partially separated the two with the bulk
of the product inseparable. A small quantity of each diastereomer was separable
before and after the main bulk of the material. Using a smaller particle size of silica
(25-40 µm instead of the standard 60 µm) also aided this separation. Finer silica
may clog the pores of a glass frit in a column and prevent eluent flow; this may be
avoided by first adding a layer of a material like sand or glass wool to the bottom of
the column.
The two diastereomers were separated, with some central overlap as above for the
Pca-Phe precursor 3.25. However, it was not possible to grow crystals of adequate
quality for X-ray crystallography; NMR data was not sufficient for elucidation of
absolute configuration of the two diastereomers. Thus, they are referred to as 3.41-A
and 3.41-B; A is the diastereomer with the higher Rf. The flexibility of the central
glycine unit causes problems for both recrystallisation and analysis of the NMR.
Synthesis of the mono-substituted 4-Pro-glycinamido[2.2]paracyclophane
As for Pro-Pca (Section 3.3.6), the mono-substituted version of Pro-Gly-Pca was syn-
thesised in the same manner, starting with 4-amino[2.2]paracyclophane, affording
the diamide 3.43 (Scheme 3.85).
Attempted synthesis of the glycine residue on Pca-Phe
With conditions for synthesis of the glycine residue in hand, we also looked at us-
ing the same strategy to form a tripeptide with Pca as the central residue. Starting
with the previously synthesised Pca-Phe, the same synthesis to Gly-Pca-Phe was
attempted (Scheme 3.86). The first reaction, amide formation with bromoacetyl bro-
mide, was unsuccessful.
Initially, we believed that the free carboxylic acid of the phenylalanine residue was
the cause. To test this, the acid was protected with a methyl ester giving 3.44.
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SCHEME 3.85: Synthesis of the mono 4-Pro-Gly-
amido[2.2]paracyclophane. i) Zn, NH4Cl ii) a. bromoacetyl
bromide, b. NaN3, c. H2, Pd/C iii) Boc-Pro-OSu iv) CF3COOH
SCHEME 3.86: Attempted synthesis of Gly-Pca-Phe.
3.4. Outcome of peptide syntheses 165
The methyl ester was formed with thionyl chloride and methanol. The amide cou-
pling with bromoacetyl bromide was attempted again and it was still unsuccessful
(Scheme 3.87).
SCHEME 3.87: Attempted amide coupling between Pca-Phe-OMe
3.44 and bromoacetyl bromide. i) SOCl2, MeOH.
Including Et3N as a base to manage the acidity did not make the coupling work.253
Enhancing solubility by changing the solvent to acetonitrile or acetone was not help-
ful.
Another cause of the failure of this coupling is considered to be the increased steric
hindrance from the phenylalanine residue. The organisation of the 22PC-amine and
the phenylalanine residue on the opposite deck of the [2.2]paracyclophane scaffold
would seem to allow hydrogen bonding between the two substituents, decreasing
the nitrogen’s propensity to react.
3.4 Outcome of peptide syntheses
Figure 3.88 shows the compounds that were synthesised. Not all were tested as
catalysts in this project: Pca-Phe 3.44 was not used since it did not contain the active
proline moiety. Resolution of 3.7, 3.41 and 3.44 was achieved. With these in hand we
could turn our attention to catalyst studies.
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FIGURE 3.88: Pca derivatives synthesised and tested in this project.
3.58: Pca; 3.44: Pca-Phe; 3.34: Gly-Pca; 3.41: Pro-Gly-Pca; 3.7: Pro-Pca.
Synthesis of new peptides containing Pca was hindered by poor reactivity but con-
ditions for peptide couplings with Pca were obtained with some success. For cou-
plings to the Pca carboxylic acid, acyl chloride formation is an effective yield giving
good yield and high purity. For peptide couplings to the unreactive Pca aniline, N-
hydroxysuccinate ester activation of the amino acid gave acceptable results. Also
developed was the synthesis of a glycine residue directly on the Pca aniline.
Four new Pca-containing peptides were described: Pro-Pca 3.7, Gly-Pca 3.34, Pro-
Gly-Pca 3.41, and Pca-Phe 3.44.
The combination of the above work sets the stage for development of interesting




Michael addition with planar chiral
amine derivatives
With the peptide synthesis complete, a catalytic screening was necessary to inves-
tigate the potential and differences of the [2.2]paracyclophane-centred peptides as
catalysts. The Michael addition was chosen since it is a useful asymmetric carbon-
carbon bond forming reaction that many proline-derived catalysts have been devel-
oped for.
Michael addition of hexanal to trans-β-nitrostyrene (Scheme 4.1) was chosen as the
test reaction system for asymmetric catalysis by the small library of pseudopeptides
synthesised.
SCHEME 4.1: Asymmetric Michael addition between trans-β-
nitrostyrene and hexanal. i) 5-20 mol % catalyst, 5-10 mol % NMM.
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4.1 Michael addition between trans-β-nitrostyrene and hex-
anal
Michael addition of an alkyl aldehyde to trans-β-nitrostyrene (Scheme 4.2) has at-
tracted attention from groups designing asymmetric organocatalysts. Two stereo-
centres are installed; the syn ((R,S) or (S,R)) configuration is usually the major di-
astereomer pair formed when asymmetric catalysts are employed. It has been re-
ported that the carboxylic acid at the C-terminus of the peptide stabilises the inter-
mediate and this influences stereochemistry of the product.254
SCHEME 4.2: Mechanism of Michael addition between trans-β-
nitrostyrene and hexanal catalysed by proline.
Syn addition is favoured because of the shape of the reaction intermediate. Figure
4.3 shows the orientation of the approach of the two molecules in the C-C bond
forming step according to Seebach’s topological model.255 The existing substituents
are staggered. The N donor will be gauche and overlapped with the acceptor NO2;
this minimises charge separation and forms a quasi-chair conformation. This gives
the syn product in our Michael addition.
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FIGURE 4.3: Syn product formation.
4.1.1 Initial reaction condition screening
Since this reaction has been studied extensively conditions and results could be com-
pared to other groups’. Hexanal was chosen as the substrate from those which had
been presented in the literature. Butanal, pentanal, 3-methylbutanal and hexanal
were trialled and the cleanest reaction was observed with hexanal.
DL-Proline and L-proline were the first catalysts tested in the Michael reaction. This
was for several reasons:
• to determine appropriate reaction conditions with this system,
• to compare results with other groups’ results with a standard catalyst, since
proline is a common catalyst to test with Michael addition of trans-β-nitrostyrene
and aldehydes, which ensured our results are standard, and
• to provide a control reaction.
These reactions also provided racemic material to standardise the HPLC analysis.
The initial reactions employed conditions used in previous studies. This helped both
ensure our results can be compared with literature, and furthermore using known
conditions decreased the amount of troubleshooting required to find a suitable set of
conditions for catalyst testing. Initial tests used 9:1 chloroform/isopropanol as the
solvent mixture. It was found that even with proline as the catalyst, it would not
fully dissolve in the reaction mixture and required the addition of a small amount
(10-15%) of methanol into the solvent mixture. With increasing catalyst size, methanol
was no longer sufficient to dissolve the compounds. For optimal catalyst solu-
bility the reaction solvent system must contain a small amount of DMSO. Thus
further control reactions were run with the final solvent mixture of 9:1:1.6 chlo-
roform/isopropanol/DMSO. Compounds containing [2.2]paracyclophane tend to
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have low solubility; the amount of intramolecular hydrogen bonding and the size
of the molecules make the Pca peptide catalysts particularly poor examples.
Wennemers et al. tested the reaction of butanal with trans-β-nitrostyrene with their
tripeptide catalysts in different solvents and found a mixture of 9:1 chloroform/iso-
propanol to give the best combination of conversion, diastereoselectivity and enan-
tioselectivity.256 NMM is used as a base additive to the peptide catalyst which is
added as the hydrochloride salt. Using DMSO as solvent increased conversion but
gave lower selectivity. Pearson et al. tested the reaction of p-nitrobenzaldehyde with
cyclohexanone with various solvents and acidic additives.222 DMSO was found to
be the best solvent for their system; running the reaction at low temperatures with
low boiling point solvents was found to be undesirable due to the pseudopeptide
catalysts crashing out of solution at temperatures below room temperature. Acidic
additives are not appropriate for our experiments since we want the carboxylic acid
of the catalyst to be active in the reaction.
We first ran a series of control reactions involving just proline as the catalyst, which
completed the reaction within hours. The next step was to investigate the influence
of our catalysts. The reactions with our peptides were slower. A number of times
and temperatures were trialled and the most effective was running the reaction at
room temperature for 2 days, then at 60°C for 2 days (Entries 9-11 in Table 4.1), so
the screening tests were standardised to this schedule.
Since the screening reactions were always taken to completion, as measured by TLC
analysis and confirmed by the absence of starting material in 1H NMR, % yield is
an irrelevant metric; and since the reactions were run on 10 mg scale, measuring
the yield was somewhat impractical, so this figure will not be quoted. Instead, the
catalysts’ effectivenesses are measured using two metrics: diastereoselectivity (the
ratio of syn addition vs. anti); and enantioselectivity (of the syn product, how much
of the major (S,R) enantiomer was made vs. the minor enantiomer (R,S)).
The former is measured using the 1H NMR spectrum, where several key protons in
the diastereomers have identifiable peaks that are separate enough to measure the
ratio between them (Fig. 4.4). The latter is measured using HPLC, where using the
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correct chiral column and conditions, we can measure the ratio of major and minor
enantiomers’ peaks (Fig. 4.5).
FIGURE 4.4: Aldehyde proton peak for the syn (9.72 ppm) and anti
(9.49 ppm) diastereomers of 2-butyl-4-nitro-3-phenylbutanal.
FIGURE 4.5: Major (S,R, 16.2 min) and minor (R,S, 19.7 min) syn prod-
uct HPLC peaks (OD-H column, 9:1 hexane/i-PrOH), 1 mL/min.
HPLC conditions were chosen so that literature values could be used to identify
the correct peaks. Several authors have published HPLC data on the compounds
with different conditions, with the most common conditions using the OD-H column
with between 3% and 20% i-PrOH in hexane.256–262 Thus, tests were run using these
column conditions and 20% i-PrOH in hexane was chosen as the solvent ratio since
it gave faster elution while retaining separation. The Michael product peaks were
found in agreement with literature.
4.2 Catalysis screening results
The amino acids and pseudopeptides presented in Figure 4.6 were tested in the stan-
dardised Michael reaction between trans-β-nitrostyrene and hexanal (Fig. 4.1).
Notably, the Pca-Phe dipeptide that was synthesised in this project was not tested as
a catalyst since it did not contain the proline residue that was desired for catalytic
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FIGURE 4.6: Catalysts tested in asymmetric organocatalysed Michael
addition. 4.1: DL-proline; 4.2: L-proline; 4.3: Pca; 4.4: Pro-PC; 4.5:
Pro-Gly-PC; 4.6: Pro-Gly-Pca; 4.7: Pro-Pca.
activity in this reaction. Since the results obtained from this tested were not as ex-
plicable as expected, as explained in the discussions to follow, it might have been
interesting to include Pca-Phe in the catalyst screening.






1 4.1 1 day RT 5:95 50:50
2 4.2 1 day RT 4:96 43:57
3 4.3, racemate - 33:67 50:50
4 4.4-A and B - 35:65 48:52
5 4.5-A and B - 23:77 42:58
6 4.6-A and B - 32:68 37:63
7 4.6-A - 32:68 39:61
8 4.6-B - 33:67 38:62
9 4.6-B 9 days RT 42:58 39:61
10 4.6-B 2 days 60°C 37:63 49:51
11 4.6-B 2 days RT then 4
days 60°C
33:67 42:58
12 4.7, single diastereomer - 29:71 30:70
TABLE 4.1: Results of asymmetric Michael addition between trans-β-
nitrostyrene and hexanal catalysed by peptides. Conditions: solvent
- 9:1:1.4 CHCl3/i-PrOH/DMSO; 2 days RT then 2 days 60°C; 5 mol %
catalyst, 10 mol % NMM.
Where possible, all tests were performed in triplicate (or more) to confirm the results
were within agreement. Figures stated in Table 4.1 are mean values.
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4.2.1 Proline 4.1 and 4.2
A control study with L-proline was found to be in agreement with literature results,
and showed L-proline gave dr (anti:syn) of 4:96, and er [(R,S):(S,R)] of 43:57.263 Pre-
dictably, DL-proline does not select for the (R,S) or (S,R) enantiomers at all. It exhibits
diastereoselectivity because of its control over the transition state as shown in Figure
4.3 which preferentially forms the s-trans intermediate, in which the enamine bond
and attached groups are arranged with the R group of the aldehyde away from pro-
line’s carboxylic acid; but cannot differentiate between the diastereomers of the syn
product since it is racemic (Figure 4.7).
SCHEME 4.7: Newman projections of Michael addition with DL-
proline catalyst.
These tests were only run at room temperature with no heating phase, unlike most
other screens, since the reaction went to completion within one day.
Proline has quite a low enantioselectivity but when combined with a co-catalyst or
included as a larger peptide it gave superior enantioselectivity of 80-90% ee.256,264,265
As Wennemers found this is probably due to the more optimal distance between the
enamine-forming nitrogen and the carboxylic acid.147 We hoped this would mean
our Pca catalysts would give good results.
4.2.2 Tests for importance of stereochemical resolution of catalysts
Since most Pca pseudopeptides were difficult to resolve, a set of tests was devised to
test the importance of enantiomeric or diastereomeric purity. Pro-Gly-Pca was able
to be resolved into its diastereomers so each diastereomer was screened separately,
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along with a mixture of the two diastereomers. Comparing these tests shows that
the diastereomeric purity of this catalyst was not an important factor for the stere-
ochemical outcome of the reaction. Entries 6-8 in Table 4.1 show each of these tests
gave similar dr and er within the range of normal variation. It was a disappointing
result since we hoped that the [2.2]paracyclophane backbone would influence the
stereochemical outcome of the reaction.
We concluded that the rest of the tests could be run with the unresolved Pca catalysts.
We assumed that using mixtures of diastereomers or enantiomers of the catalysts
would have negligible effect on their stereoselectivity, but we are aware that this may
not be the case. Each pseudopeptide or pseudoamino acid may behave differently
due to the different relative positioning of each functional group.
The lack of influence of the Pca moiety on the selectivity of the tripeptide is probably
the result of the flexible nature of the Gly residue. It would be illuminating to test
this by replacing glycine with an alternative residue, either a natural amino acid with
an R group that could decrease the conformational freedom or another unnatural
amino acid that makes this section more rigid. The results might suggest that the
carboxylic acid is not involved in this reaction and it would have been useful to test
this theory by using the ester as a catalyst.
Unfortunately, the more rigid system Pro-Pca was only available as a single diastere-
omer so it is impossible to know if the Pca moiety played a more important role.
With more time the other diastereomer could have been synthesised. While it is
dangerous to make assumptions, the fact that 4.4 (Entry 4 in Table 4.1), without the
acid functionality, gave a lower enantioselectivity suggests this group is important
in Pro-Pca’s catalysis mechanism. This could be because for Pro-Pca, the carboxylic
acid moiety is closer to the proline residue.
4.2.3 Tests for effect of time and temperature
The effects of varying the time and temperature the reaction is run for are shown in
Entries 9 - 11 in Table 4.1. Running the reaction only for two days at 60°C decreases
the enantioselectivity of the reaction. This could be due to the increased flexibility of
the glycine-proline chain at high temperature.
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Longer reaction times decreasing the diastereoselectivity of the reaction might be
due to an equilibrium existing between the diastereomers, as suggested by other
groups studying the same reaction.266 If the catalyst is able to form the enamine
with the product it can interconvert between the anti and syn products.267 Thus, the
slow rate of reaction with the Pca catalysts might to their quite low diastereoselec-
tivity. Since the reactions take about 4 days to run to completion, finishing them
as soon as the starting material is consumed, and before equilibration between the
diastereomers begins, is difficult.
4.2.4 Pca 4.3
A mixture of enantiomers of Pca gave a 33:67 mixture of anti/syn diastereomers of
the Michael product. We know from previous experiments (Section 3.3.5) that imine
formation at the Pca N is possible so Pca can act as a catalyst here - although the reac-
tion proceeds slowly, as with all the [2.2]paracyclophane-containing catalysts tested.
As with DL-proline, we see no enantioselectivity since this material was racemic.
All the Pca-containing catalysts show a reversal of stereoselectivity towards the anti
product. Recently the Wennemers group also found that altering the active pro-
line moiety to introduce steric inhibition of the formation of the Si/Si intermediate
could influence the diastereoselectivity of the reaction (Figure 4.8).268 Wennemers’
group showed that including bulky groups on the δ-C of the catalytic proline residue
of their tripeptide catalysts caused reversal of the usual syn diastereoselectivity of
amine-catalysed Michael reactions of nitroolefins. Their dimethylproline residue
caused preferential formation of the s-cis enamine intermediate since this config-
uration was sterically favoured. When the nitroolefin attacks, it is still held in Si
alignment by the carboxylic acid of the catalyst, giving a larger proportion of the
anti S,R major product.
A reversal of diastereoselectivity is also seen in the Pca catalysts tested here. A simi-
lar effect may be occurring, where the bulky [2.2]paracyclophane backbone is having
an inhibitory effect on the s-trans enamine, changing the equilibrium of the transition
state in favour of the s-cis configuration.
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FIGURE 4.8: Syn and anti transition states in Wennemers’ anti-
selective Michael addition.
4.2.5 Pro-NH-22PC 4.4
The monosubstituted Pro-NH-22PC gave similar dr and er to Pca. A mixture of di-
astereomers, stereochemically pure at the Pro moiety but unresolved at Pca gave an
essentially racemic product.
Compared to the results for L-proline, in this catalyst proline is coupled through an
amide bond to 4-amino[2.2]paracyclophane. This prevents its carboxylic acid from
interacting in the reaction and increases steric bulk. Compared to L-proline, this cat-
alyst showed a slight reversal of diastereoselectivity (4:96 anti/syn for L-proline vs
35:65 for 22PC-NHPro). Regardless of chiral orientation at 22PC, since this was a
mixture of diastereomers, the 22PC component exhibits a greater tendency to pro-
duce the anti product, as seen with Pca. Without the carboxylic acid, the incoming
nitrostyrene is not spatially directed as strongly, so there is very little enantioselec-
tivity.
4.2.6 Pro-Gly-NH-22PC 4.5
With this catalyst as a mixture of diastereomers, we see minimal enantioselectivity
(42:58 minor/major); and a higher ratio of syn product compared to Pro-NH-22PC,
i.e. less reversal of diastereoselectivity toward the anti product. The glycine residue
increases flexibility of the molecule and distance from the 22PC moiety. These com-
bine to decrease the influence of the 22PC compared to the catalytic centre of the
proline residue. By separating the proline residue from the [2.2]paracyclophane
backbone the dr starts to return to that of L-proline, compared to the mono Pro-NH-
22PC. Figure 4.9 shows the possible configurations that would lead to the anti and
syn diastereomers. When Pca is directly coupled to proline the [2.2]paracyclophane
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backbone is closer to the catalytic centre and by interaction with the nitro group
influences diastereoselectivity. Again, without the carboxylic acid on the opposing
deck of [2.2]paracyclophane, this mono-substituted amide gives very low enantios-
electivity.
FIGURE 4.9: Possible configurations of the enamine intermediate.
4.2.7 Pro-Gly-Pca 4.6
Three tests were performed with this catalyst: each diastereomer individually, then
a 1:1 mixture of diastereomers. The tests show insignificant difference between the
two diastereomers, and the mixture thereof. This suggests the stereochemistry at
Pca is not important for enantioselectivity and that Pca’s effect is mainly due to its
steric bulk and possibly the geometric arrangement of the -COOH and the -NH-Gly-
Pro peptide chain pseudo-gem from each other. We know from comparing 4.4 and
4.5 that distance between the Pca and Pro residues diminishes [2.2]paracyclophane’s
effect on dr.
Entries 5 & 6 in Table 4.1 compare the Pro-Gly chain with and without the carboxylic
acid on the opposing face of [2.2]paracyclophane. For the Pca derivative 4.6, dr de-
creases but the er increases.
DFT calculations of the peptide ground states were carried out by Tyson Dais, using
the ωB97XD functional. The ωB97XD functional is range-separated, which makes
it suitable for [2.2]paracyclophane, with its ring-to-ring interactions. Models of the
ground state Pro-Gly-Pca show a difference between diastereomers in the confor-
mation of the Pro-Gly chain due to hydrogen bonding. These are the lowest energy
conformers.
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As seen in Figures 4.10 and 4.11 the SP-diastereomer contains a hydrogen bond con-
tact where the RP-diastereomer does not: between the Pro-Gly amide C=O and the
O-H of the [2.2]paracyclophanyl carboxylic acid.
FIGURE 4.10: Computational model of RP,S-Pro-Gly-Pca.
FIGURE 4.11: Computational model of SP,S-Pro-Gly-Pca.
We might expect the RP,S-diastereomer to give better stereoselectivity since the ori-
entation of the proline N directs the substrate towards the centre of the catalyst
molecule as well as its active carboxylic acid on the opposing [2.2]paracyclophane
aryl deck. However, no difference in stereoselectivity was seen between the two di-
astereomers, which suggests that there is too much conformational flexibility in the
molecule for stereochemical information to be transmitted from the [2.2]paracyclo-
phane moiety.
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4.2.8 Pro-Pca 4.7
This catalyst showed the best er of any catalysts tested (30:70). With proline directly
coupled to Pca the enantioselectivity is increased. Crystals of this molecule could
not be produced and thus stereochemistry at the Pca residue is not known, nor is
its conformation; but computer modelling suggests the following conformation of
the compound (Fig. 4.12 and4.13). According to this model, there is little conforma-
tional flexibility in this molecule with the amide bond between Pca and Pro being
rigid. The amide C-N bond is intermediate in length between a C-N single bond and
double bond, indicating partial double bond character, giving it limited rotation. The
1H NMR spectrum, with its broad N-H peak supports this. Thus the proline-N and
Pca-COOH are held in quite static position.
FIGURE 4.12: Computational model of RP,S-Pro-Pca.
As discussed in Section 3.3.6, the Pro-Pca synthesised was found to be a single di-
astereomer. In computational models of the two diastereomers of 4.7, the RP,S- and
SP,S- diastereomers of Pro-Pca could have different relative shapes, with RP,S-4.7
looking like it might lead to a more sterically congested enamine, due to the pres-
ence of intramolecular hydrogen bonding only in the SP,S diastereomer. This orients
the pyrrolidine ring inwards with the N pointing away from the rest of the molecule,
whereas the pyrrolidine ring in RP,S-4.7 points outwards with the N pointing in-
wards towards the opposite [2.2]paracyclophane deck. In either case there is lim-
ited conformational freedom about the Pro-Pca amide bond, which is probably the
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FIGURE 4.13: Computational model of SP,S-Pro-Pca.
cause of the increased stereoselectivity compared to Pro-Gly-Pca. Given more time it
would have been ideal to make the other diastereomer and identify how the shapes
of these two diastereomers affected stereoselectivity.
The hydrogen bonding seen in SP,S-4.7 might also be the cause of only one diastere-
omer being found in the synthesised product: the compound with intramolecular
hydrogen bonds has fewer atoms involved in intermolecular hydrogen bonding.
This would decrease its solubility in aqueous solutions whereas the other diastere-
omer might be lost to aqueous washes due to its increased solubility in water.
Comparing the results of Pro-NH-22PC and Pro-Pca (Entries 4 & 12 respectively),
and Pro-Gly-NH-22PC and Pro-Gly-Pca (Entries 5 & 6 respectively), we can see
that diastereoselectivity increases when incorporating Pca instead of 4-amino[2.2]-
paracyclophane with Pro; and that it decreases when incorporating Pca instead of
amino[2.2]paracyclophane with Gly-Pro. This suggests the combination of distance
and lower rigidity puts the carboxylic acid in a less ideal position in Pro-Gly-Pca.
4.3 Conclusion
Pca and two Pca-containing pseudopeptides were studied as asymmetric organocat-
alysts in Michael addition between trans-β-nitrostyrene and hexanal and were com-
pared to proline, a known catalyst for this reaction. These tests were performed to
4.3. Conclusion 181
probe the relationship between relative conformation between the carboxylic acid
and amine moieties of the catalyst, and the catalyst’s stereoselectivity. There are
some promising preliminary results. Pca exhibited a moderate reversal of the usual
strongly syn-directing catalysis, which is in contrast to the bulk of the literature on
this Michael addition. Direct coupling of Pro to Pca gave better enantioselectivity
than coupling Pro-Gly to Pca, indicating that decreasing conformational flexibility is
important for stereoselectivity.
182
Chapter 4. Asymmetric organocatalysed Michael addition with planar chiral
amine derivatives
4.4 Future directions
4.4.1 R group functionalisation
‘R group’ functionalisation of the glycine residue would be interesting (Scheme 4.14).
The [2.2]paracyclophane backbone might allow control of diastereoselectivity when
adding the R-group. The R-group could introduce further functionality for catalysis,
solubility, stability and so forth, and also might decrease rotational freedom about
that α-carbon. Since that rotational freedom is thought to lower stereoselectivity of
the Michael reaction, this could help increase stereoselectivity of the catalyst.
SCHEME 4.14: R-group functionalisation of glycine.
4.4.2 N-alkylation
A problem encountered with the Pca catalyst was its poor solubility in aqueous and
many organic solvents. Wennemers’ work with alkylated peptide catalysts showed
that this simple modification can increase the solubility of poorly-soluble catalysts
and thus increased catalyst efficiency.148 It could be worth looking into similar mod-
ifications of Pca-peptides. Figure 4.15 shows possible N-alkylation in Pca peptides.
4.4.3 Synthesis of further peptides
This work, at its outset, intended to synthesise a wider array of peptides in order
to probe the spatial relationship between the carboxylic acid and proline moieties in
the catalyst for Michael addition. Due to time-consuming difficulties encountered in
the synthesis of Pca and Pca-centred peptides, the range of peptides synthesised was
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FIGURE 4.15: Wennemers’ N-alkylated tripeptide (left) and a Pca ana-
logue (right).
narrowed. Since the problems with these syntheses were largely overcome through
optimisation in this project, the next step would be to test a larger range of catalysts
in the Michael reaction. This would include tripeptides of the type Pro-Pca-Xaa,
where Xaa is a natural amino acid with a carboxylic acid at varying lengths from its
α carbon.
4.4.4 Acyl fluoride activation
Some peptide coupling conditions were untested because the required reagents were
inaccessible. A promising avenue is acyl fluoride activation. Fluorinating agents
are popular for their higher reactivity, increased stability to hydrolysis and high
retention of stereochemistry compared to acyl chlorides. They may be used with
protecting groups that are sensitive to acyl chloride activation. Common fluorinat-
ing agents are cyanuric fluoride and 2-fluoro-1-ethyl pyridinium tetrafluoroborate
(BEP) (Scheme 4.16).269 In this project acyl chlorides were not successful when cou-
pling natural amino acids to the aniline of Pca, but an acyl bromide (bromoacetyl
bromide) was found to be reactive enough to form an amide bond with Pca (section
3.3.7).
4.4.5 Resolution of catalysts
Resolution of diastereomers of Pca peptides, as well as synthesis of the diastereomer
of Pro-Pca not obtained in this project, would help complete this data set and give
a more complete picture of the mechanisms at work behind the stereoselectivities
exhibited by the peptides tested.
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SCHEME 4.16: Acyl fluoride activation for peptide coupling with Pca-
OMe. i. 2-Fluoro-1-ethyl pyridinium tetrafluoroborate. ii. Pca-OMe.
4.4.6 Potential thioether catalyst
During the course of this research, the successful synthesis of bromide 4.8 allowed
branching of the synthetic route to target a range of interesting and useful com-
pounds for different kinds of catalysis. As a brief proof of concept, formation of the
thioether catalysts for bromolactonisation was explored as another potential catalyst
target.
From the previously synthesised methyl 4-[(3-bromo-1-oxoethyl)amino][2.2]para-
cyclophane-13-carboxylate 4.8, the butyl thioether was synthesised using 1-butanethiol,270
by SN2 substitution (Scheme 4.17). The bromide again exhibited good reactivity and
the reaction proceeded in high yield and purity.
SCHEME 4.17: Synthesis of thioether 4.10. i) K2CO3, BuSH. ii) KOH.
1-Butanethiol is a hazardous and malodorous compound and as such should al-
ways be handled in a fume cupboard. Glassware used with this compound was
soaked in a dilute bleach bath to remove odour before cleaning. The resulting sulfide
compound retained a slight allium/brassica smell even after purification to remove
residual butanethiol.
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The methyl ester 4.9 may be cleaved with base in the usual method in 2 M ethanolic
KOH.
While this branch of catalysts could perform interesting and useful reactions such as
bromolactonisation reactions (Fig. 4.18),271–274 it is beyond the scope of the current
work and may be explored by future members of the Rowlands group.
SCHEME 4.18: Exemplar sulfide-catalysed asymmetric bromolacton-






All starting compounds and solvents were used as received from commercial sources
without further purification unless otherwise noted. Solvents were dried using the
following methods: diethyl ether and THF were heated at reflux over fresh sodium
wire in the presence of benzophenone indicator. Toluene and DMF were stored over
4 Å molecular sieves. Dioxane was stored over sodium wire. Triethylamine was
freshly distilled over sodium hydroxide pellets.
TLC analysis was performed using aluminium-backed silica gel plates, visualised
using UV light (254 nm), and stained with ninhydrin, iodine, cerium ammonium
molybdate, or KMnO4 where applicable.
NMR spectra were recorded using Bruker 400 MHz or 500 MHz Avance instru-
ments and processed using Topspin. 2D spectra were recorded on a Bruker 700 MHz
Avance instrument by Dr Pat J. Edwards. Chemical shifts are in ppm and referenced
to the NMR solvent. Multiplicities are described as follows: s = singlet, d = doublet, t
= triplet, q = quartet, dd = double doublet, ddd = double double doublet, dt = double
triplet, td = triple doublet, m = multiplet, br = broad.
For mass spectra, where data are quoted to two dp, they were recorded on a Bruker
HPLC-MS for ESI spectra. High resolution mass spectra were recorded on a Ther-
moScientific Q Exactive Focus Hybrid Quadrupole-Orbitrap Mass Spectrometer by
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David J. Lun. Analytical chiral HPLC was performed on a Bruker HPLC-MS with a
Daicel Chiralcel OD-H HPLC column (25 cm) with UV detection at 254 nm.
IR spectra were collected using a Perkin-Elmer 1600 Fourier Transform spectrometer
as either thin film (CH2Cl2) or solid, as ATR spectra.
Melting points were recorded on a Gallenkamp melting point apparatus and are
uncorrected.
Optical rotation was recorded on a Perkin Elmer 241 polarimeter using a sodium
lamp, emitting at 589 nm. All samples were measured in a 10 cm cell and are an
average of 10 readings. Average temperature was 25°C.
CD spectra were recorded using a Chirascan CD spectrophotometer (150 W Xe arc)
from Applied Photophysics with a Quantum Northwest TC125 temperature con-
troller. CD spectra (average of at least 3 scans) were recorded between 210 and 350
nm with 1 nm intervals, 120 nm/min scan rate followed by subtraction of a back-
ground spectrum (solvent only).
X-ray crystallography was performed by Prof Martyn P. Coles. Crystals were cov-
ered in Fomblin and suitable single crystals were selected under a microscope and
mounted on a Kappa CCD diffractometer. The structures were refined with SHELXL-
97.
Column chromatography was performed using flash silica column chromatography
or a Buchi automatic chromatography system, with silica size 40-63 µm (230-400
mesh) except where noted. The Buchi automatic chromatography system uses silica
cartridges and provides automated solvent mixing allowing gradient methods to be
used. Compound detection is accessible using up to 4 different UV wavelengths.
Flow rate, gradient profile, and collection conditions may be customised for the de-
sign of a suitable separation.
DFT calculations were performed by Tyson Dais using Gaussian 09, with theωB97XD
functional and the 6-311g(d,p) basis set.
Where data is stated to be of insufficient quality for further analysis, either:
• The compound had poor solubility in solvents for NMR or mass spectrometry;
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• The material could not be purified sufficiently for full analysis; or
• There was insufficient material for full analysis.
More analysis to obtain these data was not completed due to restrictions during the
COVID-19 pandemic.
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5.2 Synthetic methods
5.2.1 Synthesis of Pca, oxime methodology
[2.2]Paracyclophane-4-carboxylic acid 2.12
AlCl3 (2.25 g, 16.82 mmol, 1.75 eq.) was dissolved in CH2Cl2 (48 mL, 0.2 M) un-
der inert atmosphere and cooled to -10 °C in an ice/acetone bath. (COCl)2 (1.44
mL, 16.82 mmol, 1.75 eq) was added and the mixture was stirred at -10 °C for 30
minutes. [2.2]Paracyclophane (2.0 g, 9.61 mmol, 1.0 eq.) was added and the mix-
ture was stirred at -10 °C for a further 10 minutes. The reaction was quenched by
slowly adding water (30 mL). The aqueous layer was extracted with CH2Cl2 (3 x 50
mL). Combined organics were dried (MgSO4) and the solvent was removed under
reduced pressure, affording the intermediate oxo-acyl chloride as a white powder.
Chlorobenzene (20 mL) was added to dissolve the intermediate product and this
solution was heated at reflux overnight. Water (20 mL) was added and the mix-
ture was heated at reflux for a further three hours. After cooling, the aqueous layer
was extracted with CH2Cl2 (2 x 50 mL), dried (MgSO4) and the solvent removed
under reduced pressure. The crude material was dissolved in EtOAc (50 mL) and
extracted with 2 M aq. NaOH (3 x 80 mL). The aqueous layer was neutralised with
2 M aq. HCl and the resulting precipitate was collected with suction filtration, af-
fording [2.2]paracyclophane-4-carboxylic acid as a white powder (0.73 g, 2.89 mmol,
30%). Rf (1:1 hexane:EtOAc) 0.22. 1H NMR (500 MHz, CDCl3): δ 7.26 (1H, d, J = 1.5
Hz, H-5), 6.60 (1H, d, J = 7.5 Hz, H-13), 6.53 (1H, d, J = 7.5 Hz, H-7), 6.48 (3H, m, H-8,
H-12, H-15), 6.38 (1H, d, J = 7.5 Hz, H-16), 4.08 (1H, t, J = 10.5 Hz, H-2b), 3.53-2.93
(6H, m, H-1, H-9, H-10), 2.76 (1H, dt, J = 3.5, 1.5 Hz, H-2a). Data comparable to that
reported in the literature.209
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Methyl [2.2]paracyclophane-4-carboxylate 2.13
To a suspension of [2.2]paracyclophane-4-carboxylic acid (0.73 g, 2.90 mmol, 1.0 eq.)
in dry CH2Cl2 (14.5 mL, 0.2 M) at -10 °C under inert atmosphere was added (COCl)2
(0.30 mL, 3.48 mmol, 1.2 eq.). A catalytic amount of DMF (one drop of a solution of
one drop DMF in 5 mL CH2Cl2) was added and the reaction mixture was stirred at
room temperature until bubbling ceased, about 30 minutes. Solvent was removed
under reduced pressure. Dry CH2Cl2 (7.5 mL) and dry MeOH (7.5 mL) were added
to dissolve the material and the solution was heated at reflux overnight. The sol-
vent was removed affording methyl [2.2]paracyclophane-4-carboxylate as a white
powder (0.70 g, 2.63 mmol, 91%). MP 129-131 °C. Rf (4:1 hexane:EtOAc) 0.42. 1H
NMR (500 MHz, CDCl3): δ 7.16 (1H, d, J = 1.9 Hz, H-5), 6.68 (1H, dd, J = 7.9, 1.9
Hz, H-13), 6.59-6.56 (2H, m, H-7, H-12), 6.54-6.46 (3H, m, H-8, H-15, H-16) 4.11 (1H,
ddd, J = 12.1, 10.7, 1.5 Hz, H-2b), 3.94 (3H, s, CH3) 3.23-3.01 (6H, m, H-1, H-9, H-10),
2.89 (1H, ddd, J = 12.8, 10.1, 6.9 Hz, H-2a). Data comparable to that reported in the
literature.275
Methyl 13-formyl[2.2]paracyclophane]-4-carboxylate 2.19
To a stirred solution of methyl [2.2]paracyclophane-4-carboxylate (0.70 g, 2.63 mmol,
1.0 eq.) in dry CH2Cl2 (9 mL, 0.3M) under inert atmosphere at -10 °C was added
1,1-dichlorodimethyl ether (0.26 mL, 2.89 mmol, 1.1 eq.) and TiCl4 (0.58 mL, 5.26
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mmol, 2.0 eq.). The reaction mixture was allowed to slowly come to room temper-
ature overnight. Ice was added and once the colour changed from opaque dark
red to clear yellow, the aqueous and organic layers were separated. The aqueous
layer was extracted with CH2Cl2 (3 x 20 mL). Combined organics were washed
successively with saturated NaHCO3, water, and brine (30 mL each), then dried
(MgSO4) and the solvent removed under reduced pressure affording methyl 13-
formyl[2.2]paracyclophane]-4-carboxylate as a white powder (0.50 g, 1.69 mmol,
65%). Rf (4:1 hexane:EtOAc) 0.65. 1H NMR (500 MHz, CDCl3): δ 9.91 (1H, s, CHO),
7.07 (2H, t, J = 2.4 Hz, H-5, H-12), 6.73 (2H, ddd, J = 7.8, 5.9, 2.0 Hz, H-7, H-16), 6.66
(1H, d, J = 8.0 Hz, H-15), 6.63 (1H, d, J = 8.0 Hz, H-8), 4.20-4.11 (2H, m, H-1b, H-2b),
3.84 (3H, s, CH3), 3.18-3.11 (5H, m, H-2a, H-9, H-10), 3.03 (1H, ddd, J = 12.3, 10.3, 4.4
Hz, H-2a). Data comparable to that reported in the literature.186
Methyl 13-hydroxylimino[2.2]paracyclophane-4-carboxylate 2.20
Methyl 13-formyl[2.2]paracyclophane-4-carboxylate (1.03 g, 3.4 mmol, 1.0 eq.) and
NaOAc (1.39 g, 17.0 mmol, 5.0 eq.) were suspended in EtOH (30 mL, 0.2 M) and
heated to reflux. NH2OH ·HCl (1.07 g, 13.6 mmol, 4.0 eq.) was added and the
mixture was heated at reflux overnight. The solvent was removed under reduced
pressure and water (25 mL) was added. This aqueous residue was extracted with
EtOAc (3 x 30 mL). Combined organics were dried (MgSO4) and the solvent removed
under reduced pressure to afford methyl 13-hydroxylimino[2.2]paracyclophane-4-
carboxylate as a light yellow solid (0.81 g, 2.6 mmol, 77%). MP 160 °C (decomposes).
Rf (4:1 hexane:EtOAc) 0.43. 1H NMR (500 MHz, CDCl3): δ 8.14 (1H, s, CH=N), 7.26
(1H, d, J = 1.9 Hz, H-5), 6.87 (1H, d, J = 1.3 Hz, H-12), 6.72 (1H, dd, J = 7.8, 1.9 Hz,
H-7), 6.63 (1H, d, J = 7.8 Hz, H-16), 6.61-6.58 (2H, m, H-8, H-15), 4.33-4.36 (1H, m,
H-2b), 3.92 (3H, s, CH3), 3.72-3.67 (1H, m, H-1b), 3.20-3.00 (6H, m, H-1a, H-2a, H-9,
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H-10). 13C NMR (125 MHz, CDCl3): δ 167.1 (C=O), 149.2 (C=N), 142.7 (CH), 139.8
(CH), 139.6 (C), 139.5 (C), 136.5 (C), 136.3 (C), 135.1 (C), 134.5 (C), 134.3 (CH), 132.2
(CH), 130.5 (CH), 129.5 (CH), 51.9 (CH3), 34.9 (CH2), 34.8 (CH2), 34.8 (CH2), 32.4
(CH2). HRMS (ESI) found: [M + Na]+ 332.1260. C19H19N1O3Na requires [M + Na]+
332.1257.
Hydroxyl(tosyloxy)iodobenzene 2.31
p-Toluenesulfonic acid monohydrate (5.0 g, 26.32 mmol, 2.0 eq.) was dissolved in
a minimum quantity of MeCN and added to a suspension of iodobenzene diac-
etate (4.24 g, 13.16 mmol, 1.0 eq.) in MeCN (33 mL, 0.4 M). The reaction mixture
was left to stand without stirring for one hour. The resulting white precipitate was
filtered and washed with acetone then petroleum ether (BP 40-60°C), affording hy-
droxyl(tosyloxy)iodobenzene as fine white needles (4.60 g, 11.7 mmol, 89%). MP
132-134 °C. 1H NMR (400 MHz, DMSO-d6): δ 9.76 (1H, s, br, OH), 8.17 (2H, d, J =
6.4 Hz, H-d), 7.57 (2H, d, J = 6.4 Hz, H-c), 7.54-7.52 (1H, m, H-a), 7.47 (2H, d, J = 7.2
Hz, H-e), 7.11 (2H, d, J = 6.4 Hz, H-b), 2.29 (3H, s, CH3). Data comparable to that
reported in the literature.276
Methyl 4-(N-hydroxyamido)[2.2]paracyclophane-13-carboxylate 2.34
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Methyl 13-hydroxylimino[2.2]paracyclophane-4-carboxylate (0.80 g, 2.61 mmol, 1.0
eq.) and hydroxyl(tosyloxy)iodobenzene (1.13 g, 2.87 mmol, 1.1 eq.) were dissolved
in DMSO (30 mL, 0.1 M) and heated at 90 °C overnight. The reaction mixture
was cooled and water (30 mL) was added. The aqueous layer was extracted with
EtOAc (3 x 20 mL). Combined organics were dried (MgSO4) and the solvent re-
moved under reduced pressure. The resulting residue was separated by column
chromatography eluting a gradient of hexane:EtOAc 10:1 to 0:1 to afford methyl 4-
(N-hydroxyformamido)-[2.2]paracyclophane-13-carboxylate as a yellow oil (0.43 g,
1.32 mmol, 51%). Rf (1:1 hexane:EtOAc) 0.20. 1H NMR (500 MHz, CDCl3): δ 10.39
(1H, s, OH), 8.71 (1H, s, NH), 7.13 (1H, d, J = 1.7 Hz, H-5), 6.78 (1H, dd, J = 7.7, 1.9
Hz, H-16), 6.71-6.67 (2H, m, H-12, H-7), 6.65-6.63 (2H, m, H-8, H-15), 4.06-4.01 (1H,
m, H-2b), 3.76 (3H, s, CH3), 3.65 (1H, ddd, J = 12.5, 9.9, 5.2 Hz, H-1b), 3.10-2.97 (5H,
m, H-1a, H-9, H-10), 2.90 (1H, ddd, J = 12.2, 10.0, 5.3 Hz, H-2a). 13C NMR (125 MHz,
CDCl3): δ 166.4 (C=O), 165.3 (C=O), 142.6 (C), 139.8 (C), 139.6 (C), 139.4 (CH), 136.5
(CH), 136.4 (C), 135.8 (C), 135.3 (C), 134.4 (CH), 133.4 (CH), 130.8 (CH), 130.0 (CH),
51.9 (CH3), 35.6 (CH2), 34.6 (CH2), 34.5 (CH2), 33.5 (CH2). HRMS (ESI) found: [M +
H]+ 326.1314. C19H19N1O3Na requires [M + H]+ 326.1310.
Methyl 13-amino[2.2]paracyclophane-4-carboxylate 2.21
Methyl 13-hydroxylimino[2.2]paracyclophane-4-carboxylate (0.90 g, 2.91 mmol, 1.0
eq.) and hydroxyl(tosyloxy)iodobenzene (1.25 g, 3.20 mmol, 1.1 eq.) were dissolved
in DMSO (30 mL, 0.1 M) and heated at 110 °C overnight. NaOH pellets (0.25 g, 6.34
mmol, 1.8 eq) were ground to a powder and added. This mixture was heated at 110
°C for a further four hours. After cooling, water (25 mL) was added and the crude
product extracted with EtOAc (4x50 mL). Combined organics were dried (MgSO4)
and the solvent was removed under reduced pressure affording the crude product as
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a dark orange oil. The resulting residue was separated by column chromatography
and elution with 4:1 hexane:EtOAc, affording methyl 13-amino[2.2]paracyclophane-
4-carboxylate as a pale yellow-brown solid (0.15 g, 0.53 mmol, 18%). MP 165 °C
(decomposes). Rf (4:1 hexane:EtOAc) 0.39. 1H NMR (400 MHz, CDCl3): δ 7.25 (1H,
s, H-5), 6.69 (1H, dd, J = 7.8, 1.9 Hz, H-7), 6.42 (1H, d, J = 7.6 Hz, H-8), 6.34 (1H, d,
J = 7.6 Hz, H-15), 6.17 (1H, dd, J = 7.8, 1.9 Hz, H-16), 5.44 (1H, d, J = 1.5 Hz, H-12),
4.40-4.25 (1H, m, H-2b), 3.89 (3H, s, CH3), 3.15 (1H, ddd, J = 13.0, 9.8, 2.8 Hz, H-1b),
3.05-2.90 (5H, m, H-1a, H-9, H-10), 2.73 (1H, ddd, J = 13.9, 10.7, 5.2 Hz, H-2a). Data
comparable to that reported in the literature.181
4-Carboxyl[2.2]paracyclophane 5.1
To a stirred solution of [2.2]paracyclophane (0.96 g, 4.81 mmol, 1.0 eq.) in dry CH2Cl2
(16 mL, 0.3 M) were added TiCl4 (1.06 mL, 9.62 mmol, 2.0 eq.) and CH3OCHCl2
(0.48 mL, 5.29 mmol, 1.1 eq.) at -10 °C under Ar. This solution was allowed to
slowly come to room temperature overnight. Ice (50 mL) was added and once it was
melted the aqueous layer was extracted with CH2Cl2 (3 x 50 mL). Combined organics
were washed once each with saturated NaHCO3, water, and brine (40 mL each),
then dried (MgSO4) and the solvent removed under reduced pressure, affording 4-
carboxyl[2.2]paracyclophane as a pale yellow solid (0.98 g, 4.14 mmol, 86%). MP
(149-151 °C). Rf (4:1 hexane:EtOAc) 0.39. 1H NMR (400 MHz, CDCl3): δ 9.96 (1H, s,
CHO), 7.03 (1H, d, J = 2.0 Hz, H-5), 6.74 (1H, dd, J = 7.7, 2.0 Hz, H-13), 6.63-6.53 (2H,
m, H-15, H-16), 6.51 (1H, d, J = 8.4 Hz, H-7), 6.44 (1H, dd, J = 7.8, 1.8 Hz, H-8), 6.39
(1H, dd, J = 7.8, 1.8 Hz, H-12) 4.14-4.08 (1H, m, H-2b), 3.31-2.93 (7H, m, H-1, H-2a,
H-9, H-10). Data comparable to that reported in the literature.51
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4-Hydroxylimino[2.2]paracyclophane 5.2
4-Carboxyl[2.2]paracyclophane (0.98 g, 4.15 mmol, 1.0 eq.) and NaOAc (1.70 g,
20.75 mmol, 5.0 eq.) were suspended in EtOH (20 mL, 0.2 M) and heated to re-
flux. NH2OH ·HCl (1.30 g, 16.60 mmol, 4.0 eq.) was added portionwise and this
suspension was heated at reflux for two hours. The solvent was removed under
reduced pressure and the crude product was redissolved in EtOAc (20 mL). The or-
ganic layer was washed with water (3 x 30 mL), then dried (MgSO4) and the solvent
removed under reduced pressure affording 4-hydroxylimino[2.2]paracyclophane as
a pale yellow solid (0.88 g, 3.50 mmol, 84%). Rf (4:1 hexane:EtOAc) 0.45. 1H NMR
(500 MHz, CDCl3): δ 8.20 (1H, s, CH=N), 6.79 (1H, d, J = 1.2 Hz, H-5), 6.63 (1H, d, J
= 8.0 Hz, H-8), 6.60 (1H, dd, J = 8.0, 1.7 Hz, H-7), 6.53-6.47 (4H, m, H-12, H-13, H-15,
H-16), 3.62-3.58 (1H, m, H-2b), 3.20-2.88 (7H, m, H-1, H-2a, H-9, H-10). 13C NMR (125
MHz, CDCl3): δ 150.1 (C=N), 140.5 (C), 139.8 (C), 139.7 (C), 135.5 (C), 134.5 (C), 133.6
(CH), 133.0 (CH), 132.2 (CH), 131.9 (CH), 131.8 (CH), 131.3 (2 CH), 35.5 (CH2), 35.0
(CH2), 35.0 (CH2), 33.6 (CH2). Data comparable to that reported in the literature.186
4-Amino[2.2]paracyclophane 5.3
4-Hydroxylimino[2.2]paracyclophane (2.50 g, 9.96 mmol, 1.0 eq.) and hydroxyl-
(tosyloxy)iodobenzene (4.30 g, 10.96 mmol, 1.1 eq.) were heated at 90 °C in DMSO
(15 mL, 0.1 M) overnight. NaOH pellets (0.72 g, 17.93 mmol, 1.8 eq.) were ground to
a powder and added, and the reaction mixture was heated for a further two hours.
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Water (15 mL) was added and product was extracted with EtOAc (3 x 20 mL). Com-
bined organics were washed with water (2 x 30 mL), dried (MgSO4) and the solvent
removed under reduced pressure, affording crude product as a dark orange oil. The
resulting residue was separated by column chromatography and elution with hex-
ane:EtOAc 9:1 affording 4-amino[2.2]paracyclophane as a pale yellow solid (0.58 g,
2.60 mmol, 26%). MP 160 °C (decomposes). Rf (4:1 Hex/EtOAc) 0.35. 1H NMR (500
MHz, CDCl3): δ 7.19 (1H, dd, J = 7.9, 1.7 Hz, H-13), 6.59 (1H, dd, J = 7.9, 1.8 Hz,
H-16), 6.41 (2H, ddd, J = 7.7, 3.6, 2.0 Hz, H-12, H-15), 6.29 (1H, d, J = 7.8 Hz, H-7),
6.16 (1H, dd, J = 7.7, 1.6 Hz, H-8), 5.45 (1H, d, J = 1.7 Hz, H-5), 3.17-2.95 (7H, m,
H-1b, H-2, H-9, H-10), 2.71-2.67 (1H, m, H-1a). Data comparable to that reported in
the literature.277
5.2.2 Synthesis of Pca, nitrate methodology
4-Nitro[2.2]paracyclophane 2.38
To a solution of [2.2]paracyclophane (4.00 g, 19.2 mmol, 1.0 eq) in CH2Cl2 (400 mL)
at 0 °C was added HNO3 (2.29 mL, 38.5 mmol, 2.0 eq) and H2SO4 (4.31 mL, 76.9
mL, 4.0 eq). The mixture was stirred overnight, allowing it to come to room temper-
ature. The mixture was poured onto ice (300 mL) and stirred until the ice melted.
The aqueous layer was extracted with CH2Cl2 (3 x 150 mL). Combined organics
were dried (MgSO4) and the solvent removed under reduced pressure affording the
crude product as an oily orange solid. The resulting residue was separated by col-
umn chromatography and elution with hexane:EtOAc 7:1 affording the pure prod-
uct as an orange solid (4.54 g, 17.9 mmol, 93%). MP 155 °C (decomposes). Rf (4:1
Hex/EtOAc) 0.53. 1H NMR (500 MHz, CDCl3): δ 7.24 (1H, d, J = 1.8 Hz, H-5), 6.82
(1H, dd, J = 6.9, 0.9 Hz, H-13), 6.65 (2H, dd, J = 7.8, 2.2 Hz, H-7, H-16), 6.59 (2H, ddd,
J = 14.1, 7.9, 1.8 Hz, H-8, H-15), 6.50 (1H, dd, J = 7.8, 1.8 Hz, H-12), 4.06 (1H, ddd, J
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= 13.3, 9.5, 1.9 Hz, H-2b), 3.26-3.06 (6H, m, H-1a, H-2a, H-9, H-10), 2.92 (1H, ddd, J
= 13.3, 10.0, 7.2 Hz, H-1b). 13C NMR (125 MHz, CDCl3): δ 150.5 (C), 143.2 (C), 140.6
(C), 140.3 (C), 138.8 (CH), 138.4 (CH), 137.5 (C), 134.3 (2 C, CH), 133.5 (CH), 131.0
(CH), 130.6 (CH), 37.1 (CH2), 36.0 (CH2), 35.9 (CH2), 35.6 (CH2). Data comparable to
that reported in the literature.196
4-Amino[2.2]paracyclophane 5.3
4-Nitro[2.2]paracyclophane (3.10 g, 12.2 mmol, 1.0 eq.) was dissolved in MeOH (62
mL, 0.2 M) and heated to 80 °C. To this solution was added Zn powder (2.40 g, 36.7
mmol, 3.0 eq.) and NH4Cl (1.96 g, 36.7 mmol, 3.0 eq.) and this mixture was stirred at
80 °C overnight, then allowed to cool. The mixture was filtered through qualitative
filter paper and the solid washed with MeOH (2 x 40 mL). The filtrate and washings
were combined and the solvent removed under reduced pressure. The residue was
suspended in water and stirred for 30 minutes, then the remaining solids collected
by filtration, affording the 4-amino[2.2]paracyclophane as a green-brown powder
(2.53 g, 11.33 mmol, 93%). Data as reported earlier.
4-Nitro-13-formyl[2.2]paracyclophane 2.39
To a solution of 4-nitro[2.2]paracyclophane (4.54 g, 17.94 mmol, 1.0 eq) in dry CH2Cl2
(90 mL) under inert atmosphere at -10 °C was added 1,1-dichlorodimethyl ether
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(1.79 mL, 19.73 mmol, 1.1 eq) and TiCl4 (3.94 mL, 35.88 mmol, 2.0 eq). The mix-
ture was stirred overnight, coming to room temperature. The mixture was poured
onto ice (100 mL) and stirred until ice melted. The aqueous layer was extracted with
CH2Cl2 (3 x 80 mL). Combined organics were washed with water, dried (MgSO4)
and the solvent removed under reduced pressure affording the crude product as an
orange-brown solid. The crude product was purified using silica gel column chro-
matography using a gradient of 9:1 to 1:1 hexane:EtOAc affording the pure product
as an orange-yellow solid (3.44 g, 12.2 mmol, 68%). MP 160 °C (decomposes). Rf (4:1
Hex/EtOAc) 0.20. 1H NMR (500 MHz, CDCl3): δ 9.96 (1H, s, CHO) 7.17 (1H, d, J =
1.8 Hz, H-5), 7.12 (1H, d, J =2.0 Hz, H-12), 6.85 (1H, dd, J = 7.8, 1.9 Hz, H-7), 6.80 (1H,
dd, J = 7.8, 2.0 Hz, H-16), 6.75 (1H, d, J = 7.8 Hz, H-8), 6.70 (1H, d, J = 7.8 Hz, H-15),
4.24-4.18 (1H, m, H-1b), 4.08-3.99 (1H, m, H-2b), 3.26-3.08 (6H, m, H-1a, H-2a, H-9,
H-10). 13C NMR (125 MHz, CDCl3): δ 190.4 (CHO), 149.5 (C), 142.6 (C), 141.9 (C),
140.1 (C), 137.8 (C), 137.4 (CH), 137.4 (CH), 136.3 (CH), 136.1 (CH), 135.6 (C), 134.7
(CH), 128.3 (CH), 34.5 (CH2), 34.4 (CH2), 34.2 (CH2), 31.7 (CH2). HRMS (ESI) found:
[M + H]+ 282.1131. C17H16NO3 requires [M + H]+ 282.1125.
4-Nitro-13-[N-(1-phenylethyl)][2.2]paracyclophanyl methanimine 2.45
A solution of 4-nitro-13-formyl[2.2]paracyclophane (2.55 g, 9.1 mmol, 1.0 eq) and
(S)-1-phenylethylamine (1.23 mL, 9.5 mmol, 1.05 eq) in CH2Cl2 (45 mL, 0.2 M) was
stirred at room temperature overnight. Solvent was removed under reduced pres-
sure affording the crude product as a brown oil. The crude product was recrys-
tallised from a minimum amount of hot toluene affording pale yellow crystals. The
crystals were collected using suction filtration and washed successively with cold
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toluene and cold acetone affording {single diastereomer}-4-nitro-13-[N-(1-phenyl-
ethyl)][2.2]paracyclophanyl methanimine (0.64 g, 1.66 mmol, 18%) labelled A. 2.45-
A MP 155 °C (decomposes). Rf (4:1 Hex/EtOAc) 0.50. 1H NMR (500 MHz, CDCl3): δ
8.22 (1H, s, H-17), 7.42 (2H, dd, J = 8.0, 1.2 Hz, H-21), 7.37 (2H, td, J = 6.8, 1.8 Hz, H-
22), 7.28 (1H, d, J = 1.9 Hz, H-5), 7.25 (1H, tt, J = 7.3, 1.3 Hz, H-23), 6.87 (1H, s, H-12),
6.80 (1H, dd, J = 8.7, 1.8 Hz, H-7), 6.73 (1H, d, J = 7.9 Hz, H-8), 6.64 (1H, d, J = 7.8 Hz,
H-15), 6.62 (1H, dd, J = 7.8, 1.8 Hz, H-16), 4.48 (1H, q, J = 6.6 Hz, H-18), 4.33 (1H, ddd,
J = 13.0, 9.7, 3.5 Hz, H-2b), 4.09 (1H, ddd, J = 13.6, 9.7, 4.2 Hz, H-1b), 3.19-3.11 (5H, m,
H-1a, H-9, H-10), 3.05 (1H, ddd, J = 12.9, 10.0, 4.3 Hz, H-2a), 1.65 (3H, d, J = 6.7 Hz,
H-19). 13C NMR (125 MHz, CDCl3): δ 216.7 (C), 158.6 (C(H)=N), 149.4 (C), 145.1 (C),
141.5 (C), 140.0 (C), 139.3 (C), 137.8 (CH), 137.3 (CH), 136.8 (CH), 136.5 (CH), 135.6
(C), 134.2 (CH), 134.0 (CH), 129.1 (C), 128.3 (CH), 128.0 (CH), 126.8 (CH), 126.7 (CH),
109.7 (CH), 70.0 (CH), 34.6 (CH2), 33.6 (CH2), 33.5 (CH2), 23.6 (CH3). HRMS (ESI)
found: [M + H]+ 385.1914. C25H24N2O2 requires [M + H]+ 385.1911. [α]20D -0.010°
(CH2Cl2, 0.006 g/mL)
4-Nitro-13-formyl[2.2]paracyclophane (resolved) 2.39
A mixture of {single enantiomer}-4-nitro-13-[N-(1-phenylethyl)[2.2]paracyclophanyl
methanimine (0.64 g, 1.6 mmol, 1.0 eq) and glacial acetic acid (0.092 mL, 1.6 mmol,
1.0 eq) in CH2Cl2 (20 mL) was stirred at room temperature for two hours. The organ-
ics were washed with water (20 mL), dried (MgSO4), and the solvent was removed
under reduced pressure affording the {single enantiomer}-4-nitro-13-formyl[2.2]-
paracyclophane as a dark yellow solid (0.44 g, 1.57 mmol, 97%). Data as reported
earlier.
4-Nitro[2.2]paracyclophane-13-carboxylic acid 2.40
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To a stirred solution of 4-nitro-13-formyl[2.2]paracyclophane (0.52 g, 1.8 mmol, 1.0
eq) in acetone (36 mL) was added a solution of KMnO4 (0.44 g, 2.8 mmol, 1.5 eq) in
water (14 mL) slowly over 10 minutes. The mixture was stirred overnight at room
temperature then acidified to pH 2-3 (2 M HCl) and filtered through filter paper.
The aqueous layer was extracted with EtOAc (3 x 40 mL). Combined organics were
washed once each with water and brine, dried (MgSO4), and the solvent was re-
moved under reduced pressure. The crude solid was partitioned into 2 M NaOH
and EtOAc (50 mL each). The organic layer was separated, dried (MgSO4), and the
was solvent removed under reduced pressure. The yellow solid obtained is the start-
ing material (0.18 g, 35% RSM). The aqueous layer was neutralised (conc. HCl) and
extracted with EtOAc (3 x 50 mL). The solvent was removed from the combined ex-
tracts under reduced pressure affording the product as a pale yellow solid (0.32 g,
1.08 mmol, 60%). Rf (4:1 Hex/EtOAc) 0.12. 1H NMR (500 MHz, DMSO-d6): δ 7.26
(1H, d, J = 1.8 Hz, H-5), 7.10 (1H, d, J = 1.9 Hz, H-12), 6.95 (1H, dd, J = 7.7, 1.8 Hz,
H-7), 6.88 (1H, d, J = 7.8 Hz, H-8), 6.83 (1H, dd, J = 7.7, 1.9 Hz, H-12), 6.76 (1H, d, J =
7.8 Hz, H-15), 4.05 (1H, ddd, J = 12.7, 9.7, 3.3 Hz, H-2b), 3.84 (1H, ddd, J = 13.4, 9.7,
4.0 Hz, H-1b), 3.19-3.10 (5H, m, H-1a, H-9, H-10), 3.03 (1H, ddd, J = 12.5, 10.1, 4.1 Hz,
H-2a). HRMS (ESI) found: [M + Na]+ 320.0897. C17H15NO4Na requires [M + Na]+
320.0893.
Resolution of 4-(p-Toluenesulfonamido)[2.2]paracyclophane-13-carboxylic acid
2.50
To a solution of 4-(p-toluenesulfonamido)[2.2]paracyclophane-13-carboxylic acid (0.10
g, 0.24 mmol, 1.0 eq.) in acetone (0.6 mL, 0.4 M) was added dropwise a solution of
cinchonine (63 mg, 0.21 mmol, 0.9 eq.) in a minimum amount of MeOH (2 mL).
The resulting mixture was stirred for one hour then left to stand for one hour. The
resulting white crystals were filtered affording the first diastereomeric salt (95 mg,
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0.13 mmol, 56%). The solvent was removed from the filtrate to afford the second
diastereomeric salt as a pale brown solid (65 mg, 27%). 1H NMR (400 MHz, CDCl3):
δ 9.14 (1H, s), 8.97 (1H, d, J = 4.4 Hz), 8.34 (1H, d, J = 8.4 Hz), 8.17 (1H, d, J = 8.3 Hz),
7.82 (1H, d, J = 4.4 Hz), 7.75 (1H, t, J = 7.4 Hz), 7.67 (1H, d, J = 7.8 Hz), 7.34 (2H, d, J
= 8.2 Hz), 7.06 (2H, d, J = 8.1 Hz), 6.98 (1H, d, J = 1.7 Hz), 6.66 (1H, s), 6.57 (1H, d, J
= 7.8 Hz), 6.48 (1H, dd, J = 7.6, 1.5 Hz), 6.44 (1H, dd, J = 7.7, 1.5 Hz), 6.40 (1H, d, J =
7.7 Hz), 6.09 (1H, ddd, J = 17.2, 10.3, 7.0 Hz), 5.90 (1H, d, J = 1.2 Hz), 5.33 (1H, d, J =
12.8 Hz), 5.30 (1H, d, J = 5.9 Hz), 4.54 (1H, ddd, J = 12.8, 9.0, 1.9 Hz), 4.05 (1H, ddd,
J = 13.1, 9.9, 3.5 Hz), 3.73-3.57 (4H, m), 3.30 (1H, ddd, J = 12.1, 9.6, 9.6 Hz), 3.10-3.04
(1H, m), 2.99-2.87 (4H, m), 2.75-2.63 (2H, m), 2.37-2.33 (2H, m), 2.02 (1H, s), 1.96 (1H,
t, J = 11.0 Hz), 1.87-1.73 (2H, m), 1.27 (1H, s), 1.02-0.99 (1H, t, J = 7.2 Hz).
2.48
The resolved diastereomeric salt (95 mg, 0.133 mmol) was suspended in MeOH (1.3
mL, 0.1 M) and 2 M HCl (3 mL) was added. The resulting mixture was agitated by
sonication for 5 minutes. The mixture was left to stand for one hour and the resulting
solid was filtered and washed with MeOH (3 x 3 mL) affording the resolved 4-(p-
toluenesulfonamido)[2.2]paracyclophane-13-carboxylic acid as a white powder (28
mg, 0.07 mmol, 50%). Rf (19:1 CH2Cl2/MeOH) 0.27. 1H NMR (400 MHz, CDCl3): δ
7.68 (1H, s, H-17), 7.52 (2H, d, J = 8.1 Hz, H-18), 7.13 (1H, d, J = 1.8 Hz, H-12), 7.10
(2H, d, J = 8.0 Hz, H-19), 6.75 (1H, dd, J = 7.5, 1.8 Hz, H-15), 6.62 (1H, d, J = 7.8 Hz,
H-16), 6.53 (1H, d, J = 7.8 Hz, H-8), 6.39 (1H, dd, J = 7.8, 1.9 Hz, H-7), 6.31 (1H, d, J
= 1.8 Hz, H-5), 4.39 (1H, t, J = 10.7 Hz, H-1b), 3.80-3.75 (1H, m, H-2b), 3.19- 2.87 (6H,
m, H-1a, H-2a, H-9, H-10), 2.32 (3H, s, H-20). 13C NMR (100 MHz, CDCl3): δ 173.2
(C=O), 144.8 (C), 144.3 (C), 141.5 (C), 139.9 (C), 137.9 (CH), 137.5 (CH), 137.3 (CH),
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137.0 (CH), 136.9 (C), 136.4 (CH), 135.0 (C), 132.2 (CH), 130.2 (C), 129.2 (2 CH), 129.0
(C), 128.3 (2 CH), 37.0 (CH2), 35.6 (CH2), 35.6 (CH2), 32.1 (CH2), 22.6 (CH3).
Methyl 4-nitro[2.2]paracyclophane-13-carboxylate 2.41
4-Nitro[2.2]paracyclophane-13-carboxylic acid (0.20 g, 0.67 mmol, 1.0 eq) was dis-
solved in SOCl2 (3.4 mL, 0.2 M) under inert atmosphere and heated at reflux overnight.
The solvent was removed by vacuum distillation. The crude acyl chloride was dis-
solved in dry MeOH under inert atmosphere (3.4 mL, 0.2 M) and stirred at room
temperature overnight. The solvent was evaporated under reduced pressure afford-
ing methyl 4-nitro[2.2]paracyclophane-13-carboxylate as a yellow solid (0.20 g, 0.64
mmol, 97%). MP 160 °C (decomposes). 1H NMR (500 MHz, CDCl3): δ 7.24 (1H, d,
J = 1.3 Hz, H-5), 7.11 (1H, d, J = 1.5 Hz, H-12), 6.96 (1H, dd, J = 7.8, 1.3 Hz, H-7),
6.88 (2H, d, J = 7.7 Hz, H-8, H-15), 6.80 (1H, d, J = 7.5 Hz, H-16), 3.97 (1H, ddd, J =
12.7, 9.9, 3.1 Hz), 3.88 (1H, d, J = 1.8 Hz), 3.78 (1H, ddd, J = 13.3, 9.7, 3.9 Hz), 3.72
(3H, s, CH3), 3.19-3.05 (6H, m, H-1a, H-2a, H-9, H-10). 13C NMR (125 MHz, DMSO-
d6): δ 166.9 (C=O), 149.1 (C), 142.5 (C), 141.8 (C), 140.4 (CH), 138.9 (CH), 137.9 (C),
137.1 (C), 136.8 (CH), 135.8 (CH), 134.1 (C), 129.5 (CH), 127.8 (CH), 52.0 (CH3), 34.3
(2 CH2), 34.0 (CH2), 33.1 (CH2).
4-Amino[2.2]paracyclophane-13-carboxylic acid 2.3
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To a solution of 4-nitro[2.2]paracyclophane-13-carboxylic acid (0.20 g, 0.67 mmol, 1.0
eq) in MeOH (3.0 mL, 0.2 M) was added NH4Cl (0.108 g, 2.02 mmol, 3.0 eq) and Zn
powder (0.132 g, 2.02 mmol, 3.0 eq), and heated at 80 °C overnight. The mixture was
filtered through a sintered glass funnel connected to a Büchner apparatus. The solid
was washed with MeOH (3 x 10 mL) and the combined filtrate was concentrated
under reduced pressure. The reduced filtrate was suspended in water (15 mL) and
stirred for 30 minutes at room temperature. The solids were collected by filtration
and dried under vacuum. The residue was purified by a silica plug and elution with
5% MeOH in CH2Cl2 afforded 4-amino[2.2]paracyclophane-13-carboxylic acid as a
pale brown solid (0.15 g, 0.56 mmol, 81%). Rf (9:1 CH2Cl2/MeOH) 0.63. mp 165 °C
(decomposes). 1H NMR (500 MHz, DMSO-d6): δ 7.11 (1H, d, J = 1.7 Hz, H-12), 6.65
(1H, dd, J = 7.3, 1.7 Hz, H-16), 6.35 (1H, d, J = 7.7 Hz, H-15), 6.21 (1H, d, J = 7.6 Hz,
H-8), 5.99 (1H, dd, J = 7.4, 1.5 Hz, H-7), 5.27 (1H, d, J = 1.5 Hz, H-5), 4.29 (1H, ddd, J
= 13.3, 9.7, 6.0 Hz, H-1b), 3.28-3.23 (1H, m, H-2b), 2.98-2.75 (5H, m, H-2a, H-9, H-10),
2.50-2.55 (1H, m, H-1a). Data comparable to that reported in the literature.177
Methyl 4-amino[2.2]paracyclophane-13-carboxylate 2.21
To a solution of methyl 4-nitro[2.2]paracyclophane-13-carboxylate (0.210 g, 0.68 mmol,
1.0 eq) in MeOH (3.4 mL, 0.2 M) was added NH4Cl (0.11 g, 2.02 mmol, 3.0 eq) and
Zn powder (0.13 g, 2.02 mmol, 3.0 eq), and heated at 80 °C overnight. The mix-
ture was filtered through a sintered glass funnel connected to a Büchner apparatus.
The reduced filtrate was washed with MeOH (3 x 10 mL) and the combined filtrate
was concentrated under reduced pressure. The solids were suspended in water (20
mL) and stirred for 30 minutes. The solids were collected by filtration and dried
under vacuum, affording the crude product as a brown solid. The residue was pu-
rified by a silica plug and elution with 5% MeOH in CH2Cl2 afforded the methyl 4-
amino[2.2]paracyclophane-13-carboxylate as a pale brown solid (0.15 g, 79%). Data
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as reported earlier.
4-Amino[2.2]paracyclophane-13-carboxylic acid, ester hydrolysis 2.3
To a solution of methyl 4-amino[2.2]paracyclophane-13-carboxylate (0.107 g, 0.38
mmol, 1.0 eq) in 3:1 EtOH/H2O (5.7 mL) was added ground KOH (0.104 g, 1.85
mmol, 4.9 eq). This mixture was heated at 50 °C overnight then cooled to room
temperature. The mixture was adjusted to pH 6 with conc. H2SO4 and the EtOH re-
moved under reduced pressure. The remaining aqueous mixture was extracted with
EtOAc (3 x 15 mL). Combined extracts were dried (MgSO4) and the solvent removed
under reduced pressure affording 4-amino[2.2]paracyclophane-13-carboxylic acid as
a yellow solid (0.060 g, 0.22 mmol, 59%). Data as reported earlier.
5.2.3 Synthesis of Gly-Pca
Methyl 4-[(2-bromo-1-oxoethyl)amino][2.2]paracyclophane-13-carboxylate 3.35
To a solution of methyl 4-amino[2.2]paracyclophane-13-carboxylate (50 mg, 0.18 mmol,
1.0 eq) in 1:1 dry DMF/dioxane (2.2 mL, 0.1 M) under inert atmosphere at -10 °C
was added dropwise bromoacetyl bromide (20 µL, 1.3 eq). The reaction mixture was
stirred overnight, coming to room temperature. Water (5 mL) was added and the
mixture stirred for 30 minutes. The light brown precipitate was collected by filtra-
tion through filter paper on a Büchner apparatus. The solid was washed with water
(3 x mL) and dried under vacuum, affording the product as a light brown solid (45
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mg, 0.11 mmol, 62%). Rf (2:1 hexane:EtOAc) 0.48. 1H NMR (500 MHz, DMSO-d6): δ
9.27 (1H, s, NH), 7.12 (1H, d, J = 1.2 Hz, H-5), 6.79-6.76 (2H, m, H-7, H-12), 6.63 (1H,
d, J = 7.8 Hz, H-8), 6.58 (1H, d, J = 7.8 Hz, H-15), 6.43 (1H, dd, J = 7.7, 1.3 Hz, H-16),
4.15 (1H, d, J = 11.1 Hz, H-17a), 4.04-3.98 (2H, m, H-17b, H-2b), 3.79 (3H, s, CH3),
3.29 (1H, ddd, J = 9.8, 6.0, 4.2 Hz, H-1b), 3.11-2.87 (1H, m, H-2a), 3.03-2.81 (5H, m, H-
1a, H-9, H-10). HRMS (ESI) found: [M + Na]+ 424.0508, 426.0489. C20H20BrNO3Na
requires [M + Na]+ 424.0519, 426.0499. The material was used as is due to the com-
pound’s rapid decomposition.
Methyl 4-[(2-azido-1-oxoethyl)amino][2.2]paracyclophane-13-carboxylate 3.36
To a stirred solution of methyl 4-[(3-bromo-1-oxoethyl)amino][2.2]paracyclophane-
13-carboxylate (0.10 g, 0.25 mmol, 1.0 eq) in DMF (1.2 mL, 0.2 M) was added NaN3
(65 mg, 4.0 eq) and the mixture was heated at 80 °C overnight. The solvent was
removed under reduced pressure affording methyl 4-[(2-azido-1-oxoethyl)amino]-
[2.2]paracyclophane-13-carboxylate as a pale yellow solid (38 mg, 0.10 mmol, 42%).
Note: taking this mixture to dryness is not advisable on a large scale due to the risk
of explosion by the azide present. Rf (2:1 hexane:EtOAc) 0.48. 1H NMR (500 MHz,
DMSO-d6): δ 8.03 (1H, s, br, NH), 7.21 (1H, s, H-5), 6.80 (1H, s, H-12), 6.73 (1H, d, J =
7.8 Hz, H-7), 6.60 (1H, d, J = 7.8 Hz, H-8), 6.57 (1H, d, J = 7.8 Hz, H-15), 6.49 (1H, d,
J = 7.8 Hz, H-16), 4.19-4.11 (1H, m, H-2b), 4.11 (2H, s, H-17), 3.91 (3H, s, CH3), 3.32-
3.28 (1H, m, H-1b), 3.19-3.00 (6H, m, H-1a, H-2a, H-9, H-10). 13C NMR (125 MHz,
DMSO-d6): δ 168.8 (C=O), 164.2 (C=O), 141.7 (C), 140.7 (C), 139.6 (C), 136.7 (C), 136.1
(C), 135.8 (CH), 134.9 (CH), 134.0 (CH), 131.0 (CH), 130.0 (C), 128.4 (CH), 126.3 (CH),
53.2 (CH3), 51.9 (CH2), 34.8 (2 CH2), 33.3 (CH2), 31.7 (CH2). HRMS (ESI) found: [M
+ H]+ 387.1609. C20H21N4O3 requires [M + H]+ 365.1608.
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Methyl 4-[(2-amino-1-oxoethyl)amino][2.2]paracyclophane-13-carboxylate 3.37
To a solution of methyl 4-[(2-azido-1-oxoethyl)amino][2.2]paracyclophane-13-carb-
oxylate (50 mg, 0.14 mmol, 1.0 eq) in dry MeOH was added 10% Pd/C (5 mg, 10
wt%). The suspension was put under H2 atmosphere and stirred at room tem-
perature until TLC analysis indicated the starting material had been consumed;
about 30 minutes. The suspension was filtered through filter paper and the solid
was washed with MeOH (3 x 3 mL). Combined filtrate and washings were con-
centrated under reduced pressure. The crude solid was purified by flash column
chromatography and elution with 1:1 hexane:EtOAc affording methyl 4-[(2-amino-1-
oxoethyl)amino]-[2.2]paracyclophane-13-carboxylate as a light yellow solid (34 mg,
0.10 mmol, 73%). Rf (2:1 hexane:EtOAc) 0.03. 1H NMR (500 MHz, DMSO-d6): δ
7.15 (1H, d, J = 1.7 Hz, H-5), 6.95 (1H, d, J = 1.5 Hz, H-12), 6.76 (1H, dd, J = 7.5, 1.7
Hz, H-7), 6.59 (1H, d, J = 7.7 Hz, H-8), 6.57 (1H, d, J = 7.8 Hz, H-15), 6.42 (1H, dd,
J = 7.7, 1.5 Hz, H-16), 4.09 (1H, ddd, J = 13.4, 9.4, 4.3 Hz, H-2b), 3.77 (3H, s, CH3),
3.25-3.17 (3H, m, H-1b, H-17), 3.10-2.85 (5H, m, H-2a, H-9, H-10), 4.09 (1H, ddd, J =
13.4, 9.4, 4.3 Hz, H-1a). 13C NMR (125 MHz, DMSO-d6): δ 165.9 (C=O), 162.2 (C=O),
137.4 (C), 135.4 (C), 134.4 (C), 132.5 (CH), 131.8 (C), 131.5 (C), 130.0 (CH), 129.0 (CH),
124.4 (CH), 123.2 (C), 122.8 (CH), 119.3 (CH), 46.9 (CH3), 40.5 (CH2), 29.7 (CH2), 29.5
(CH2), 27.6 (CH2), 26.8 (CH2). HRMS (ESI) found: [M + H]+ 339.1699. C20H23N2O3
requires [M + H]+ 339.1703.
4-[(2-Amino-1-oxoethyl)amino][2.2]paracyclophane-13-carboxylic acid 3.38
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To a stirred solution of methyl 4-[(2-amino-1-oxoethyl)amino][2.2]paracyclophane-
13-carboxylate (0.56 g, 1.65 mmol, 1.0 eq.) in EtOH (7.2 mL, 0.2 M) was added
ground KOH (1.61 g, 33.1 mmol, 20 eq.). The mixture was stirred at room tem-
perature overnight. The mixture was neutralised with 2 M HCl (approx. 8 mL). The
aqueous layer was extracted with EtOAc (3 x 15 mL). Combined organics were dried
(MgSO4) and the solvent was removed under reduced pressure, affording the prod-
uct as an oily yellow solid (0.47 g, 1.45 mmol, 88%). HRMS (ESI) found: [M + H]+
323.1390. C19H19N2O3 requires [M + H]+ 323.1401. Material could not be purified
for further characterisation.
5.2.4 Peptide couplings & transformations
Pivaloyl-L-valine 5.4
Prepared according to literature procedure.278
To a solution of L-valine (0.20 g, 1.71 mmol, 1.0 eq.) in 1:1 MeOH/1 M aq. NaOH (3.4
mL, 0.5 M) at 0 °C was added pivaloyl chloride (0.21 mL, 1.71 mmol, 1.0 eq.) and
the mixture was stirred overnight with no further cooling. The reaction mixture was
washed with EtOAc (10 mL) and the aqueous layer was acidified to pH 2-3 with 1
M HCl, then extracted with EtOAc (3 x 10 mL). The combined organic extracts were
dried (MgSO4) and the solvent removed under reduced pressure affording pivaloyl-
L-valine (0.20 g, 0.99 mmol, 58%). Rf (1:1 hexane:EtOAc) 0.63. 1H NMR (500 MHz,
CDCl3): 10.18 (1H, s, CO2H), 6.15 (1H, d, J = 8.0 Hz, NH), 4.54 (1H, dd, J = 8.3, 5.0
Hz, H-1), 2.29 (1H, td, J = 6.9, 5.0 Hz, H-2), 1.26 (9H, s, H-4), 1.00 (6H, dd, J = 15.0,
6.9 Hz, H-3). Data comparable to that reported in the literature.278
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2-(Boc-prolinamido)-6-aminotoluene 5.5
To a stirred solution of N-methylmorpholine (0.36 mL, 3.28 mmol, 2.0 eq.) and EtO-
COCl (0.31 mL, 3.28 mmol, 2.0 eq.) in CH2Cl2 (6.5 mL, 0.25 M) at 0 °C was added por-
tionwise Boc-L-proline (0.70 g, 3.28 mmol, 2.0 eq.), followed by 2,6-diaminotoluene
(0.20 g, 1.64 mmol, 1.0 eq.). The reaction mixture was stirred overnight, coming
to room temperature. Water (10 mL) was added and the aqueous layer extracted
with CH2Cl2 (3 x 10 mL). Combined organics were washed once each with 2 M
HCl then sat. aq. NaHCO3 (20 mL), then dried (MgSO4) and the solvent removed
under reduced pressure. The reaction was intended to couple a Boc-proline moi-
ety to both amino groups of 2,6-diaminotoluene, however only singly substituted
diaminotoluene was found, which was purified by column chromatography and
elution with hexane:EtOAc 1:1 affording 2-(Boc-prolinamido)-6-aminotoluene as a
pale yellow solid (0.38 g, 1.19 mmol, 73%). MP 162 °C (decomposes). Rf (1:1 hex-
ane:EtOAc) 0.23. 1H NMR (500 MHz, CDCl3) δ 8.89 (1H, s, NH), 7.70-7.67 (2H, m,
H-6, H-8), 7.21 (1H, d, J = 7.5, 7.4 Hz, H-7), 4.51 (2H, s, NH2), 3.45 (3H, s, H-9), 2.57
(2H, s, H-4), 2.09-1.98 (5H, m, H-1, H-2, H-3), 1.51 (9H, s, H-5). MS (ESI) found:
320.1971. C17H26N3O3 requires [M + H]+ 320.1969. Material was of insufficient qual-
ity for further analysis.
2-(Pivaloyl-L-valinamido)-6-aminotoluene 3.23
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To a solution of pivaloyl-L-valine (0.37 g, 1.86 mmol, 2.0 eq.) in MeCN (10 mL, 0.2 M)
at 0 °C was added 2,6-diaminotoluene (0.20 g, 0.93 mmol, 1.0 eq.), DMAP (0.23 g, 1.86
mmol, 2.0 eq.), HOBt (0.37 g, 2.42 mmol, 2.6 eq.), and EDC ·HCl (0.46 g, 2.42 mmol,
2.6 eq.). The reaction mixture was stirred overnight at room temperature. Water
(10 mL) was added, the layers separated and the aqueous layer was extracted with
CH2Cl2 (3 x 10 mL). Combined organics were dried (MgSO4) and the solvent was
removed under reduced pressure. The crude product was purified on a silica column
eluting 1:1 hexane:EtOAc affording 2-(pivaloyl-L-valinamido)-6-aminotoluene as a
white solid (0.25 g, 0.82 mmol, 88%). Rf (1:1 hexane:EtOAc) 0.72. 1H NMR (500
MHz, DMSO-d6): 9.19 (1H, s, NH2), 6.88-6.80 (2H, m, NH), 6.76 (1H, d, J = 8.5 Hz,
H-6), 6.50-6.44 (2H, m, H-5, H-7), 3.91 (1H, dd, J = 8.0, 6.0 Hz, H-1), 2.10-2.03 (1H,
m, H-2), 1.89 (3H, s, H-8), 1.41 (9H, s, H-4), 0.94 (6H, dd, 10.0, 6.5 Hz, H-3). Material
was of insufficient quality for further analysis.
2-(Pivaloyl-L-valinamido)toluene 3.13
To a solution of pivaloyl-L-valine (0.20 g, 1.0 mmol, 1.0 eq.) in MeCN (5.0 mL, 0.2 M)
at 0 °C was added o-toluidine (0.10 g, 1.0 mmol, 1.0 eq.), DMAP (0.12 g, 1.0 mmol,
1.0 eq.), HOBt (0.20 g, 1.29 mmol, 1.3 eq.), and EDC ·HCl (0.25 g, 1.29 mmol, 1.3
eq.). The reaction mixture was stirred overnight at room temperature. Water (5 mL)
was added and the aqueous layer was extracted with CH2Cl2 (3 x 5 mL). Combined
organics were dried (MgSO4) and the solvent was removed under reduced pressure
affording a white solid containing crude 2-(pivaloyl-L-valinamido)toluene in a mix-
ture of compounds. The compound was not purified further. Rf (1:1 hexane:EtOAc)
0.45. 1H NMR (500 MHz, DMSO-d6): δ 7.82 (2H, d, J = 8.2 Hz, NH), 7.23-7.17 (2H, m,
H-5, H-7), 7.09 (1H, dd, J = 8.0, 7.8 Hz, H-6), 5.18 (1H, d, J = 13.4 Hz, H-8), 4.07 (1H,
dd, J = 8.4, 6.5 Hz, H-1), 2.39-2.31 (1H, m, H-2), 2.27 (3H, s, H-9), 1.48 (9H, s, H-4),
1.04 (6H, d, J = 7.0 Hz, H-3). Material was of insufficient quality for further analysis.
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4-Nitro[2.2]paracyclophan-13-(amido-Phe) 3.25
4-Nitro[2.2]paracyclophane-13-carboxylic acid (0.57 g, 1.0 mmol, 1.0 eq) was heated
at reflux in SOCl2 (10 mL) overnight under inert atmosphere. The solvent was re-
moved under reduced pressure and the acyl chloride dissolved in dry THF (3 mL)
was added dropwise over 20 minutes to a stirred solution of L-phenylalanine (0.63
g, 3.84 mmol, 2.0 eq) in 1 M aqueous NaOH (3.8 mL, 1 M) at 0 °C. The mixture
was stirred for two hours at 0 °C then acidified to pH 2-3 (1 M HCl) and extracted
with EtOAc (3 x 10 mL). Combined organics were washed with brine (20 mL), dried
(MgSO4) and the solvent removed under reduced pressure affording the crude prod-
uct as a pale yellow solid. The crude product was purified using column chromatog-
raphy eluting 1:1 hexane:EtOAc with 1% AcOH affording partial separation of the
two diastereomers (SP,S)-3.25 0.043 g, (RP,S)-3.25 0.075 g, mixture of diastereomers
0.25 g, total 0.37 g, 0.83 mmol, 43%).
(SP,S)-3.25: Rf (1:1 hexane:EtOAc + 1% AcOH) 0.45. 1H NMR (500 MHz, DMSO-d6):
δ 12.40 (1H, s, br, OH), 7.92 (1H, d, J = 7.8 Hz, H-17), 7.38-7.25 (5H, m, H-20, H-21, H-
22), 7.12 (1H, s, H-5), 6.88 (1H, d, J = 7.6 Hz, H-7), 6.80-6.76 (2H, m, H-8, H-16), 6.72
(1H, d, J = 7.7 Hz, H-15), 6.44 (1H, s, H-12), 4.50 (1H, dd, J = 14.1, 8.3 Hz, H-2b), 3.94
(1H, ddd, J = 11.2, 9.8, 3.5 Hz, H-1b), 3.73-3.69 (1H, m, H-2a), 3.13-2.90 (8H, m, H-1a,
H-9, H-10, H-18, H-19). Note: this sample/spectrum was of insufficient quality to
define all multiplets and J couplings. Many doublets with small J couplings (<2)
are not resolved and are characterised here as singlets or multiplets. 13C NMR (125
MHz, DMSO-d6): δ 173.5 (C=O), 172.5 (C=O), 168.0 (C), 148.0 (C), 142.0 (CH), 139.6
(C), 138.8 (C), 138.5 (CH), 138.4 (C), 137.8 (CH), 136.2 (C), 135.8 (CH), 134.5 (CH),
131.9 (CH), 129.5 (C), 129.1 (CH), 128.6 (CH), 127.8 (2 CH), 126.8 (CH), 54.5 (CH),
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36.7 (CH2), 34.3 (CH2), 34.1 (CH2), 33.8 (CH2), 21.5 (CH2). [α]20D -0.025° (DMSO,
0.006 g/mL)
(RP,S)-3.25: Rf (1:1 hexane:EtOAc + 1% AcOH) 0.40. 1H NMR (500 MHz, DMSO-d6):
δ 12.61 (1H, s, br), 7.97 (1H, d, J = 8.0 Hz, H-17), 7.36-7.31 (4H, m, H-20, H-21), 7.28-
7.24 (1H, m, H-22), 7.22 (1H, d, J = 1.7 Hz, H-5), 6.90 (1H, dd, J = 7.7, 1.7 Hz, H-7),
6.76-6.73 (2H, m, H-8, H-16), 6.69 (1H, d, J = 7.8 Hz, H-15), 6.64 (1H, d, J = 1.8 Hz,
H-12), 4.49 (1H, ddd, J = 10.6, 8.0, 4.4 Hz, H-2b), 3.61 (1H, ddd, J = 13.0, 9.7, 3.4 Hz,
H-1b), 3.21 (1H, ddd, J = 13.0, 9.7, 4.2 Hz, H-2a), 3.15-3.05 (4H, m, H-9, H-10), 2.94
(1H, dd, J = 13.9, 10.6 Hz, H-18), 2.91-2.86 (2H, m, H-19), 2.78 (1H, ddd, J = 13.0, 9.8,
3.3 Hz, H-1a). 13C NMR (125 MHz, DMSO-d6): δ 173.60 (C=O), 172.50 (C=O), 168.08
(C), 148.63 (C), 141.66 (CH), 139.72 (C), 139.30 (C), 138.42 (CH), 138.36 (C), 137.82
(CH), 136.24 (C), 135.96 (CH), 135.02 (CH), 133.11 (CH), 129.57 (C), 128.64 (2 CH),
127.43 (2 CH), 126.82 (CH), 54.05 (CH), 34.96 (CH2), 34.34 (CH2), 34.17 (CH2), 33.63
(CH2), 21.52 (CH2). [α]20D +0.029° (DMSO, 0.013 g/mL)
Pca-Phe 3.26
A suspension of 4-nitro[2.2]paracyclophan-13-(amido-Phe) (0.06 g, 0.13 mmol, 1.0
eq) and 10% Pd-C (0.06 g) in EtOH (0.3 mL) was heated to reflux and conc. HCl (0.02
mL, 0.27 mmol, 2.0 eq) was added. The reaction apparatus was flushed with H2 and
a H2 balloon was fitted to the top of the reflux condenser. The mixture was heated
at reflux overnight. Once cool, the mixture was filtered through celite on a Büchner
apparatus. The residue was washed with copious EtOH, EtOAc and CH2Cl2. The
combined filtrate and washings were evaporated under reduced pressure affording
the crude product as a yellow solid. The crude product was purified by column
chromatography using silica gel and 19:1 CH2Cl2:MeOH affording the product as a
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pale yellow solid (36 mg, 0.087 mmol, 65%). Rf (19:1 CH2Cl2:MeOH) 0.19. 1H NMR
(500 MHz, DMSO-d6, mixture of rotamers): δ 7.74 (1H, t, J = 7.6 Hz, H-17), 7.34-7.25
(4H, m, H-20, H-21), 7.18 (1H, d, J = 6.7 Hz, H-22), 6.80 (1H, s, H-12), 6.53 (1H, t, J =
7.5 Hz, H-16), 6.33 (1H, d, J = 7.3 Hz, H-15), 6.22 (1H, t, J = 8.4 Hz, H-7), 6.00 and 5.98
(1H, d, J = 7.8 Hz, H-8), 5.41 and 5.30 (1H, s, H-5), 4.71-4.61 (1H, m, H-1b), 4.38-4.18
(1H, m, H-2b), 4.10 (1H, q, J = 5.3 Hz, H-18), 3.14-2.74 (8H, m, H-1a, H-2a H-9, H-10,
H-19). MS (ESI) [M + 3H]+ 139.03.
Fmoc-L-proline 5.6
Prepared according to literature procedure.279
To a stirred solution of L-proline (0.93 g, 8.12 mmol, 1.05 eq.) and K2CO3 (2.78 g,
20.10 mmol, 2.6 eq.) in a 10:3 mixture of water/dioxane (150 mL, 0.05 M) at 0 °C was
added Fmoc chloride (2.00 g, 7.73 mmol, 1.0 eq.). The resulting mixture was stirred
overnight without further cooling. The reaction mixture was washed with Et2O (2 x
100 mL). The aqueous layer was acidified to pH 1 with 1 M HCl and extracted with
CH2Cl2 (3 x 100 mL). Combined organics were dried (MgSO4) and the solvent was
removed under reduced pressure affording Fmoc-L-proline as a yellow solid (2.33 g,
6.90 mmol, 85%). MP 137 °C (decomposes). 1H NMR (500 MHz, CDCl3): δ 7.82 (2H,
d, J = 1.0 Hz), 7.64 (2H, d, J = 1.0 Hz), 7.36 (2H, dd, J = 2.0, 1.0 Hz), 7.31-7.26 (2H,
m), 4.42 (2H, d, J = 7.0 Hz), 4.38-4.29 (2H, m), 3.59-3.51 (2H, m), 2.39-2.32 (1H, m),
2.02-1.98 (3H, m). Data comparable to that reported in the literature.279
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4-Pivalamido[2.2]paracyclophane-13-carboxylic acid 5.7
To a stirred solution of 4-amino[2.2]paracyclophane-13-carboxylic acid (50 mg, 0.19
mmol, 1.0 eq.) in THF (0.4 mL, 0.5 M) under inert atmosphere at -80 °C was added n-
BuLi in hexane (1.7 M, 0.28 mL, 4.68 mmol, 2.5 eq.) dropwise over 8 minutes and the
reaction mixture maintained at -80 °C for 20 minutes. Pivaloyl chloride (28 µL, 0.22
mmol, 1.2 eq.) was added and the reaction mixture was stirred overnight, allowing
to come to room temperature. Water (1 mL) and EtOAc (1 mL) were added with
vigorous stirring, then the layers were separated and the organic layer washed suc-
cessively with water (1 mL) and brine (1 mL). The organic layer was dried (MgSO4)
and the solvent removed under reduced pressure. The resulting residue was puri-
fied by column chromatography and elution with a gradient of hexane:EtOAc 7:1
to 4:1 to afford 4-(pivalamido)[2.2]paracyclophane-13-carboxylic acid as a dark yel-
low oil (48 mg, 0.14 mmol, 72%). Rf (4:1 hexane:EtOAc) 0.30.1H NMR (500 MHz,
DMSO-d6): δ 12.66 (1H, s, br), 7.98 (1H, s), 7.15 (1H, s), 6.73 (1H, s), 6.57 (2H, d), 6.43
(2H, s), 3.89 (1H, s), 3.10-2.88 (5H, m), 2.78 (1H, s), 1.24 (9H, s). Note: this spectrum
was not well-resolved so J-couplings are not reported and multiplets with smaller
J-couplings are not apparent). 13C NMR (125 MHz, DMSO-d6): δ 175.4 (C=O), 169.2
(C=O), 142.2 (C), 139.8 (C), 139.3 (C), 137.2 (C), 136.5 (CH), 136.4 (CH) 136.3 (CH),
134.8 (CH), 134.3 (C), 134.2 (CH), 130.2 (C), 127.1 (CH), 39.1 (C), 34.7 (CH2), 34.6
(CH2), 33.9 (CH2), 32.5 (CH2), 27.6 (CH3).
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Boc-Pro-Gly-Pca-OMe 3.39
To a stirred solution of NHS (0.048 g, 0.414 mmol, 1.0 eq) and Boc-L-proline (0.089
g, 0.414 mmol, 1.0 eq) in THF (2.1 mL, 0.2 M) was added DCC (0.085 g, 0.414 mmol,
1.0 eq) and the was mixture stirred for 30 minutes. The precipitate was removed
by filtration and washed with THF (3 x 1 mL). The combined filtrate and wash-
ings were added to a stirred solution of methyl 4-[(3-amino-1-oxopropyl)amino]-
[2.2]paracyclophane-13-carboxylate (0.140 g, 0.414 mmol, 1.0 eq) in DMF (5.0 mL,
0.1 M) followed by DMAP (0.005 g, 0.041 mmol, 0.1 eq). The resulting solution was
stirred at room temperature overnight. Water (5 mL) was added and the aqueous
layer was extracted with EtOAc (3 x 10 mL). The combined organic layers were
washed once each with water and brine (20 mL), dried (MgSO4) and the solvent re-
moved under reduced pressure. The crude product was purified on a silica column
eluting 19:1 CH2Cl2/MeOH affording the desired product as a light yellow solid
(0.144 g, 0.27 mmol, 65%). Rf (19:1 CH2Cl2/MeOH) 0.06. MP 170 °C (decomposes).
1H NMR (500 MHz, CDCl3): δ 8.08-7.93 (1H, m, H-17), 7.56-7.45 (1H, m, H-19), 7.19
(1H, br s, H-12), 6.86-6.75 (1H, m, H-5), 6.70 (1H, d, J = 7.0 Hz, H-15), 6.58 (1H, dd, J =
7.7, 3.9 Hz, H-16), 6.54 (1H, dd, J = 7.7, 2.2 Hz, H-7), 6.47-6.49 (1H, m, H-8), 4.49-4.30
(1H, m, H-20), 4.17-4.14 (1H, m, H-2b), 4.07-3.99 (2H, m, H-18), 3.91 (3H, d, J = 10.4
Hz, CH3), 3.52 and 3.42 (2H, two br s without baseline separation, H-23), 3.28 (1H,
ddd, J = 13.5, 9.9, 3.7 Hz, H-1b), 3.18-3.10 (2H, m, H-9), 3.07-2.95 (4H, m, H-1a, H-2a,
H-10), 2.43-2.38 (1H, m, H-21a), 2.05-2.00 (2H, m, H-22), 1.94-1.93 (1H, m, H-21b),
1.51 and 1.46 (9H, two s without baseline separation, H-24). Note: many peaks are
broad, undefined and/or twinned due to slow tumbling of the compound in the sol-
vent, as well as the presence of two diastereomers. 13C NMR (125 MHz, DMSO-d6):
δ 173.6 (C=O), 173.2 (C=O), 167.3 (C=O), 154.2 (C=O), 142.8 (C), 142.9 (C), 140.1 (C),
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139.4 (CH), 137.7 (C), 136.4 (CH), 135.2 (CH), 134.2 (CH), 130.5 (CH), 128.8 (C), 128.0
(CH), 124.5 (CH), 79.1 (C), 60.1 (C), 51.9 (CH3), 47.2 (CH2), 43.3 (CH2), 33.8 (CH2),
33.3 (CH2), 32.2 (CH2), 31.5 (CH2), 30.4 (CH2), 25.8 (CH2), 23.7 (3 CH3). HRMS (ESI)
found: [M + Na]+ 558.2570. C30H37N3NaO6 requires [M + Na]+ 558.2575.
Boc-Pro-Gly-Pca 3.40
Boc-Pro-Gly-Pca-OMe (1.7 g, 3.17 mmol, 1.0 eq.) was dissolved in EtOH (32 mL,
0.1 M) then ground KOH (3.56 g, 63.5 mmol , 40 eq.) was added and the solution
was stirred overnight at room temperature. 2 M HCl (approx. 30 mL) was added to
neutralise the mixture. The aqueous layer was extracted with EtOAc (3 x 50 mL),
affording the product as an oily yellow solid (0.94 g, 1.81 mmol, 57%). Rf (19:1
CH2Cl2/MeOH) 0.26. 1H NMR (500 MHz, CDCl3): δ 8.59-8.39 (1H, m, NH), 7.64-
7.59 (1H, m, NH), 7.31 (1H, dd, J = 7.1, 1.4 Hz, H-12), 6.90-6.86 (1H, m, H-5), 6.72
(1H, d, J = 7.7 Hz, H-16), 6.55 (2H, d, J = 7.7 Hz, H-8, H-15), 6.44-6.42 (1H, m, H-8),
4.64-4.59 (1H, m, H-20), 4.36-4.32 (1H, m, H-2b), 4.27-4.21 (2H, m, H-18), 3.57-3.52
(1H, m, H-1b), 3.41-3.37 (2H, m, H-23), 3.14-3.10 (2H, m, H-9), 3.00-2.89 (4H, m, H-1a,
H-2a, H-10), 2.31-2.30 (1H, m, H-21a), 2.12-2.06 (1H, m, H-21b), 2.04-1.93 (2H, m, H-
22), 1.45 (9H, two s without baseline separation, H-24). Note: many peaks are broad,
undefined and/or twinned due to slow tumbling of the compound in the solvent,
as well as the presence of two diastereomers. 13C NMR (125 MHz, CDCl3): δ 174.0
(C=O), 171.2 (C=O), 170.2 (C=O), 166.9 (C=O), 143.0 (C), 143.0 (C), 140.4 (C), 140.4
(C), 139.5 (C), 136.7 (CH), 136.3 (CH), 135.1 (CH), 134.8 (CH), 129.5 (CH), 128.4 (C),
125.8 (CH), 81.2 (C), 60.5 (CH), 47.4 (CH2), 44.4 (CH2), 34.2 (CH2), 34.0 (CH2), 31.6
(CH2), 31.4 (CH2), 29.2 (CH2), 28.4 (3 CH3), 24.5 (CH2). HRMS (ESI) found: [M + H]+
520.2440. C29H34N3O6 requires [M + H]+ 520.2453.
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Pro-Gly-Pca 3.41
Boc-Pro-Gly-Pca-OH (0.35 g, 0.67 mmol, 1.0 eq) was dissolved in 6.7 mL 3:1 TFA/CH2Cl2
at 0 °C. The solution was stirred for 30 minutes then the solvent was removed under
reduced pressure affording an orange oil. The crude material was purified by au-
tocolumn chromatography (silica gel, 0-10% MeOH in CH2Cl2 as eluent) affording
the desired product as a mixture of diastereomers in an oily yellow solid (0.26 g, 0.62
mmol, 92%). Separation of the diastereomers was achieved by gravity column (silica
gel, 10% MeOH in CH2Cl2 as eluent) affording three fractions: diastereomer A, A+B,
and diastereomer B. 1H NMR (500 MHz, DMSO-d6): δ 9.84 (1H, s, NH), 9.07 (1H, t,
J = 6.1 Hz, NH), 6.67 (1H, s, H-12), 6.52 (1H, d, J = 7.8 Hz, H-15), 6.45 (2H, d, J = 7.7
Hz, H-7, H-16), 6.43 (1H, d, J = 7.7 Hz, H-8), 6.11 (1H, s, H-5), 4.43 (1H, t, J = 7.7 Hz,
H-20), 3.95-3.90 (1H, m, J = 6.7 Hz, H-2b), 3.63 (1H, ddd, J = 12.4, 9.4, 4.2 Hz, H-1b),
3.52 (2H, dd, J = 17.2, 5.5 Hz, H-18), 3.13-3.07 (2H, m, H-23), 3.02-2.89 (4H, m, H-9,
H-10), 2.76 (1H, ddd, J = 12.9, 10.1, 3.2 Hz, H-1a), 2.65 (1H, ddd, J = 12.6, 10.8, 3.8 Hz,
H-2a), 2.22-2.15 (1H, m, H-21a), 2.07-2.03 (1H, m, H-21b), 2.00-1.92 (2H, m, H-22). 13C
NMR (125 MHz, CDCl3): δ 174.0 (C=O), 170.2 (C=O), 166.9 (C=O), 141.9 (C), 140.9
(C), 139.5 (C), 139.4 (C), 135.5 (C), 133.8 (CH), 133.7 (CH), 132.2 (CH), 130.7 (CH),
128.7 (CH), 128.5 (C), 126.23 (CH), 62.3 (CH), 47.2 (CH2), 45.7 (CH2), 35.2 (CH2), 35.0
(CH2), 32.9 (CH2), 30.0 (CH2), 27.1 (CH2), 25.2 (CH2). HRMS (ESI) found: [M + H]+
422.2081. C24H28N3O4 requires [M + H]+ 422.2075.
L-Phenylalanine, methyl ester hydrochloride 5.8
218 Chapter 5. Methods and Materials
To a stirred solution of L-phenylalanine (0.202 g, 1.21 mmol, 1.0 eq.) in dry MeOH
(6.0 mL, 0.2 M) under inert atmosphere at 0 °C was added SOCl2 (0.35 mL, 4.84
mmol, 4.0 eq.). This mixture was stirred, coming to room temperature, overnight.
The solvent was removed by vacuum distillation affording (S)-methyl 2-amino-3-
phenylpropanoate as the hydrochloride salt (0.243 g, 1.13 mmol, 93%). Rf (9:1 CH2Cl2/MeOH)
0.74. 1H NMR (500 MHz, D2O): δ 7.33 (2H, t, J = 7.3 Hz, H-2), 7.30 (1H, t, J = 7.0 Hz,
H-1), 7.25 (2H, d, J = 7.3 Hz, H-3), 4.25 (1H, t, J = 6.5 Hz, H-5), 3.34 (3H, s, CH3), 3.20
(1H, dd, J = 14.0, 5.7 Hz, H-4a), 3.10 (1H, dd, J = 14.0, 7.4 Hz, H-4b). Data comparable
to that reported in the literature.280
(4-N-Boc-Pro-Gly-amino)[2.2]paracyclophane 5.9
To a stirred solution of N-hydroxysuccinimide (0.45 g, 3.92 mmol, 1.0 eq) and Boc-
L-proline (0.85 g, 3.92 mmol, 1.0 eq) in THF (20 mL, 0.2 M) was added dicyclo-
hexylcarbodiimide (0.81 g, 3.92 mmol, 1.0 eq) and further stirred for 30 minutes.
The precipitate was removed by filtration and washed with THF (3 x 10 mL). The
combined filtrate and washings were added to a stirred solution of 4-[(3-amino-1-
oxopropyl)amino]-[2.2]paracyclophane (1.10 g, 3.92 mmol, 1.0 eq) in DMF (40 mL,
0.1 M) followed by DMAP (48 mg, 0.39 mmol, 0.1 eq). The resulting solution was
stirred at 60 °C overnight. The solvent was removed under reduced pressure and
the crude product was purified on a silica column eluting 19:1 CH2Cl2/MeOH af-
fording (4-N-Boc-Pro-Gly-amino)[2.2]paracyclophane as a light yellow solid (1.06 g,
2.22 mmol, 57%). Rf (19:1 CH2Cl2/MeOH) 0.23. MP 168 °C (decomposes). MS (ESI)
found: [M + Na]+ 500.10. C28H35N3O4Na requires [M + Na]+ 520.25. The compound
was not fully characterised until the Boc protecting group was removed. Rotamers
made it impossible to assign spectra until removal of the Boc group.
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(4-N-Pro-Gly-amino)[2.2]paracyclophane 3.43
(4-N-Boc-Pro-Gly-amino)[2.2]paracyclophane (1.06 g, 2.22 mmol, 1.0 eq) was dis-
solved in CH2Cl2 (16.5 mL) at 0 °C and TFA was added (5.5 mL, 0.2 M total). The
mixture was stirred at 0 °C for one hour then the solvent was removed under re-
duced pressure. The residue was purified by flash column eluting 9:1 CH2Cl2/MeOH
to afford (4-N-Pro-Gly-amino)[2.2]paracyclophane as an oily yellow solid (0.50 g,
1.32 mmol, 60%). Rf (CH2Cl2/MeOH) 0.23. 1H NMR (500 MHz, DMSO-d6): δ 9.36
(1H, d, J = 6.1 Hz, H-24), 8.89 (1H, t, J = 5.5 Hz, H-19), 8.61 (1H, s, H-17), 6.76 (1H, d,
J = 7.7 Hz, H-8), 6.56 (1H, d, J = 1.5 Hz, H-5), 6.52 (1H, dd, J = 7.7, 1.6 Hz, H-7), 6.44
(2H, dd, J = 8.0, 2.0 Hz, H-12, H-13), 6.41-6.39 (2H, m, H-15, H-16), 4.29-4.27 (1H, m,
H-20), 4.19-4.08 (2H, m, H-18), 3.33-3.22 (3H, m, H-2b, H-23), 3.01-2.86 (6H, m, H-1,
H-9, H-10), 2.68-2.63 (1H, m, H-2a), 2.37-2.33 (1H, m, H-21a), 1.97-1.89 (3H, m, H-21b,
H-22). 13C NMR (125 MHz, DMSO-d6): δ 169.2 and 169.2 (C=O), 166.6 (C=O), 140.4
(C), 139.6 (C), 139.1 (C), 137.0 (C), 135.5 (CH), 133.3 (CH), 133.3 (CH), 132.7 (CH),
132.6 (CH), 129.4 (C), 129.4 (C), 127.3 (C), 59.5 (CH), 46.2, 43.1 (CH2), 35.2 (CH2), 35.0
(CH2), 33.7 (CH2), 30.1 (CH2), 30.1 (CH2), 24.0 (CH2). MS (ESI) found: [M + H]+
378.13. C23H28N3O2 requires [M + H]+ 378.22.
4-(N-benzylidene)-[2.2]paracyclophane-13-carboxylic acid 5.10
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To a stirred solution of 4-amino-[2.2]paracyclophane-13-carboxylic acid (15 mg, 0.07
mmol, 1.0 eq.) in dry EtOH (0.7 mL, 0.1 M) at 60 °C was added benzaldehyde (0.015
mL, 0.15 mmol, 2.0 eq.). The mixture was stirred for two hours at 60 °C then cooled
slowly to 4 °C and left undisturbed overnight. The precipitated solid was collected
by filtration and washed with cold dry EtOH. The filtrate was recrystallised from
dry EtOH and the solid was collected again in the same manner, affording 4-(N-
benzylidene)-[2.2]paracyclophane-13-carboxylic acid (7 mg, 0.02 mmol, 28%). Rf (4:1
hexane:EtOAc) 0.17. The material’s identity is confirmed by the characterisation of
the following compound.
4-(N-benzylamino)-[2.2]paracyclophane-13-carboxylic acid 5.11
To a stirred suspension of 4-(N-benzylidene)-[2.2]paracyclophane-13-carboxylic acid
(7 mg, 0.02 mmol, 1.0 eq.) in dry MeOH (0.5 mL, 0.05 M) at 60 °C was added H3BO3
(1.3 mg, 0.02 mmol, 1.1 eq.). NaBH4 was added in small portions until bubbling
upon addition ceased. Water (1 mL) was added and the mixture was extracted with
CH2Cl2 (3 x 1 mL). Combined organics were dried (MgSO4) and the solvent evapo-
rated under reduced pressure affording 4-(N-benzylamino)-[2.2]paracyclophane-13-
carboxylic acid as an off-white solid. (5 mg, 0.01 mmol, 70%). MP 160 °C (decom-
poses). Rf (4:1 hexane:EtOAc) 0.10. 1H NMR (500 MHz, CDCl3): δ 7.36 (1H, d, J =
1.5 Hz, H-20), 7.32 (2H, d, J = 7.4 Hz, H-19), 7.20 (2H, t, J = 7.4 Hz, H-18), 7.18-7.13
(1H, m, Hz, H-12) 6.81 (1H, d, J = 7.7, 1.4 Hz, H-16), 6.47 (1H, d, J = 7.7 Hz, H-15),
6.40 (1H, d, J = 7.6 Hz, H-7), 6.23 (1H, dd, J = 7.6, 1.5 Hz, H-8), 5.42 (1H, s, H-5),
4.38 (1H, ddd, J = 13.8, 9.4, 5.3 Hz, H-1a), 4.22 (1H, d, J = 13.1 Hz, H-17a), 3.94 (1H,
d, J = 13.1 Hz, H-17b), 3.17-2.97 (6H, m), 2.80 (1H, ddd, J = 14.1, 10.7, 5.4 Hz, H-2b).
13C NMR (125 MHz, CDCl3): δ 172.3 (C=O), 147.2 (C), 142.7 (C), 141.0 (C), 139.0 (C),
138.7 (CH), 136.3 (CH), 135.7 (C), 134.5 (C), 133.9 (C), 128.6 (2 CH), 127.2 (2 CH),
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126.0 (CH), 124.3 (2 CH), 120.9 (CH), 116.0 (CH), 48.1 (CH2), 35.0 (CH2), 34.8 (CH2),
31.2 (CH2), 29.7 (CH2).
(S)-N-(tert-butoxycarbonyl)prolinal 3.46
Prepared according to literature procedure.281,282
To a stirred solution of (COCl)2 (0.10 mL, 1.19 mmol, 1.2 eq.) in CH2Cl2 (2.6 mL, 0.4
M) at -40 °C was added dropwise over 10 minutes a solution of DMSO (0.16 mL,
2.19 mmol, 2.2 eq.) in CH2Cl2 (0.6 mL, 4 M). This mixture was stirred for a further
10 minutes, then (S)-N-(tert-butoxycarbonyl)prolinol (0.20 g, 1.0 mmol, 1.0 eq.) in
CH2Cl2 (10 mL, 0.1 M) was added dropwise over 10 minutes. The reaction mixture
was stirred for 30 minutes, maintaining the temperature of the reaction vessel below
-40 °C. DIPEA (0.69 mL, 3.97 mmol, 4.0 eq.) was added and the reaction mixture
was stirred for a further 30 minutes. The mixture was washed successively with 2 M
HCl (2 x 10 mL), water (2 x 10 mL), and brine (1 x 10 mL), then dried (MgSO4) and
the solvent removed under reduced pressure. The resulting residue was separated
by column chromatography and elution with hexane:EtOAc 2:1 to afford (S)-N-(tert-
butoxycarbonyl)prolinal as an off-white oil (130 mg, 0.65 mmol, 65%). IR (KBr) cm-1
2975 (C-H), 1732 (C=O), 1691 (C=O). 1H NMR (500 MHz, CDCl3, mixture of ro-
tamers) δ 9.58 and 9.48 (1H, s, CHO), 4.23 and 4.07 (1H, ddd, J = 8.4, 6.0, 2.6 Hz,
H-1), 3.55-3.40 (2H, m, H-4) 2.20-1.81 (4H, m, H-2, H-3), 1.49 and 1.45 (9H, s, H-5).
Data comparable to that reported in the literature.283
Imine 5.12
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To a stirred solution of 4-amino-[2.2]paracyclophane-13-carboxylic acid (30 mg, 0.11
mmol, 1.0 eq.) in dry EtOH (1.1 mL, 0.1 M) at 60 °C was added Boc-L-prolinal (45 mg,
0.22 mmol, 2.0 eq.). The mixture was stirred for three hours at 60 °C then the solvent
was removed under reduced pressure affording the imine 5.12 as a yellow-brown
oily solid. Rf (7:1 hexane:EtOAc) 0.74. The material was of insufficient quality for
full characterisation.
tert-Butyl (2S)-2-[(p-toluenesulfonyloxy)methyl]pyrrolidine-1-carboxylate 3.50
Prepared according to literature procedure.284
To a solution of (S)-1-Boc-2-pyrrolidinemethanol (0.20 g, 1.0 mmol, 1.0 eq) in pyri-
dine (0.6 mL) and CH2Cl2 (1.9 mL) at 0 °C was added p-toluenesulfonyl chloride
(0.24 g, 1.24 mmol, 1.25 eq) and the mixture was stirred for 24 hours at room tem-
perature. The mixture was diluted with 3 mL CH2Cl2 and washed successively with
5 mL each of water, 1 M HCl, sat. aq. NaHCO3, and brine, then dried (MgSO4) and
concentrated under reduced pressure affording the crude product as a colourless
oil. The crude product was purified by flash column chromatography through silica
eluting with 4:1 hexane:EtOAc affording the product as a colourless oil (0.18 g, 0.51
mmol, 51%). 1H NMR (500 MHz, CDCl3): δ 7.80 (2H, d, J = 8.2 Hz, H-7), 7.37 (2H,
m, H-8), 4.11 (1H, dd, J = 9.0, 2.8 Hz, H-1), 3.99-3.92 (2H, m, H-5), 3.36-3.31 (2H, m,
H-4), 2.47 (3H, s, H-9), 1.94-1.81 (4H, m, H-2, H-3), 1.43 and 1.39 (9H, two s without
baseline separation, H-6). Data comparable to that reported in the literature.279
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Boc-L-proline, N-hydroxysuccinimide ester 3.38
To a stirred solution of Boc-L-proline (0.38 g, 1.74 mmol, 1.0 eq.) and N-hydroxysucc-
inimide (0.20 g, 1.74 mmol, 1.0 eq.) in CH2Cl2 (17 mL, 0.1 M) under inert atmosphere
at 0 °C was added DCC (0.36 g, 1.74 mmol, 1.0 eq.). The mixture was stirred, com-
ing to room temperature, overnight. The mixture was filtered to remove the white
precipitate and the filtrate was concentrated to a volume of 5 mL under reduced
pressure. The filtrate was cooled to 4 °C for three hours. The resulting white pre-
cipitate was again removed by filtration. The filtrate was evaporated to dryness un-
der reduced pressure affording Boc-L-proline N-hydroxysuccinimide ester as a white
powder (0.36 g, 1.15 mmol, 66%). MP 134-136 °C. 1H NMR (500 MHz, DMSO-d6): δ
4.58 (1H, dd, J = 8.9, 3.6 Hz, H-1), 3.43-3.37 (1H, m, H-4a), 3.36-3.34 (1H, m, H-4b),
2.83-2.77 (4H, m, H-6), 2.45-2.37 (1H, m, H-2a), 2.09-2.04 (1H, m, H-2b), 1.95-1.84 (2H,
m, H-3), 1.40 (9H, two s without baseline separation, H-6).
Boc-Pro-Pca-OMe 3.54
A stirred solution of 4-amino[2.2]paracyclophane (85 mg, 0.30 mmol, 1.0 eq.) and
Boc-L-proline N-hydroxysuccinimide ester (104 mg, 0.33 mmol, 1.1 eq.) in CH2Cl2
(12 mL, 0.025 M) under inert atmosphere was heated at reflux for 3 days. The sol-
vent was removed under reduced pressure. The residue was purified by column
chromatography and elution with a gradient of hexane:EtOAc 10:1 to 3:1 affording
the Boc-Pro-Pca-OMe as a pale yellow oily solid (87 mg, 0.18 mmol, 60%). Rf (2:1
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hexane:EtOAc) 0.37. 1H NMR (500 MHz, CDCl3): δ 7.31-7.29 (1H, m, H-12), 7.23
(1H, d, J = 1.9 Hz, H-5), 6.71 (1H, dd, J = 7.7, 1.9 Hz, H-16), 6.45 (1H, d, J = 7.7 Hz,
H-15), 6.39 (1H, d, J = 7.7, Hz, H-8), 6.23 (1H, dd, J = 7.7, 1.6 Hz, H-7), 4.51-4.36 (2H,
m, H-21) 4.27 (1H, ddd, J = 13.5, 9.8, 5.1 Hz, H-1b), 3.91 (3H, s, H-23), 3.22 (2H, ddd,
J = 13.7, 10.2, 3.2 Hz, H-1a, H-2b), 3.08-2.98 (5H, m, H-9, H-10, H-18), 2.95 (2H, dd,
J = 7.9, 6.4 Hz, H-19), 2.83 (2H, ddd, J = 14.0, 10.7, 5.1 Hz, H-2a), 1.52 (9H, s, H-22),
1.28 (2H, dd, J = 8.2, 6.6 Hz, H-20). 13C NMR (125 MHz, CDCl3): δ 169.4 (C=O),
164.5 (C=O), 163.5 (C=O), 141.8 (C), 140.7 (C), 138.9 (C), 136.2 (CH), 136.0 (C), 135.5
(CH), 134.9 (CH), 133.6 (CH), 127.6 (C), 125.4 (C), 123.6 (CH), 121.7 (CH), 80.6 (C),
60.4 (CH), 51.8 (CH3), 47.0 (CH2), 34.8 (CH2), 34.7 (CH2), 34.7 (CH2), 32.1 (CH2), 31.7
(CH2), 31.5 (CH2), 28.5 (3 CH3). HRMS (ESI) found: [M + H]+ 479.2537. C28H35N2O5
requires [M + H]+ 479.2540.
Boc-Pro-Pca 3.57
Boc-Pro-Pca-OMe (0.13 g, 0.27 mmol, 1.0 eq.) was dissolved in EtOH (2.5 mL, 0.1
M) then ground KOH (0.61 g, 10.8 mmol, 40 eq.) was added and the solution was
stirred overnight at room temperature. The mixture was neutralised with 2 M HCl
(approx. 3 mL). The aqueous layer was extracted with EtOAc (3 x 5 mL). The com-
bined organics were dried (MgSO4), and the solvent was removed under reduced
pressure. The residue was purified by column chromatography and elution with
19:1 CH2Cl2/MeOH affording the product as an oily yellow solid (70 mg, 0.15 mmol,
55%). Rf (19:1 CH2Cl2/MeOH) 0.23. 1H NMR (500 MHz, DMSO-d6): δ 8.81 and 8.40
(1H, s, H-17), 7.11 (1H, s, H-12), 6.91 and 6.76 (1H, s, H-5), 6.72-6.70 (1H, m, H-16),
6.58-6.51 (2H, m, H-15, H-8), 6.41 (1H, dd, J = 7.7, 1.1 Hz, H-7), 4.54-4.50 (1H, m, H-
18), 4.39-4.35 (1H, m, H-2b), 3.51-3.47 (1H, m, H-2a), 3.08-3.06 (2H, m, H-21), 2.97-2.94
(5H, m, H-1b, H-9, H-10), 2.81-2.77 (2H, m, H-19), 2.25-2.20 (1H, m, H-1a), 1.92-1.82
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(2H, m, H-20), 1.45 (9H, s, H-22). 13C NMR (125 MHz, CDCl3): δ 170.4 (C=O), 169.6
(C=O), 156.7 (C=O), 143.2 (C), 140.7 (C), 140.4 (C), 137.3 (C), 136.7 (CH), 136.4 (CH),
135.8 (CH), 134.6 (CH), 134.5 (C), 129.2 (CH), 127.8 (C), 125.5 (CH), 81.3 (C), 61.2
(CH), 47.3 (CH) 39.0 (CH), 34.6 (CH), 31.0 (CH), 30.9 (CH), 29.8 (CH), 28.7 (CH), 25.3
(3 CH3), 24.5. As described above for other amide bond-containing compounds (e.g.
for Boc-Pro-Gly-Pca), this compound exhibits peak broadening in the1H NMR spec-
trum that disguises certain J-couplings as well as twinned peaks for certain protons.
HRMS (ESI) found: [M + H]+ 463.2236. C27H31N2O5 requires [M + H]+ 463.2227.
Pro-Pca 3.7
To a stirred solution of Boc-Pro-Pca (25 mg, 0.054 mmol, 1.0 eq.) in CH2Cl2 (0.75 mL)
at 0 °C was added TFA (0.25 mL, 0.2 M total). The mixture was stirred at 0 °C for
90 minutes then the solvent was removed under reduced pressure affording Pro-Pca
as an oily yellow solid (18 mg, 0.049 mmol, 91%). Rf (19:1 CH2Cl2/MeOH) 0.13. 1H
NMR (500 MHz, DMSO-d6): δ 9.44 (1H, s, br, NH), 9.33 (1H, s, OH), 8.61 (1H, s, br,
H-17), 7.13 (1H, d, J = 1.4 Hz, H-12), 7.06 (1H, d, J = 1.1 Hz, H-5), 6.77 (1H, dd, J =
7.6, 1.3 Hz, H-16), 6.62 (1H, d, J = 4.2 Hz, H-15), 6.60 (1H, d, J = 4.3 Hz, H-8), 6.44
(1H, dd, J = 7.7, 1.1 Hz, H-7), 4.41-4.36 (1H, m, H-18), 4.10 (1H, ddd, J = 12.4, 9.4,
2.9 Hz, H-2b), 3.48-3.43 (1H, m, H-1b), 3.31-3.26 (2H, m, H-21), 3.15-3.10 (1H, m, H-
2a), 2.99-2.83 (5H, m, H-1a, H-9, H-10), 2.47-2.40 (1H, m, H-19a), 2.19 (1H, sextet, J
= 7.1 Hz, H-19b), 2.03 (1H, sextet, J = 6.4 Hz, H-20a), 1.99-1.92 (1H, m, H-20b). 13C
NMR (125 MHz, DMSO-d6): δ 168.4 (C=O), 166.6 (C=O), 142.6 (C), 140.3 (C), 139.3
(C), 137.1 (C), 136.7 (CH), 136.4 (CH), 135.3 (CH), 134.6 (CH), 130.2 (CH), 129.6 (C),
128.9 (C), 124.7 (CH), 60.2 (CH), 46.2 (CH2), 34.9 (CH2), 34.7 (CH2), 33.9 (CH2), 31.7
(CH2), 29.5 (CH2), 24.2 (CH2). HRMS (ESI) found: [M + H]+ 365.1852. C22H25N2O3
requires [M + H]+ 365.1860.
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4-N-Boc-Pro-amino[2.2]paracyclophane 3.53
A stirred solution of 4-amino[2.2]paracyclophane (0.27 g, 1.21 mmol, 1.0 eq.) and
Boc-L-proline N-hydroxysuccinimide ester (0.42 g, 1.33 mmol, 1.1 eq.) in CH2Cl2 (48
mL, 0.025 M) was heated at reflux for 3 days under inert atmosphere. The solvent
was removed under reduced pressure. The residue was purified by column chro-
matography and elution with CH2Cl2 affording the 4-N-Boc-Pro-amino[2.2]paracyclophane
as a pale yellow solid (0.39 g, 0.93 mmol, 70%). Rf (19:1 CH2Cl2/MeOH) 0.77. MS
(ESI) found: [M + H]+ 419.21. C26H33N2O3 requires [M + H]+ 419.26. Further data
was not available as the NMR spectra are too complicated to interpret. The mate-
rial’s identity is confirmed by the characterisation of the following compound.
4-N-Pro-amino[2.2]paracyclophane 3.61
To a stirred solution of 4-N-Boc-Pro-amino[2.2]paracyclophane (0.244 g, 0.58 mmol,
1.0 eq.) in CH2Cl2 (4.35 mL) at 0 °C was added TFA (1.45 mL, 0.2 M total). The mix-
ture was stirred at 0 °C for two hours then the solvent removed under reduced pres-
sure. The residue was purified by flash column eluting 19:1 CH2Cl2/MeOH afford-
ing 4-N-Pro-amino[2.2]paracyclophane as an oily yellow solid (0.13 g, 0.41 mmol,
70%). Rf (19:1 CH2Cl2/MeOH) 0.17. 1H NMR (500 MHz, DMSO-d6): δ 9.93 and 9.83
(1H, s, H-17), 6.85-6.84 (1H, m, H-8), 6.69 and 6.66 (1H, dd, J = 7.8, 1.6 Hz, H-7),
6.53 and 6.52 (1H, d, J = 2.2 Hz, H-5), 6.45-6.38 (4H, m, H-12, H-13, H-15, H-16),
4.06-4.03 (1H, m, H-18), 3.92 (1h, ddd, J = 14.7, 8.9, 5.7 Hz, H-2b), 3.37-3.28 (3H, m,
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H-21, H-20a), 3.15-3.09 (1H, m, H-20b), 2.99-2.98 (2H, m, H-9), 2.92-2.83 (2H, m, H-
10), 2.77-2.74 (1H, m, H-2a), 2.24-2.12 (1H, m, H-19a), 1.87-1.77 (3H, m, H-1, H-19b).
As described above for other amide bond-containing compounds (e.g. for Boc-Pro-
Gly-Pca), this compound exhibits peak broadening in the 1H NMR spectrum that
disguises certain J-couplings as well as twinned peaks for certain protons. Twinned
peaks are also present in the 13C NMR spectrum. 13C NMR (125 MHz, DMSO-d6):
δ 174.87 and 174.48 (C=O), 153.96 and 153.59 (C), 140.81 and 140.79 (C), 139.31 and
139.24 (C), 139.11 and 138.99 (C), 135.37 and 135.32 (CH), 133.56 and 133.53 (CH),
133.43 and 133.40 (CH), 132.35 and 132.31 (CH), 130.55 and 130.49 (CH), 128.71 and
128.65 (C), 128.49 and 128.45 (CH), 126.30 and 126.24 (CH), 70.25 (CH), 61.05 and
60.90 (CH2), 47.08 and 47.02 (CH2), 35.17 and 34.98 (CH2), 33.71 and 33.53 (CH2),
29.87 (CH2), 25.96 (CH2), 24.33 (CH2). MS (ESI) found: [M + H]+ 321.24. C21H25N2O
requires [M + H]+ 321.20.
5.2.5 Michael addition
Protocol for Michael reaction of trans-β-nitrostyrene and hexanal
A stock solution was prepared with trans-β-nitrostyrene (0.746 g, 5.0 mmol, 1.0 eq)
and NMM (0.051 g, 0.50 mmol, 0.1 eq) in 9:1 CH3Cl/i-PrOH (10 mL, 0.5 M). In a
typical experiment, 0.2 mL stock solution was added to a 1.5 mL vial, along with 1.5
eq. hexanal (18 µL, 0.15 mmol) and 28 µL of a solution of the chosen catalyst (0.37
M, 0.05 eq, 5 µM) in DMSO. The mixture was allowed to stand at room temperature
for 48 hours, then at 60 °C for 48 hours. The reaction mixture was quenched by
the addition of 0.2 mL water. The layers were separated, and the aqueous layer
was extracted twice with EtOAc. Combined organics were dried (MgSO4) and the
solvent was removed under reduced pressure. The crude product was analysed
without further purification.
For HPLC analysis, 2 mg of the residue was dissolved in 1 mL of 4:1 hexane/i-PrOH
in a 1.5 mL glass vial with screw-lid cap fitted with a rubber septum. HPLC was
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performed on an OD-H 25 cm column eluting 4:1 hexane/i-PrOH at 1 mL/min at 25
°C for 30 minutes.
5.2.6 2-Butyl-4-nitro-3-phenylbutanal 5.13
This compound was prepared according to the general procedure described above.
The residue was separated by column chromatography and elution with 9:1 hex-
ane:EtOAc affording the (2S,3R)-2-butyl-4-nitro-3-phenylbutanal as an oily yellow
solid. Rf (7:1 hexane:EtOAc) 0.35. 1H NMR (500 MHz, CDCl3): δ 9.72 (1H, d, J =
2.8 Hz, H-1), 7.38-7.29 (3H, m, H-9, H-11), 7.20-7.19 (2H, m, H-10), 4.73 (1H, dd, J =
12.8, 5.1 Hz, H-4), 4.66 (1H, dd, J = 12.8, 9.7 Hz, H-3), 3.80 (1H, ddd, J = 9.7, 9.7, 4.9
Hz, H-2), 2.72 (1H, tdd, J = 3.5, 9.4, 3.1 Hz, H-5), 1.35-1.11 (4H, m, H-6, H-7), 0.80
(3H, dt, J = 7.0 Hz, H-8). 13C NMR (125 MHz, CDCl3): δ 203.39 (C=O), 136.84 (C),
129.10 (2 CH), 128.24 (2 CH), 128.13 (CH), 78.45 (CH2), 53.88 (CH), 43.12 (CH), 28.51
(CH2), 25.25 (CH2), 22.48 (CH2), 13.63 (CH3). HRMS (ESI) found: [M - H]- 248.1423.
C14H18NO3 requires [M - H]- 248.1287.
The diastereomeric ratio was determined by 1H NMR. δ 9.72 (syn), 9.49 (anti) (CHO).
The enantiomeric ratio was determined by HPLC with an OD-H column eluting 4:1
hexane/i-PrOH at 25 °C at 1 ml/min, UV detection at 254 nm. Rt (syn, major) = 10.8
min, (syn, minor) 13.2 min. Data comparable to that reported in the literature.221,285
Sulfide 4.9, methyl ester
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To a stirred solution of methyl 4-[(3-bromo-1-oxoethyl)amino][2.2]paracyclophane-
13-carboxylate (0.19 g, 0.46 mmol, 1.0 eq.) in DMF (1.5 mL, 0.3 M) under inert at-
mosphere was added K2CO3 (0.13 g, 2.0 eq.) and BuSH (60 µL, 0.55 mmol, 1.2 eq.),
and the mixture was stirred at 60 °C overnight. The mixture was allowed to cool to
room temperature then EtOAc (25 mL) was added. The organic layer was washed
successively with water (2 x 25 mL), brine (25 mL), and sat. aq. Na2CO3, then dried
(MgSO4) and the solvent removed under reduced pressure. The resulting residue
was separated by column chromatography eluting a gradient of hexane:EtOAc 4:1
to 1:1 to afford the sulfide 4.9 as a pale yellow solid (0.10 mg, 0.24 mmol, 48%). Rf
(4:1 hexane:EtOAc) 0.14. 1H NMR (500 MHz, CDCl3): δ 8.59 (1H, s, NH), 7.23 (1H,
d, J = 1.5 Hz, H-5), 6.81 (1H, s, H-12), 6.70 (1H, dd, J = 7.6, 1.3 Hz, H-7), 6.58 (1H,
d, J = 7.8 Hz, H-8), 6.54 (1H, d, J = 7.8 Hz, H-15), 6.46 (1H, dd, J = 7.8, 1.3 Hz, H-
16), 4.16 (1H, ddd, J = 13.3, 9.7, 3.8 Hz, H-2b), 3.88 (3H, s, CH3), 3.68 (2H, s, H-17),
3.16-2.90 (7H, m, H-1, H-2a, H-9, H-10), 2.67-2.61 (2H, m, H-18), 1.67-1.60 (2H, m,
H-19), 1.48-1.40 (2H, m, H-20), 0.93 (3H, J = 7.4 Hz, H-21). HRMS (ESI) found: [M+
H]+ 412.1898. C24H30NO3S requires [M+ H]+ 412.1941. Material was of insufficient
quality for further characterisation.
Sulfide 4.10
To a stirred solution of sulfide 4.9 (0.17 g, 0.41 mmol, 1.0 eq.) in EtOH (2 mL, 0.2
M) was added ground KOH (0.22 g, 8.6 mmol, 20 eq) and the solution was stirred
overnight at room temperature. The mixture was neutralised with 2 M HCl (ap-
prox. 3 mL). The aqueous layer was extracted with EtOAc (3 x 5 mL). The combined
organics were washed with brine (15 mL), then dried (MgSO4) and the solvent re-
moved under reduced pressure affording the sulfide 4.10 as a yellow solid (0.13 g,
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0.33 mmol, 80%). Rf (19:1 CH2Cl2/MeOH) 0.42. 1H NMR (500 MHz, CDCl3): δ 8.82
(1H, s, NH), 7.38 (1H, d, J = 1.2 Hz, H-5), 6.90 (1H, s, H-12), 6.77 (1H, dd, J = 7.8, 1.4
Hz, H-7), 6.60 (1H, d, J = 7.7 Hz, H-8), 6.58 (1H, d, J = 8.0 Hz, H-15), 6.49 (1H, dd, J =
7.8, 1.1 Hz, H-16), 4.32 (1H, ddd, J = 13.0, 9.8, 3.3 Hz, H-2b), 3.18-2.98 (2H, m, H-17),
3.20-3.02 (6H, m, H-1, H-9, H-10), 2.76-2.72 (2H, m, H-18), 2.57 (1H, t, J = 7.4 Hz,
H-2a), 1.57 (2H, quint., J = 7.4 Hz, H-19), 1.38 (2H, sextet, 7.4 Hz, H-20), 0.89 (3H, t,
J = 7.3 Hz, H-21). HRMS (ESI) found: [M+ H]+ 398.1782. C23H28NO3S requires [M+
H]+ 398.1785. Material was of insufficient quality for further characterisation.
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paracyclophanes: from synthetic curiosity to applications in asymmetric syn-
thesis and materials. Chemical Society Reviews 2018, 47, 6947–6963.
232 Bibliography
(8) Wang, Y.; Zhao, C.-Y.; Wang, Y.-P.; Zheng, W.-H. Enantioselective Intramolec-
ular Dearomative Lactonization of Naphthols Catalyzed by Planar Chiral
Iodoarene. Synthesis 2019, 51, 3675–3682.
(9) Xie, E.; Huang, S.; Lin, X. Design of Planar Chiral Phosphoric Acids with a
[2.2]Paracyclophanyl Backbone as Organocatalysts for the Highly Enantiose-
lective Aza-Friedel–Crafts Reaction. Organic Letters 2019, 21, 3682–3686.
(10) Hopf, H. [2.2]Paracyclophanes in Polymer Chemistry and Materials Science.
Angewandte Chemie International Edition 2008, 47, 9808–9812.
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(73) Barišić, L.; Čakić, M.; Mahmoud, K. A.; Liu, Y.-n.; Kraatz, H.-B.; Pritzkow, H.;
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M.-O.; Wennemers, H. Conformational Properties of a Peptidic Catalyst: In-
sights from NMR Spectroscopic Studies. Journal of the American Chemical Soci-
ety 2018, 140, 10829–10838.
246 Bibliography
(148) Duschmale, J.; Kohrt, S.; Wennemers, H. Peptide catalysis in aqueous emul-
sions. Chemical Communications 2014, 50, 8109–8112.
(149) Darbre, T.; Reymond, J.-L. Peptide Dendrimers as Artificial Enzymes, Recep-
tors, and Drug-Delivery Agents. Accounts of Chemical Research 2006, 39, 925–
934.
(150) Douat-Casassus, C.; Darbre, T.; Reymond, J.-L. Selective Catalysis with Pep-
tide Dendrimers. Journal of the American Chemical Society 2004, 126, 7817–7826.
(151) Wende, R. C.; Seitz, A.; Niedek, D.; Schuler, S. M. M.; Hofmann, C.; Becker,
J.; Schreiner, P. R. The Enantioselective Dakin–West Reaction. Angewandte
Chemie International Edition 2016, 55, 2719–2723.
(152) Müller, C. E.; Zell, D.; Hrdina, R.; Wende, R. C.; Wanka, L.; Schuler, S. M. M.;
Schreiner, P. R. Lipophilic Oligopeptides for Chemo- and Enantioselective
Acyl Transfer Reactions onto Alcohols. Journal of Organic Chemistry 2013, 78,
8465–8484.
(153) Hrdina, R.; Müller, C. E.; Schreiner, P. R. Kinetic resolution of trans-cycloalkane-
1,2-diols via Steglich esterification. Chemical Communications 2010, 46, 2689–
2690.
(154) Dalla-Vechia, L.; Santos, V. G.; Godoi, M. N.; Cantillo, D.; Kappe, C. O.; Eber-
lin, M. N.; de Souza, R. O. M. A.; Miranda, L. S. M. On the mechanism of the
Dakin–West reaction. Organic & Biomolecular Chemistry 2012, 10, 9013–9020.
(155) Hofmann, C.; Schuler, S. M. M.; Wende, R. C.; Schreiner, P. R. En route to
multicatalysis: kinetic resolution of trans-cycloalkane-1,2-diols via oxidative
esterification. Chemical Communications 2014, 50, 1221–1223.
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